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ABSTRACT
It has been reported that fructose is rapidly converted to 
lactate by the liver. The only regulatory enzyme involved in this 
conversion is L-type pyruvate kinase. Thus the effects of fructose 
and other related substrates which enter the glycolytic sequence at 
the triose phosphate level are of physiological importance.
Incubation of isolated hepatocytes with fructose at high con­
centrations and with glycerol caused an apparent inhibition of py­
ruvate kinase. This inhibition was correlated to the depletion of 
ATP caused by these substrates since dihydroxyacetone and ^-glyceral- 
dehyde did not affect the enzyme activity. When hepatocytes were 
washed with fresh medium after the incubation, but before the extrac­
tion of enzyme, fructose, dihydroxyacetone and D-glyceraldehyde all 
caused stimulation whereas glycerol was without effect. This stimu­
lation correlated closely with the increase in concentrations of 
fructose-1, 6-bisphosphate and/or fructose-l-phosphate within the 
hepatocytes.
The accumulation of inhibitor(s) in the extrahepatocyte medium 
in response to fructose, prevented the stimulation of the enzyme by 
fructose-1, 6-bisphosphate which occurs despite the large dilution 
of the cellular contents during the extraction and assay procedure.
It was found that the accumulation of two inhibitors of pyruvate 
kinase could explain the effect of fructose on hepatocyte pyruvate 
kinase activity. These are alanine, a known inhibitor of the enzyme, 
and allantoin.
The regulation of the intracellular pyruvate kinase was examined 
by estimating glycolytic flux from the accumulation of lactate and 
pyruvate. The glycolytic flux from fructose exceeded that from other
substrates despite the inhibition of pyruvate kinase described above.
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Glycolysis from dihydroxyacetone although initially rapid, was much 
slower than from fructose whereas glycerol and other reduced sub­
strates caused an inhibition of glycolysis probably as a result of 
an increase in the (NADH)/(NAD^) ratio. The rapid glycolysis from 
fructose can be explained by the accumulation of fructose-1, 6-bisphos­
phate and fructose-l-phosphate, causing a stimulation of pyruvate 
kinase and a depletion of ATP, relieving the inhibition of the enzyme. 
Changes in hepatocyte phosphoenolpyruvate concentrations correlate 
well with the rates of glycolysis observed.
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ADP Adenosine 5 '-diphosphate
AMP Adenosine 5 '-monophosphate
ATP Adenosine 5 '-triphosphate
BSA Bovine serum albumin
cAMP Adenosine 3' '5'-phosphate
DHAP Dihydroxyacetone phosphate
EDTA Ethylenediaminetetra-acetate
EGTA Ethyleneglycolbis-(aminoethylether)tetra-acetate
FFA Free fatty acid
Fru-l-P Fructose-l-phosphate
Fru-6-P Fructose-6-phosphate
FrUj^BP Fructose-1, 6-bisphosphate
Fruz^BP Fructose-2, 6-bisphosphate
Fru^^BPase Fructose-1, 6-bisphosphatase
G3P Glycerol-3-phosphate
Glu-6-P Glucose-6-phosphate
Glu-6-Pase Glucose-6-phosphatase
IMP Inosine 5'-phosphate
KRB Krebs-Ringer bicarbonate
LDH Lactate dehydrogenase
NAD"^ Nicotinamide-adenine dinucleotide (oxidized)
NADH Nicotinamide-adenine dinucleotide (reduced)
Pi Orthophosphate (inorganic)
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PFK 1 Phosphofructokinase 1
PFK 2 Phosphofructokinase 2
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INTRODUCTION
The first indication of the potential toxicity of fructose was
considered when intravenous injection of a high fructose dose 
was found to cause hyperuricemia (Peheentupa & Raivo, 1967) and lactic 
acidosis (BergstrUm et al., 1968) in normal humans. The noxious in­
fluence of excess dietary consumption of fructose was also suspected 
when it was shown that in experimental animals and in human subjects, 
plasma triglyceride levels are raised by this ketose (NikkilM, 1969).
The hepatic metabolism of fructose is different " ^ h a t  of 
glucose in several important respects. However, the glycolysis of both 
these substrates involve a common regulatory enzyme, pyruvate kinase. 
Indeed, pyruvate kinase is the only regulatory enzyme in the glycolysis 
of fructose to lactate. The activity of this enzyme in the liver is 
under hormonal and dietary regulation (Seubert & Schoner, 1971). In 
the present study the activity of pyruvate kinase in isolated hepato­
cytes is studied under various conditions which allow investigation of 
the regulation of the enzyme by fructose and other related substrates. 
This thesis reports on the metabolic effects of various substrates and 
investigates the metabolic regulation of pyruvate kinase vivo.
I. CARBOHYDRATE METABOLISM
A MEDICAL INTEREST IN FRUCTOSE METABOLISM
Several reports in the literature indicate that the nature of 
dietary carbohydrate is a contributory factor in the causation of 
human diseases (Grande, 1967; Burke, 1971; Yudkin, 1971; NikkilU, 1974) 
It has been repeatedly shown that when part or all of the starch in the 
diet of experimental animals or man is replaced with sucrose, plasma 
triglyceride and cholesterol levels increase (Bender & Damji, 1971; 
Macdonald, 1971; Naismith, 1971). Since starch and sucrose are composed 
of different carbohydrates, the suggestionsput forward to explain these
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observations were that either the fructose component of the sucrose 
molecule might be more readily converted to lipids than is glucose 
derived from starch, or that sucrose was more rapidly digested and 
absorbed and this would result in a higher concentration of mono­
saccharides entering the liver after a sucrose load, which in turn 
would lead to changes in the activity of the enzymes responsible for 
the conversion of monosaccharides to lipids.
The mechanisms by which fructose causes medical problems are 
manifold. For example,the role of this ketose in the causation of 
coronary disease may be due to an alteration in the circulating hormo­
nes and in the enzyme patterns that determine the metabolic rates 
(Yudkin, 1971).
Oral administration of fructose has also been shown to cause
elevation of serum uric acid levels (Stf:ipe e_t al^., 1970; Emmerson, 1974)
in normal human subjects. In patients with gout and in their healthy
children, a more pronounced and prolonged effect of fructose on the
serum level of uric acid has been reported (Stt*pe et al., 1970). This 
hyperuricémie effect of fructose is also observed in higher apes which 
like humans lack the capacity to oxidize uric acid (Simkin, 1972).
Thus, from this evidence it is clear that fructose, unlike glu­
cose, may cause various diseases presumably because of the nature of 
its metabolism. However, it should be noted that dietary sucrose (and 
therefore fructose) is not the sole or the major cause of these disea­
ses, since for example,cigarette smoking and physical inactivity are 
also involved in the causation of coronary diseases.
B. FATE OF DIETARY CARBOHYDRATES
Dietary carbohydrates are absorbed into the blood stream as mono­
saccharides which means that their initial hydrolysis plays a major 
role in their metabolism. Higher molecular weight starches are 
hydrolysed by o-amylase, an enzyme present in the saliva, while the
- 14 -
disaccharides and oligosaccharides are split into glucose, 
fructose and other related monosaccharides by enzymes located in 
the mucosal cells (Widdas, 1971).
The simple sugars are absorbed across the brush border of the 
mucosal cells. Glucose and galactose are actively absorbed by a 
carrier mechanism which utilizes the existing Na^ gradient into the 
cell and which is therefore indirectly dependent on the cellular me­
tabolism (Crane, 1968). In rat and man fructose is absorbed across 
the intestinal epithelial cells by a mechanism which may not involve 
active transport (Crane, 1960; Herman, 1974). However, this is not 
a simple passive diffusion of the ketose since its transport in rat 
small intestine is a saturable rate-limiting process (Cuy & Deren, 
1971; Cracey e_^  a^., 1972; Sigrist-Nelson & Hopfer, 1974). Evidence 
for a distinct transport system of D-fructose in humans came from 
studies on patients with malabsorption symptoms, where it was obser­
ved that patients with glucose-galactose malabsorption were able to 
absorb fructose at a normal rate (Dahlqvist (1974).
C. GLUCOSE METABOLISM
Glucose is a major metabolic fuel utilized by most tissues.
The blood glucose level in the fasting human adult ranges from 3 to 
6 mM (Bold & Wilding, 1975), and is under hormonal and dietary re­
gulation. Excess glucose can be stored as glycogen in the liver or 
as triglycerides in the adipose tissue (Newsholme & Start, 1976). The 
relative constancy of blood glucose levels despite various disturbing 
factors is an example of homeostatic regulation.
The entry of blood glucose into the tissue Glu-6-P pool(s) may 
be controlled by many factors such as, the permeability of the tissue 
to glucose, the type(s) of hexokinase present in the tissue, the inhi­
bition of hexokinase by Glu—6-P, the availability of ATP and the rate 
of supply of glucose to the tissue. Skeletal muscle and heart are not 
freely permeable to glucose and require the presence of insulin for
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maximal glucose transport (Scrutton & Utter, 1968), whereas trans­
port through the blood-brain barrier is insulin independent (Bachelard, 
1970; Pardridge & Oldendorf, 1977; Sokoloff et al.,1977) and may be 
governed by the metabolic rate of glucose since brain hexokinase is 
inhibited by Glu-6-P (Wilson, 1980).
Liver provides a different aspect of glucose uptake because 
this organ has been reported to be freely permeable to the inward 
and outward flow of glucose (Cahill ^1958a). However, experiments 
using liver slices indicated that insulin is necessary for proper uti­
lization of glucose by the liver (Spiro ej^  , 1958), and furthermore, 
Cahill e_t al., (1958b) and Spiro (1959) reported that uptake of this 
hexose by liver slices is highly concentration dependent. The concen­
tration dependency of glucose uptake by liver cells was also observed 
using perfused liver (Williams et al., 1968) and isolated hepatocytes 
(Baur & Heldt, 1976). The hexokinase present in hepatocytes is gluco- 
kinase (E.C. 2.7.1.2) (Crisp & Pogson, 1972), an enzyme which differs 
from brain and muscle hexokinase in several aspects (Purich et al., 
1973). Hepatic glucokinase is under hormonal and dietary control (Salas 
et al., 1963; Sharma et al., 1963; Walker & Rao, 1964; Pilkis, 1970; 
Niemeyer e_t a_l., 1975; Weinhouse, 1976). The most important feature 
of glucokinase is possibly its high for glucose (about 10 mM) which 
enables the liver to respond to changes in blood glucose level in the 
physiological range (Di Pietro & Weinhouse, 1960; Walker, 1963; Vinuela 
et al., 1963) .
1. Glycolysis - Gluconeogenesis
The liver is thought to be the major gluconeogenic tissue in 
fasted animals (Scrutton & Utter, 1968). In fed animals gluconeogenesis 
is inhibited and glycolysis may predominate. The glycolytic enzymes 
occur exclusively in the cytoplasm whereas part of the gluconeogenic 
pathway involves the mitochondria. However, since flux through both 
of these pathways can occur within the same cell, a precise control 
of the regulatory enzymes is of great importance.
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Figure 1. Hepatic glycolysis and gluconeogenesis
1. glucokinase
2. glucose phosphate isomerase
3. phosphofructokinase 1
4. phosphofructokinase 2 
5* aldolase
6. triose phosphate isomerase
7. glyceraldehyde-3-phosphate dehydrogenase
8. phosphoglycerate kinase
9. phosphoglycerorautase
10. enolase
11. pyruvate kinase
12. lactate dehydrogenase
13. pyruvate carboxylase
14. phosphoenolpyruvate carboxy. 
kinase
15. fructose-1,6-bisphosphatase
16. glucose-6-phosphatase
17. fructose-2,6-bisphosphatase
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The glycolytic pathway common to both glycogen and glucose 
starts at the Glu-6-P crossroads and ends as pyruvate and lactate.
The reaction sequence between glucose and pyruvate is catalysed by a 
group of ten enzymes which are thought to have no physical dependence 
on each other, i.e. they appear not to be associated into a stable 
multienzyme complex. There are two major stages of glycolysis. The 
first stage serves as a preparatory or collection phase, in which a 
number of different hexoses after phosphorylation by ATP enter the 
glycolytic sequence and are converted into a common product glyceral- 
dehyde-3-phosphate. In this stage, two ATP molecules are expended to 
phosphorylate the 1 and 6 positionsof glucose. The second stage of 
glycolysis is the common pathway for all sugars. This involves the 
oxidoreduction steps and the energy conserving mechanisms by which 
ADP is phosphorylated to ATP. In this second stage four molecules 
of ATP are formed, so that the net yield is two molecules of ATP 
per molecule of glucose degraded to pyruvate.
The key glycolytic enzymes are phosphofructokinase 1 (E.C.2.7.1. 
11) which catalyses the phosphorylation of Fru-6-P by ATP to Fru^^BP, 
and pyruvate kinase (E.C. 2.7.1.40) which catalyses the formation of 
pyruvate from PEP with the production of one ATP molecule (figure 1). 
The reactionïcatalysed by these two enzymes are irreversible under 
physiological conditions and their precise control affects the flow 
of glycolysis. The other enzymes catalyse reversible steps and are 
also involved in gluconeogenesis.
Gluconeogenesis is the process whereby lactate, pyruvate and 
certain amino acids are converted to glucose and glycogen. The meaning 
of this term has been expanded to include synthesis of glucose from 
fructose (Exton & Park, 1967; Vernon e^ £l., 1968; Assimacopoulos- 
Jeannet et al., 1973). The liver is the major site of gluconeogenesis, 
although the kidney becomes important during prolonged starvation. The 
most important function of gluconeogenesis is the maintenance of blood 
glucose levels when food intake is restricted and/or glycogen stores 
are depleted.
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During gluconeogenesis lactate and most amino acids are con­
verted to pyruvate in the cytoplasm. Pyruvate enters the mitochon­
dria where it is converted to oxaloacetate by pyruvate carboxylase 
(E.C. 6.4.1.1) or to acetyl CoA by pyruvate dehydrogenase (E.C. 1.2. 
-4.1). The distribution of PEP carboxykinase (E.C.4.1.1.32) between 
the mitochondria and cytoplasm largely determines the fate of mito­
chondrial oxaloacetate (Tilghman, 1976). In chicken, pigeon and 
rabbit liver, this enzyme is in the mitochondria and thus oxaloace­
tate is directly converted to PEP which is then transported to the 
cytoplasm. In the rat liver PEP carboxykinase is located in the cyto­
plasm and thus oxaloacetate is first converted to malate and/or 
aspartate which are then transported to the cytoplasm where they can 
be reconverted to oxaloacetate. This complicated series of intercon­
versions is apparently necessary because the mitochondrial membrane 
is presumed to be impermeable to oxaloacetate. However, Gimpel et al., 
(1973) reported that oxaloacetate may be transported across the mito­
chondrial membrane in exchange for dicarboxylate or phosphate ions. 
Cytosolic PEP is then converted to glucose by a series of enzymes, 
some of which are common to both glycolysis and gluconeogenesis (figure 
1). The conversion of PEP to Fru^^BP is catalysed by a series of rever­
sible enzymes. The bisphosphate is converted to Fru-6-P by Fru^^BPase 
(E.C.3.1.3.11) and the resulting Fru-6-P is converted to Glu-6-P which 
in turn is dephosphorylated to glucose by Glu-6-Pase (E.C.3.1.3.9).
Glycolysis and gluconeogenesis have been reported to be under 
hormonal control. The pathways have opposite functions so that factors 
that stimulate one process inactivate the other. In the early 1960's 
it was reported that glucagon stimulates gluconeogenesis in the rat 
liver (Schiraassek & Mitzkat, 1963; Gracia e_t al^., 1964; Struck et al., 
1965; Exton & Park, 1966). Exton & Park (1966, 1969); postulated that 
the effect of glucagon in the perfused liver system was modulated by 
an increase in cAKP levels. The evidence for this was based on the fact 
that both glucagon and adrenaline caused a rapid elevation of cAMP 
levels, and also the concentration of hormone necessary to elicit the 
elevation of cAMP concentrations was similar to that needed to stimulate
- 19 -
gluconeogensLS. In addition, exogenous cAMP mimicked the effect of 
these hormones (Garrison & Haynes, 1973), Regulation of cAMP levels 
has also been used to explain the inhibitory effect of insulin on 
gluconeogenesis. Exton e£ a^.,(1971), reported that cAMP levels are 
lowered by insulin in perfused liver exposed to glucagon and adrena­
line. Similar effects have also been reported to occur in isolated 
hepatocytes (Pilkis al^., 1975; Claus & Pilkis, 1976). However, 
insulin does not suppress the effects of high concentrations of 
glucagon which is probably because the hepatic cyclic nucleotide 
concentrations had become so great that a reduction in its level 
by insulin was not apparent.
These observations are consistent with the concept of cAMP as the 
second messenger (Robison, ejt al^., 1971), According to this concept, 
the hormone is the first messenger which carries the relevant informa­
tion to the cell where it binds to specific hormone receptors. This 
event stimulates the conversion of ATP to cAMP by adenylate cyclase 
(E.C. 4.6.1.1). cAMP acts as the second messenger which transfers the 
information to the cell's enzymatic mechanisms.
While it appears that glucagon effects in the liver are mediated 
by cAZiP, recent evidence suggests that catecholamine effects may not 
involve cAMP. Adrenaline has been shown to stimulate gluconeogenesis 
by an a-adrenergic mechanism which is not associated with changes in 
the cAIlP levels (Sherline et al. ,1972; Tolbert e_t * 1973; Tolbert 
& Fain, 1974) and that catecholamine effects can be blocked by a-adren* 
ergic blocking agents such as phentolamine even though cAîlP levels 
remain unchanged. These observations were confirmed by Exton & Harper, 
(1975) and Cherrington al_., (1976), who showed that the a-effect 
of catecholamines in rat hepatocytes was not associated with an acti­
vation of cAMP dependent protein kinase. However, it is also possible 
that catecholamines activate gluconeogenesis in some species by a 
predominantly p-adrenergic mechanism and in some by an a-adrenergic 
mechanism.
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Calcium ions have also been shown to play an important role
in the regulation of gluconeogenesis in isolated hepatocytes (Kneer
2+
ejt a_l., 1979). These authors reported that Ca was required to 
enhance hormonal stimulation of gluconeogenesis from substrates that 
enter the gluconeogenic pathway prior to PEP and from reduced sub­
strates that enter at the triose phosphate or at the Fru-6-P stage, 
whereas extracellular Ca^* was not required to enhance the rate of
glucose production from the oxidised substrates that enter at the
2+
triose phosphate stage. Ca is also believed to mediate catechola­
mine effects, since activation of the a-adrenergic receptors has
2+
been associated with cytosolic Ca mobilization (Stubbs e_t al., 
1976; Assimacopoulos-Jeannet et al.,1977; Keppens et al., 1977;
Van de Werve e^ , 1977; Blackmore et al., 1978; Chen et al., 
1978), though some of thi 
(Blackmore et al., 1979).
s Ca^* may originate from the mitochondria
The other possible regulatory mechanism involved in achieving 
an unidirectional flow of metabolites is the regulation of a few 
key reactions. Between glucose and pyruvate there are three irrever­
sible steps which are; the interconversion of glucose and Glu-6-P 
which is catalysed by glucokinase and Glu-6-Pase; the interconversion 
between Fru-6-P and Fru^^BP where the action of PFK 1 is opposed by 
FrUj^^BPasejand at the level of pyruvate and PEP where PK is opposed 
to a multi-step conversion of pyruvate into PEP involving pyruvate 
carboxylase and PEP carboxykinase.
Therefore, if the antagonistic reactions operate simultaneously 
and at the same rate, there is no net flux of metabolites only a 
’futile' recycling of substrates. Such a cycling of substrates either 
between glucose and Glu-6-P or between Fru-6-P and Fru^^BP results 
in the apparently wasteful hydrolysis of ATP. However, the demonstra­
tion of the operation of such cycles makes it possible that these 
apparently 'futile' processes have a physiological role. For example, 
since these processes are characterised by energy dissipation, i.e. 
heat production, they were ascribed a possible role in the regulation
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of thermogenesis (Clark, M.G., et al.,1973; Newsholme, 1978).
Another useful function of cycling, particularly between Fru-6-P 
and Fru^^BP is that it might provide an amplification mechanism
for allosteric control of metabolic flow (Newsholme & Crabtree,
1976; Newsholme, 1978). Thus it seems logical not to dismiss these 
cycles as 'futile' and to use the term substrate cycles instead. 
Therefore the regulation of the three cycles occurring in the gly­
colytic/gluconeogenic pathways may change the direction of metabolic 
flow.
i) The glucose/glucose-6-phosphate substrate cycle
The operation of this cycle as well as its role in the regulation
of the glucose flux is of interest since Glu-6-P is located at a major
metabolic crossroads which involves synthesis and breakdown of glycogen, 
glycolysis, gluconeogenesis and the oxidative pentose phosphate path­
way. Glucose phosphorylation is catalysed by glucokinase, an enzyme 
found exclusively in the parenchymal cells (Crisp & Pogson, 1972), 
and the rate of phosphorylation is proportional to the extracellular 
glucose concentrations (Clark,D.G., e_t , 1973). The hydrolysis of 
Glu-6-P is catalysed by Glu-6-Pase which serves to produce glucose 
under hypoglycemic conditions. Glu-6-Pase is bound to microsomes (Hers 
et al., 1951) and has been purified for kinetic studies (Cori et al., 
1973). This enzyme is half-saturable between 2.0 and 7.0 mM Glu-6-P 
(Beaufay & de Duve,1954; Arion et al.^^-1972). _ The concentration of 
Glu-6-P in the liver is far below these values (Faupel e^ aT., 1972; 
Williamson & Brosnan, 1974; Hue & Hers, 1974) and therefore under most 
conditions the rate of Glu-6-P hydrolysis is a first order reaction re­
gulated by the substrate concentrations.
Although the activities of glucokinase and Glu-6-Pase do not 
appear to be sensitive to short-term regulation by hormones, their 
simultaneous operation may be important for the regulation of carbo­
hydrate metabolism, because this substrate cycle allows large changes 
in the net flux of carbon to be controlled by substrate concentration 
(Hue & Hers, 1974). Thus a small elevation in blood glucose level
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leads to a decrease in Glu-6-P concentration. The decrease in the 
level of this intermediate is attributed to an activation by glu­
cose of glycogen synthetase (E.C. 2.4.1.11) and increased incorpo­
ration into glycogen.
ii) The fructose-6-phosphate/fructose-l, 6-bisphosphate
substrate cycle
The enzymes involved in this cycle are Fru^^BPase and PFK 1 
whose activities are tightly regulated by allosteric control and, 
perhaps, by covalent modification of the enzyme molecule. Since the 
hexose-6-phosphates are located at a metabolic crossroads, a change 
in the activity of PFK 1 and/or Fru^^BPase determines whether the 
flux of carbon occurs in the direction of glycolysis or of gluco­
neogenesis.
A study of hepatic Fru^^BPase has revealed that this enzyme 
displays a K^ for Fru^^BP in the pmolar range (Taketa & Pogell, 1963; 
1965; Underwood & Newsholme, 1965; Tejwani e_t , 1976). The enzyme 
is inhibited by concentrations of substrate higher than 0.1 mM 
(Mendicino & Vasarhely, 1963; Taketa & Pogell, 1965; Underwood & 
Newsholme, 1965), but this probably has no physiological significance 
since the concentration of Fru^^BP in the liver, under physiological 
conditions ranges between 20 and 40 pM (Faupel et. * 1972; Williamson 
& Brosnan, 1974; Lawson e_t , 1976). There is also a good indication 
that the major part of Fru^^BP is bound to proteins and that the con­
centration of free bisphosphate could be as low as 1 pM (Sols & Marco, 
1970; Lawson e^ , 1976). The products of the reaction, i.e. Fru-6-P 
and Pi, are competitive inhibitors of the enzyme with K^ values of 
0.07 and 2.7 mM respectively (Dudman et al., 1978). These values are 
in the range of the concentrations usually found in the liver (Williamson 
& Brosnan, 1974). Therefore the decrease in Pi known to occur in the 
liver after a fructose load (Van den Berghe, 1978) could increase the 
activity of Fru^^BPase. The activity of Fru^^BPase is also subject to a 
multiplicity of metabolic controls(Horecker £ £  fJL* » 1975) including 
allosteric inhibition by AMP (Mendicino & Vasarhely, 1963; Taketa &
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Pogell, 1963; 1965; Underwood & Newsholme, 1965; Rosenberg et al., 
1973; Da^a et al., 1974; Nimrao & Tipton, 1975; Tejwani et al.,
1976; Riou e_t , 1977), and activated by a number of substances
such as histidine (Pogell al., 1968), chelators and fatty acids 
(Carlson e_t al. , 1973), Furthermore, Fru^^BPase is also inhibited 
by Fru^^BP (Van Schaftingen & Hers, 1981a) a metabolic product of 
PFK 2 (Van Schaftingen & Hers, 1981b; Furuya & Uyeda, 1981) (see 
also figure 1). The main characteristics of this inhibition are that 
it is much stronger at low than at high substrate concentrations, 
it changes the substrate saturation curve from almost hyperbolic to 
a sigmoidal curve and the inhibition is synergistic with the inhibi­
tion by AMP.
There is evidence to suggest that Fru^^BPase is phosphorylated 
by ATP Û 1 vitro in the presence of relatively high concentrations of 
a purified catalytic subunit of the cAMP-dependent protein kinase 
(Riou et al., 1977; Mendicino e_t , 1978). However, although in 
vivo studies have suggested that short-term treatment with hormones 
causes changes in the activity of Fru^^BPase (Greene et al.,1974; 
Stifel » 1974; Taunton et al.,1972; 1974), these findings did
not give conclusive evidence that the activity of this enzyme depends 
on its phosphorylation state. Indeed recent evidence provided by Van 
Schaftingen e_t a_l., (1981a) indicates that the effect of glucagon on 
Fru^^BPase is mediated indirectly via a cAMP-dependent phosphorylation 
of PFK 2 leading to an elevation of Fru2 ^BP. Fru^^BPase may also be 
subject to long-term adaptive changes in the amount of enzyme protein 
(Weber et^  • » 1965a).
The other enzyme in this cycle is PFK 1 which is regulated by 
various effectors, dietary status and hormonal conditions. The amount 
of enzyme « has been shown to decrease during starvation (Dunaway & 
Weber, 1974; SUling & Kleineke, 1976), or when the rats are made dia­
betic with alloxan. Refeeding the starved rats or insulin treatment 
for 72 h increases enzyme levels between 6 and 8-fold. The activity of 
hepatic PFK 1 can also be affected by phosphorylation and dephosphory­
lation (Brand & Sbling, 1975; Brand e_t i 1976; SBling et al., 1981).
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The rat enzyme can be phosphorylated by cAMP-independent kinase
with a resulting increase in enzyme activity. Glucagon and catecho­
lamines have been reported to affect the activity of PFK 1 within 
minutes of their administration (Taunton ejt al^., 1974; Stifel et al., 
1974; Castaîio et al., 1979). The same hormones inhibit flux through 
the enzyme in intact hepatocytes (Clark e^ al., 1974; Kneer et al., 
1974; Rognstad & Katz, 1976).
PFK 1 is also regulated by various effectors. ATP, citrate,
PEP and creatine phosphate are negative effectors and increase the 
sigmoidal nature of the saturation curve for Fru-6-P, whereas posi­
tive effectors such as AMP, Pi and Fru-6-P, have the opposite effect 
(Ramaiah, 1974; Hofmann, 1976). Monovalent cations such as K^ and 
NH^ activate PFK 1 and decrease the allosteric inhibition by ATP 
(Otto et al., 1976). A newly recognized positive effector of PFK 1 
is Fru^^BP (Claus et al., 1980; Richards & Uyeda, 1980; Van ^ 
Schaftingen & Hers, 1980; Van Schaftingen e_t , 1980c, Pilkis e^ 
al., 1981; Uyeda e_t , 1981a; 1981b). The hepatic concentration of 
this effector is greatly increased under conditions in which glyco­
lysis occurs and greatly decreased by glucagon so that glycolysis is 
inhibited (Van Schaftingen ejt , 1980b). Thus, although it has 
been suggested that the glucagon effects on PFK 1 might result from 
a phosphorylation of the enzyme (Kagimoto & Uyeda, 1979; 1980) it 
seems more likely that the effect of glucagon is mainly based on the 
decrease in the concentration of Fru^^BP.
Fru^^BP and AMP have in common the 
properties of inhibiting Fru^^BPase and stimulating PFK 1. Changes in 
the concentration of these effectors could therefore explain the 
effects of glucose and glucagon on this substrate cycle. The concen­
tration of FrUg^BP in the liver is greatly increased by glucose and 
decreased by glucagon (Van Schafting^^^$80b), whereas in contrast, 
the concentration of AMP in the liver is increased by glucagon but
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is not affected by glucose (Van Schaftingen e_t , 1980a). There­
fore it seems that Fru^^BP rather than AMP acts as a second messenger 
in the regulation of glycolysis and gluconeogenesis at this substrate 
cycle. The importance of this effector on the Fru-6-P/Fru^^BP sub­
strate cycle is further emphasized by the observation that Pi and 
AMP at physiological concentrations increase the activity of PFK 2, 
whereas, both PEP and citrate are inhibitory in the presence and 
absence of Pi (Van Schaftingen & Hers, 1981b). Thus if PEP levels are 
elevated during^lycolysis, PFK 2 activity is decreased. This in turn 
would result in a decrease in the Fru^^BP levels, which may be the 
signal that activates Fru^^BPase and inactivates PFK 1. From these 
reports it is evident that the most important factor in the regula­
tion of the Fru-6-P/Fru^^BP cycle is the Fru^^BP concentration.
iii) The pyruvate/phosphoenolpyruvate substrate cycle
The most complicated substrate cycle in the regulation of 
glycolysis and gluconeogenesis is that between PEP and pyruvate; it 
consists of various steps involving two different compartments within 
the cell. In rat liver, the following steps are involved in this cycle; 
the transport of pyruvate to the mitochondria, the carboxylation of 
pyruvate yielding oxaloacetate, the reduction of oxaloacetate to malate 
or its transamination to aspartate, the transport of these metabolites 
to the cytosol, their reconversion to oxaloacetate, the formation of 
PEP catalysed by PEP carboxykinase and the conversion of PEP to pyru­
vate via the reaction catalysed by PK.
Pyruvate entry into the mitochondria has been shown to be under 
hormonal control (Adam & Haynes, 1969). Support for this hypothesis 
is provided by the observation that mitochondria from hepatocytes 
treated with glucagon, adrenaline or cAMP, as well as liver mitochon­
dria from rats treated with glucagon or adrenaline take up more pyru­
vate than those from control rats (Adam & Haynes, 1969; Garrison & 
Haynes, 1975; Titheradge & Coore, 1976a; 1976b). Since there is some 
indirect evidence to suggest that pyruvate carboxylation may be
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limited by the rate of pyruvate entry into the mitochondria (Haynes, 
1972), the regulation of gluconeogenesis at the pyruvate uptake stage 
is a plausible mechanism.
The synthesis of oxaloacetate from pyruvate in the mitochondria 
is catalysed by pyruvate carboxylase (Utter & Keech, 1960; 1963; Keech 
& Utter 1963), an enzyme located exclusively in rat liver mitochondria 
(Walter, 1976). In rat liver the maximal activity of this enzyme is 
higher in starved than in fed animals (SUling & Kleineke, 1976). The 
for pyruvate is 0.15 mM (McClure & Lardy, 1971) and this is in 
the physiological range (Williamson & Brosnan, 1974). The activity 
of pyruvate carboxylase is regulated by the concentrations of pyruvate, 
acetyl CoA,adenine nucleotides and certain amino acids (Pilkis ejt al., 
1978a). The rat liver enzyme requires acetyl CoA for activity (Keech 
& Utter, 1963) with a K^ of the purified enzyme ranging from 15 to 
70 uM (Barritt et al., 1976), but values as high as 170 uM have been 
found with intact mitochondria (Walter, 1976). The hepatic mitochon­
drial acetyl CoA concentration ranges between 0.24 and 1.25 mM (Sobell 
al^., 1976; Siess > 1977; Tischler e_t al., 1977). Part of this
mitochondrial acetyl CoA may be bound to protein (Sols & Marco, 1970; 
Barritt e_t , 1976), so that the actual concentration of free acetyl 
CoA might be smaller. Thus the importance of the regulation of pyru­
vate carboxylase by acetyl CoA is difficult to evaluate. The other 
possible regulatory mechanism of pyruvate carboxylase is hormonal re­
gulation. Glucagon is known to decrease the concentration of lactate 
and pyruvate in the liver (Exton & Park, 1969), but there is evidence 
to suggest that the decrease in pyruvate concentrations is confined 
within the cytosolic compartment (Siess £t al., 1977), while the 
mitochondrial pyruvate remains unaltered. However, glucagon has been 
reported to cause a 25% increase in the concentration of mitochondrial 
acetyl CoA, which acting together with the small increase in the mito­
chondrial ATP/ADP ratio could slightly stimulate pyruvate carboxylase 
activity (Siess et_ al., 1977). Nevertheless, the most important regu­
lator of this enzyme seems to be the inhibitor, glutamate (Scrutton & 
White, 1974; Siess et al., 1977), whose concentration is knowi^o decrease
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after glucagon treatment (Ui £l_*, 1973a; 1973b; Cook et al., 1977). 
Therefore,it appears that pyruvate carboxylase is regulated by glu­
cagon,not by a phosphorylation- dephosphorylation mechanism (Leiter 
e^ al., 1978) but by an alteration of the mitochondrial concentrations 
of acetyl CoA, ATP and glutamate.
Since rat liver PEP carboxykinase is located mainly in the 
cytosol (Nordlie & Lardy, 1963), the oxaloacetate formed via the 
pyruvate carboxylase reaction has to be transported from the mito­
chondrial compartment to the cytosol. The efflux of oxaloacetate 
from the mitochondria is too slow a process to keep pace with the 
rate of gluconeogenesis, thus the transport of malate and aspartate 
formed from oxaloacetate is an obligatory step in gluconeogenesis from 
lactate and pyruvate (Lardy ^  a_l•> 1965). In the cytosol, oxaloacetate 
is resynthesized by malate dehydrogenase (E.C.1.1.1.37) and aspar­
tate aminotrap^erase (E.C.2.6.1.1).
Oxaloacetate is metabolised to PEP in a reaction catalysed 
by PEP carboxykinase. This enzyme is also responsive to dietary and 
hormonal changes. The level of the enzyme is raised by fasting, by 
diabetes and by administration of glucagon if the hormone is admini­
stered for periods of hours or days to the intact animal. The level is 
reduced by prolonged administration of insulin (Tilghman , 1976).
The apparent for oxaloacetate is reported to range from 1 to 10 pM
(Ballard, 1970; Walsh & Chen, 1971; Jomair.-Baum et al.,1976), but
2+
reaches about 60 pM in the presence of 0.15 mM Hn with saturating 
concentrations of GTP (Jomain-Baum & Schramm, 1978). Since the concen­
tration of cytosolic oxaloacetate ranges between 5 and 50 pM (Zuurendonk 
et al., 1976; Siess a^., 1977; Tischler ££  a_l., 1977) and is not 
influenced by glucagon (Siess e_t , 1977),and the total concentra­
tion of GTP in the liver is about 0.5 mM (Van den Berghe e_t , 1977a) 
which is sufficient to saturate the enzyme (K^ 0.02 mM) according to 
Jomain-Baum & Schramm,(1978); it therefore appears that the variations 
in the concentrations of oxaloacetate may affect the activity of PEP 
carboxykinase.
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The remaining enzyme involved in this cycle is PK. The liver 
content of PK is greatly increased by a diet enriched in carbohydrate 
and decreased upon starving (Seubert & Schoner, 1971; Ibsen, 1977;
Van Berkel e^ fJL' * 1977a). This enzyme is allosterically inhibited 
by ATP and several amino acids such as alanine, cysteine, phenyla­
lanine and serine and it is stimulated by Fru_,BP, Fru-l-P and by 
+ + 2+
cations such as K , NH^ and Mg (Seubert & Schoner, 1971). The 
liver PK is also under hormonal regulation by a mechanism which in­
volves phosphorylation-déphosphorylation of the enzyme (Engstrüm,
1978). Phosphorylation of the enzyme increases the apparent S^ ^ for 
PEP 2 or 3-fold (Ekman et al., 1976; Ljungstrdm et al., 1976) and 
the affinity for the allosteric inhibitors alanine and ATP increases 
whereas the affinity for the allosteric activator Fru^^BP decreases. 
Gluconeogenesis stimulating hormones such as glucagon inactivate PK 
whereas insulin activates the enzyme. A detailed review of the pro­
perties of this enzyme is given in section II.
Thus, the regulation of the pyruvate/PEP cycle may occur at
various points. The operation of this cycle is energetically waste­
ful because it consumes 1 mol. of GTP per mol. of pyruvate recycled.
It must be noted that the occurrence of substrate cycling between pyru­
vate and PEP has been reported (Friedman et al., 1971;Rognstad & Katz,
1972). The rate of gluconeogenesis from pyruvate in perfused liver 
from starved animals is greater than its rate of recycling whereas 
the reverse situation is observed with fed animals (Friedmann et al., 
1971).
Therefore, generally it seems that factors that stimulate glyco­
lysis have the opposite effect on gluconeogenesis which implies that 
when one pathway is dominant the other is depressed but not completely 
blocked and hence substrate cycling occurs.
2. Glycogen Metabolism
Glycogen is stored in the liver as a reserve of glucose to meet 
the energetic need of extrahepatic tissues. When glucose is abundant 
(for example after feeding), glycogen accumulates and it is subsequently
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mobilized when there is extrahepatic demand for glucose. Glucose 
itself is a potent regulator of the hepatic uptake or output of 
glucose, so that the hepatic blood glucose homeostasis is auto­
regulated. The hepatic threshold of glucose is the concentration at 
which the liver stops producing glucose and starts to take up the 
hexose. The glucose is produced as a result of both gluconeogenesis 
and glycogenolysis.
The rate-limiting steps of glycogen synthesis and breakdown 
in the liver are catalysed by glycogen synthetase (E.C. 2.4.1.11) 
and glycogen phosphorylase (E.C.2.4.1.1). Each of these enzymes 
exists in two forms, *a'(active) and *b'(inactive), which are inter­
convertible through phosphorylation by kinases and dephosphorylation 
by phosphatases (Hers, 1976). Thus stimulation of glycogen degrada­
tion by hormones will therefore be achieved by the inactivation of 
glycogen synthetase and activation of phosphorylase (see figure 2).
The activation of phosphorylase can be brought about by the 
cAMP-dependent activation of protein kinase (E.C.2.7.1.37), which 
in turn leads to the activation of a phosphorylase kinase (E.C.2.7. 
1.38) and the consequent activation of phosphorylase. On the other 
hand, cAMP-dependent protein kinase can phosphorylate glycogen synthe­
tase and hence cause its inactivation. Thus, hormones which raise 
cAMP levels (glucagon and adrenaline) can stimulate glycogenolysis 
via this mechanism while insulin is thought to have the reverse effects 
(Friedman e_t , 1970; Hue & Feliu, 1978; Nyfeler e_t al^., 1981). Sti­
mulation of glycogenolysis in rabbit liver by adrenaline, noradrenaline 
and phenylephérine has been shown to involve g-adrenergic mediated 
mechanisms (Rufo £ l ., 1981). Changes in physiological concentra­
tions of glucose can also regulate glycogen metabolism (Hers e_t al^.,
1973). When glucose binds to phosphorylase'a*, the enzyme is inhibited 
and thus the conversion of phosphorylase 'a* to phosphorylase 'b* is 
increased. A secondary effect is that the inhibition of synthetase 
phosphatase by phosphorylase *a* is reversed and thus glycogen synthe­
tase is activated (Stalman, 1976).
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D. FRUCTOSE METABOLISM
In humans, Medeloff & Weichselbaum,(1953) and Wolfe et al., 
(1975) demonstrated that after prolonged infusion with fructose, 
the liver accounts for 75% of its removal. Similar results were 
obtained by Topping & Mayes,(1971) who administered high fructose 
concentrations to rats by gastric intubation. Utilization of fruc­
tose by kidney and intestine has also been documented but the quan­
titative participation^of these organs is unclear and seems to be 
species dependent (Bollman & Mann, 1931; Reinecke, 1944). In humans, 
the use of splanchnic vein catheterization during infusion indicates 
that the small intestine accounts for less than 10% of the total 
metabolism of fructose and that a considerable proportion of the 
hexose is absorbed unchanged (Med*eloff & Weichselbaum,1953).
Fructose is transported to the liver from the small intestine 
via the portal blood vessel. Liver is the major site of fructose 
metabolism.. ( A steep gradient exists between the extra- and intra­
cellular concentrations of the sugar (Sestoft, 1974) and thus elimi­
nation of fructose from the blood is a function of its concentration 
and follows Michaelis-Menten kinetics (Sestoft e^ , 1972). In
rat liver the carrier - mediated membrane transport of fructose has
. -1 -1
a high K and V (67 mM and 30 ymole rain g respectively); in 
in ni3.x
comparison to the intracellular phosphorylation constants calculated
for fructokinase (E.C.2.7.1.1) (K of about-1.0 mM and V of 10.3
m max
ymole min g with fructose) (Sestoft et al., 1972; Sestoft, 1974; 
Sestoft & Fleron, 1974). The transport values for fructose suggest 
that at physiological fructose concentrations, membrane transport 
limits the rate of uptake, thus protecting the liver from severe de­
pletion of adenine nucleotide (see section 1.D.4).
The first step of fructose metabolism is its phosphorylation by
hepatic fructokinase to yield Fru-l-P and AD? (Cori et al., 1951;
2+
Hers, 1952a). The enzyme utilizes ATP in the form of the Mg complex 
as the phosphate donor (Hers, 1952b; Parks et. ±1' * 1957). Hepatic 
fructokinase has a high affinity for fructose with values between
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0.46 and 1.0 mM reported and K values between 0.2 and 2.0 mM re-
2+
ported for Mg ATP (Adelman e^ al^., 1967; Sanchez e^ , 1971; 
Sestoft, 1974). Fructokinase, however, is not specific for fruc­
tose because it also catalyses the phosphorylation of ^-sorbose, 
D^^agatose, D-xylulose and IL-galactoheptulose (Adelman e_t al^., 1967; 
Sanchez et al., 1971) and therefore can be regarded as a ketohexo- 
kinase.
The next step is the cleavage of Fru-l-P by hepatic aldolase 
(E.C.4.1.2.13) to yield DHAP and D^glyceraldehyde. This same enzyme 
also catalyses the splitting of Fru^^BP to DHAP and D^glyceraldehyde- 
3-phosphate in addition to condensation of the triose phosphates 
(Hers & Kusaka, 1953). This differentiates the liver enzyme from 
muscle or brain aldolase, because unlike hepatic aldolase, the 
types are more specific for Fru^^BP (Penhoet e_t , 1966). The meta­
bolism of ID-glyceraldehyde is discussed in section I.E.
Metabolic effects of fructose in the liver
As already discussed, liver is the major site of fructose meta­
bolism. The effects of increased fructose concentrations on various 
metabolites and metabolic pathways in the liver have been studied.
1. Accumulation of fructose-l-phosphate
The accumulation of Fru-l-P in the liver after a fructose
load has been demonstrated using intact animals (Burch et al.,
1969; Bode £ £  » 1973; Van den Berghe e^ , 1973; 1977a) as
well as perfused organ ( Woods e^ fl.* » 1970; Sestoft e_t , 1972).
This accumulation of the monophosphate in these conditions indicates
that the breakdown of Fru-l-P is much slower than its formation.
However, from an examination of the in vitro data available, it
seems clear that both the K and the V of fructokinase and aldo-
ra max
lase are in the same range (Van den Berghe, 1973). Thus an explanation 
for this accumulation is not immediately apparent. One possible ex­
planation offered by Woods £t al^., (1970) is that the accumulation of
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an inhibitor of aldolase (IMP), which is apparent after a fructose 
load, may play a role in the regulation of Fru-l-P accumulation.
However, the finding that the accumulation of the fructose ester 
preceeds the increase of IMP ijri vivo (Van den Berghe e_t al., 1977a) 
contradicts this interpretation. Furthermore, measurement of the 
initial rate of hepatic Fru-l-P formation iji vivo (Van den Berghe 
et al., 1977a) reveals that it is several times faster than that 
expected from the consideration of the enzyme activities determined 
in vitro. The reason for this discrepancy is not clear. One possi­
bility is that since fructokinase has been shown to require high 
concentrationsof (Hers, 1952a; 1952b), the possibility exists 
that all ionic and metabolite requirements have not been met for 
optimal activity in the in vitro assay.
From these observations, it has been proposed that the accumu­
lation of Fru-l-P is due to the fact that both fructokinase and 
aldolase can act much more rapidly than the metabolic pathways that 
convert triose phosphates into glucose and pyruvate (Exton and Park, 
1967).
2. Glycolysis
Fructose enters the glycolytic pathway at the triose phosphate 
stage (figure 3) and can produce lactate and pyruvate as its end 
products. In liver slices (Thieden & Lundquist, 1967), perfused organ 
(Exton & Park, 1967) as well as in the isolated liver cells (Seglen, 
1974), lactate formation from fructose is several fold faster than 
from glucose. The explanation offered for this difference in the rate 
of utilization are;(i) hepatic fructokinase has a much higher acti­
vity than the glucose phosphorylating capacity of glucokinase,(ii) fruc­
tose metabolism bypasses the PFK regulatory step of glycolysis,
G-ii) pyruvate kinase is stimulated by Fru-l-P (Eggleston & Woods, 1970), 
Seglen (1974) showed that fructose was utilized very effectively by 
isolated liver cells from both fed and fasted rats, the glycolytic 
rate being 10-30 times higher than with glucose under aerobic as well
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as anaerobic conditions. In the presence of ethanol, lactate produc­
tion from fructose was considerably lowered (Scholz & Nohl, 1976). 
Similar results were obtained by Lundquist e_t al., (1974) and Sestoft
(1974) and were interpreted to be due to an inhibition of the glycer- 
aldehyde-3-phosphate dehydrogenase (E.C.1.2.1.12) reaction as a 
consequence of NAD redox changes induced by ethanol (Furfine &
Velick, 1965).
3. Gluconeogenesis
Glucose is the major end product of hepatic fructose metabolism. 
Exton & Park,(1967) used perfused livers from fasted rats and showed 
that after 1 h perfusion with 20 mM fructose, 52% of the ketose was 
recovered as glucose, 18% as lactate and pyruvate, 8% as glycogen 
and the remaining 22% is assumed to be metabolised to glycerol, sor­
bitol, triglycerides, carbon dioxide and ketone bodies. Fructose is 
a very good gluconeogenic substrate in perfused liver, the maximum 
rate of glucose produced being about twice that from lactate (Ross e^ 
al., 1967a). Using isolated hepatocytes,Veneziale & Lohmar,(1973); 
Seglen, (1974) and Arinze & Rowley (1975) reported similar findings.
The fructose carbon enters the glycolytic/gluconeogenic pathways 
as DHAP and D-glyceraldehyde-3-phosphate (figure 3), thus bypassing 
pyruvate carboxylase and PEP carboxykinase, the regulatory enzymes for 
gluconeogenesis from lactate and pyruvate. Fructokinase, aldolase and 
triokinase (E.C.2.7.3.10) are required for the conversion of fructose 
to triose phosphates. Thus the segment of gluconeogenesis between 
DHAP or D-glyceraldehyde-3-phosphate and glucose serves as the common 
pathway for gluconeogenesis whether the carbon source for the newly 
formed glucose is pyruvate or fructose.
Such pathway differences between pyruvate and fructose provide 
a useful model, in gluconeogenic studies, to evaluate which metabolic 
segment(s) is actually influenced by glucagon or its mediator, cAMP.
An action of glucagon on the initial segment of fructose metabolism
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should have no influence of gluconeogenesis from pyruvate, while an 
action of glucagon in the early segment of pyruvate metabolism 
should have no influence on the rate of gluconeogenesis from fruc­
tose. Failure to observe a glucagon induced stimulation of gluconeo­
genesis from fructose by Ross e^ al., (1967b) led to the suggestion 
that the stage between pyruvate and oxaloacetate is the site of 
action of glucagon, and that ....a physiologically meaningful sti­
mulation of reactions (by glucagon) between the triose phosphate and 
glucose seems unlikely*(Exton et al., 1970). In contrast, Veneziale, 
(1971) perfused isolated fasted rat liver with glucagon and fructose 
in the presence of quinolinate and observed a stimulation of fructose 
conversion to glucose. Quinolinate was added to minimize, if not 
prevent, the glucagon stimulation of gluconeogenesis from endogenous 
substrates via PEP carboxykinase. However,Garrison & Haynes,(1973) 
also found a lack of stimulation of gluconeogenesis from fructose 
by glucagon and dibutryl cAMP in isolated hepatocytes.
This discrepancy between these reports may be related to the 
use of different fructose concentrations. It seems that gluconeogenesis 
from fructose at low concentrations is stimulated by glucagon but not 
when high levels of the ketose were used. This may be related to the 
observation that low fructose concentrations raise Fru^^BP levels 
in isolated hepatocytes whereas high fructose lowers the level of 
this effector (Hue, 1981).
Furthermore, a study of the rate of uptake of D^-fructose by 
isolated rat liver in the presence and absence of glucagon indicates 
that approximately 40% of the added fructose is cleared from the per­
fusate, both in the presence and absence of glucagon (Veneziale, 1971). 
Therefore, the action of glucagon must be on an intracellular aspect 
of the process.
Other factors such as diabetes (Renold et al., 1954; Friedmann 
e_t al., 1970; Exton e_t ad., 1973) and fasting (Seglen, 1974) also 
increase glucose production from fructose. Ethanol administration has
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been shown to increase gluconeogenesis from fructose (Madison et al., 
1967; Exton & Park, 1969; Lundquist £l.-» 1974; Scholz & Nohl,
1976; Cederbaum & Dicker, 1979), but contradictory to these reports, 
Krebs (1968), Krebs ejt a^^., (1969), Papenberg e_t , (1970) and 
Ylikahri et al., (1972) reported that hepatic gluconeogenesis from 
fructose is inhibited by ethanol. Studies carried out on the rate of 
total fructose metabolism indicate that ethanol does not affect 
fructose entry into hepatocytes nor its phosphorylation nor its 
aldolytic cleavage (Scholz & Nohl, 1976). This suggests that at the 
level of triose phosphates^ fructose metabolism is switched over from 
fructolysis to glucose production. Since ethanol administration in­
duces an increase in the (NADH)/(NAD^) ratios, which in turn would 
cause the inhibition of glyceraldehyde-3-phosphate dehydrogenase 
(Furfine & Velick, 1965), it is more plausible that ethanol would 
inhibit glycolysis from fructose and increase the gluconeogenic rates 
from this ketose.
4. Adenine nucleotide metabolism
When large doses of fructose are injected intravenously to 
experimental animals the concentration of Fru-l-P in the liver increa­
ses within a few min (Burch e^ fJi' * 1969; Van den Berghe et. Ê l ' * 1977a) 
and the concentration accumulated depends on the dose injected (Burch 
et al., 1970). This effect was also observed by MMenpMM et. ^1«»
(1968) who reported that as a consequence of this rapid accumulation 
of Fru-l-P, the intracellular concentrations of Pi and ATP decrease. 
However, the decrease in ATP levels is not followed by an equivalent 
increment in the sum of ADP plus AMP levels, but preceeds an increase 
in plasma concentrations of uric acid and allantoin, providing evidence 
for the degradation of the adenine nucleotide pool (Burch et al., 1969; 
Burch £t £l., 1970; Bode e_t al^., 1973). Woods £t £l^., (1970) also 
showed the degradation of adenine nucleotides and accumulation of 
LIP in the perfused liver treated with fructose.
When ATP levels are depleted, two ADP molecules combine in the 
presence of adenylate kinase (E.C.2.7.4.3) to yield ATP and AMP. The
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resulting AMP can be catalysed by either of two pathways (figure 4) 
which lead to the formation of uric acid and allantoin. These end 
products thus come from the nucleotide pool as a whole since adeny­
late kinase maintains an equilibrium between the nucleotides. The 
amino group of the adenine nucleotide can be removed either directly 
by AMP deaninase (E.C. 3.5.4.2) or following hydrolysis of the phos­
phate group by 5* nucleotidase (E.C. 3.1.3.5),In the latter case 
the enzyme responsible for the deamination is adenosine deaminase 
(E.C. 2.5.4.4). The common product of both pathways is inosine, 
which is further metabolised to hypoxanthine and ribose-l-phosphate 
by purine nucleoside phosphorylase (E.C. 2.4.2.1). Hypoxanthine is 
converted to xanthine and uric acid by xanthine oxidase (E.C.1.2.3.2) 
and further metabolised by uricase (E.C.1.7.3.3) to allantoin in rats.
Adenine nucleotide catabolism in vivo is kept to a minimum by 
inhibition of the enzymes AMP deaminase by Pi (Nikiforuk & Colowick,
1956), and 5'-nucleotidase by ATP (Baer ejt a^. , 1966). The precise
role of these enzymes was studied by Van den Berghe et al., (1977a), 
(1977b). An investigation of the kinetic properties of the 5*-nucleo- 
tidase present in the cytosol of rat liver showed that when IMP is used 
as substrate the enzyme displays hyperbolic kinetics; similar kinetics 
are observed with CMP whereas AMP displays sigmoidal kinetics. At 
pH 7.4 the enzyme activity with 0.2 mM AMP is undetectable under physio­
logical conditions. This led to the conclusion that in vivo, AMP 
is not hydrolysed by 5'-nucleotidase and that normal as well as fruc­
tose-induced catabolism of adenine nucleotides requires prior deamina­
tion to IMP (Van den Berghe, 1973).
A study of the kinetic properties of AZIP deaminase at physiological
substrate concentrations (0.2 mM AMP) reveals that a low activity can 
be measured which is inhibited by Pi (Van den Berghe » 1977a,
1977b). ATP (3mM) increases the enzyme activity 200-fold. Pi alone does 
not influence the ATP activated enzyme, but GTP (0.5 mM) causes a 
60% inhibition. The combined effects of the inhibitors at their
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Figure 4. Pathway of AMP degradation in the liver
1. 5^-nucleotidase
2. AMP deaminase
3. adenosine deaminase
4. purine nucleoside phosphorylase
5. xanthine oxidase
6. uricase
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physiological concentrations cause a 95% inhibition of the enzyme.
Thus Van den Berghe and co-workers proposed that the rapid degrada­
tion of adenine nucleotides that occurs after a fructose load is 
caused by a decrease in the concentration of both AMP deaminase in­
hibitors, Pi and GTP. This activation is then counter#acted by the 
decrease in the concentration of AMP deaminase stimulator, ATP. The 
increase in IMP concentrations, initially described by Woods et al., 
(1970) provides further evidence that the pathway of AMP deamination 
occurs through AMP deaminase in vivo. Accumulation of adenosine cannot 
be detected in isolated hepatocytes treated with fructose (Smith 
e^ al_., 1977a, 1977b).
Uric acid is formed from hypoxanthine by two consecutive reac­
tions catalysed by xanthine oxidase. This enzyme looses its ability 
to catalyse the oxidation reaction when it is incubated with allo- 
purinol (4-hydroxypyraxolo(3,4-d)pyrimidine). Allopurinol is an ana­
logue of hypoxanthine which is converted to oxipurinol (4,6-dihydroxy- 
parazolc(3,4-d)pyrimidine) by this enzyme (Spector & Johns, 1970). Both 
allopurinol and oxipurinol inhibit xanthine oxidase (Elion et al.,1963).
Uric acid constitutes the end product of the catabolism of ade­
nine nucleotides in humans and higher apes which lack uricase (Simkin, 
1972). In species lacking this enzyme, the catabolism of AMP is nor­
mally kept to a minimum because the low solubility of uric acid, 
coupled with limited renal excretion constitutes a potential Hanger 
of precipitation of crystals with the damaging consequences found in 
gout. In experimental animals (e.g.rats) that possess uricase, the 
administration of a fructose load causes an increase in plasma allan­
toin concentration in addition to increased uric acid levels(M^enpHM 
et al., 1968; Kekomaki e_t £ l ., 1972). Smi th e_t al^., (1977b) also repor­
ted that incubating isolated hepatocytes with fructose causes an 
accumulation of allantoin.
5. Glycogen Metabolism
Fructose has been shown to activate the enzyme cascade respon­
sible for glycogen breakdown, whereas glucose promotes glycogen
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synthesis (Miller, 1978). These findings are in contrast to the 
suggestion put forward by Seglen (1974), that fructose is a good 
glycogen precursor. In the perfused liver, the activation of phos­
phorylase by fructose appears to be transient (Walli et al.,1975;
Jakob, 1976) and to be followed by an inactivation of the enzyme; 
whereas in vivo a late inactivation of phosphorylase by fructose 
in mouse liver has been reported (Van den Berghe e_t al., 1973; Thurston 
££ aJ., 1974). The activation of phosphorylase by fructose in isola­
ted hepatocytes was explained by Miller (1978), to be the result of 
increased cAMP levels. This mechanism was found to be applicable only 
at high fructose concentrations (about 30 mM) (Van de Uerve & Hers, 
1979). Another factor that can be considered is the depletion of hepa­
tic Pi and ATP which occurs after a fructose load. Liver and muscle 
phosphorylase kinase are optimally active at an ATP/Mg ratio of about
0.5 (Van de Werve & Hers, 1979). In the liver the ATP is present 
mainly as an ATP/Mg (1:1) complex with only slight magnesium excess 
(Veloso a^., 1973), such that the depletion of ATP could result 
in an increase of free Mg thus shifting the ratio towards 0.5, which 
results in the activation of phosphorylase. This was confirmed by Wood 
e_t a_l., (1981) who observed that low concentrations of fructose stimu­
late glycogen synthesis whereas high concentrations (above 5 mM) are 
inhibitory.
6. Other fructose effects
Studies with humans and animals have indicated that serum lipid 
levels are affected by the type of carbohydrate in the diet. A high 
fructose diet (Zakim £l^., 1967),as well as addition of the ketose 
to the perfused liver (S8ling • > 1970) increase the hepatic con­
centration of acetyl CoA by 40-60% compared to controls perfused with 
glucose. This effect can be attributed to the high rate of fructolysis - 
as compared to glycolysis. Harris, (1975) concluded that the rate of 
de novo fatty acid synthesis by isolated hepatocytes is dependent on 
the accumulation of pyruvate and lactate. This was also confirmed by 
Walli (1978), using isolated perfused liver.
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The rate of disappearance of blood ethanol has been shown to 
be stimulated by fructose. Intravenous injection of the ketose in­
creases the ethanol elimination rate by 25-80% (Lowenstein et al.,
1970; Brown et al., 1972), whereas oral ingestion is less efficient 
(Pawan, 1968; Soterakis & Iber, 1975). Thieden e^ al^., (1972) using 
isolated perfused liver demonstrated that this effect was due to a 
stimulation of ethanol oxidation by fructose. The rate-limiting step 
in the metabolism of ethanol is the formation of acetaldehyde, catalysed 
by NAD^- dependent alcohol dehydrogenase (E.C.1.1.1.1). The maximum 
activity of this enzyme in liver slices (Videla & Israel, 1970) and 
perfused liver (Lindros • > 1972) is approximately twice the rate
of ethanol metabolism and it is widely accepted that the capacity to 
reoxidize NADH is rate limiting (Li^er & De Carti, 1968). Addition of 
fructose lowers the cytosolic (NADH)/(NAD^) ratio (Thieden & Lundquist 
1967) which is raised 5 to 10 fold as a consequence of ethanol meta­
bolism (Forsander e_t , 1965; Krebs e_t a_l,, 1969).
Essentially two mechanisms have been proposed to explain the in­
fluence of fructose on ethanol metabolism, depending upon whether the 
effect is thought to be exerted on the cytoplasmic reoxidation of 
NADH or on the respiratory chain. Extramitochondrial reoxidation of 
NADH can be accomplished by the reduction of fructose and its meta­
bolites, DHAP and D^glyceraldehyde,to sorbitol, G3P and glycerol. How­
ever, measurements of the production of glycerol and sorbitol from 
fructose by the perfused liver (Scholz & Nohl, 1976) and calculations 
based on the kinetic parameters of the enzymes involved (Thieden et al.,
1972) indicates that the formation of sorbitol and glycerol accounts 
for the utilization of only 30% of the reducing equivalents provided 
by the supplementary oxidation of ethanol. The other possible mecha­
nism for the reoxidation of cytoplasmic NADH is involved with the 
coupling of cytoplasmic NADH reoxidation to the reduction of oxalo­
acetate to malate by malate dehydrogenase (see figure 5B). The second 
postulated mechanism is the reoxidation of NADH by the respiratory 
chain. Fructose increases the hepatic consumption of oxygen by up to 
100% in vivo (Tygstrup et al., 1965), in slices (Thieden & Lundquist,
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Figure 5. Shuttle mechanisms proposed for the transport of reducing 
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FH - flavine nucleotide (half-reduced form); FH2  ~ reduced 
flavine nucleotide).
A - glycerol-3-phosphate shuttle; 
B - malate aspartate shuttle.
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1967), in the perfused liver (Sestoft e_t al^ . , 19^2; Zehner et al.,
1973; Sestoft, 1974) and in isolated cells (Seglen, 1974). Ethanol 
by itself has no effect on this parameter (Forsander et al.,1965) 
but if fructose is added while ethanol is being metabolised the 
increase in oxygen consumption is approximately doubled as compared 
with the fructose effect alone (Thieden & Lundquist, 1967). Scholz 
& Nohl, (1976) proposed that fructose stimulates the oxidation of 
ethanol by enhancing the hepatic energy utilization, which is reflec­
ted by increased oxygen consumption.
E. D-GLYCERALDEHYDE, DIKYDROXYACETONE AND GLYCEROL METABOLISM!
In conftrast to fructose, D^glyceraldehyde is not a normal 
dietary constituent. However, it is important as a natural product 
mainly because it is formed enzymatically from fructose (figure 3).
This product appears to be metabolised by three different routes which 
are; (i) direct conversion into D-glyceraldehyde-3-phosphate by 
triokinase; (ii) reduction to glycerol by NADH- or NADPH- linked 
alcohol dehydrogenase (E.C.1.1.1.1 or E.C.1.1.1.2) followed by phos­
phorylation via glycerokinase (E.C.2.7.1.30); (iii) oxidation to 
D-glycerate by aldehyde dehydrogenase (E.C.1.2.1.2), followed by 
phosnhorylation to 2-phosphoglycerate by glycerate kinase (E.C.2.7.
1.31). The first route is believed to be favoured (Burch e_t , 1970) 
because fructose is utilized more rapidly than glycerol. The demonstra­
tion of a D^glyceraldehyde (0.01 mM) for triokinase, in contrast 
to the higher values . for aldehyde dehydrogenase (0.3 mM) NAD - 
linked alcohol dehydrogenase (11 mM) and NADP^ -linked alcohol dehy­
drogenase (0.6 mM) also points ta preferential transformation of D- 
glyceraldehyde into D^glyceraldehyde-3-phosphate (Veneziale, 1976).
Dihydroxyacetone is phosphorylated by triokinase in the pre­
sence of ATP as the phosphate donor to yield DHAP. A triokinase 
preparation from rat liver exhibits a V^^^ for dihydroxyacetone, 
which is 2-5 times greater than the for D-glyceraldehyde
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(Frandsen & Grunnet, 1971). The effect of a dihydroxyacetone load 
on hepatic adenine nucleotides was studied by Woods & Krebs, (1973) 
who concluded that in the perfused liver there is no significant 
decrease of adenine nucleotides.
The enzyme which catalyses the phosphorylation of glycerol is 
glycerokinase. This enzyme has been found to be inhibited by high 
levels of glycerol when the concentration of ATP is low (Robinson 
& Newsholme, 1969). The physiological significance of this inhibi­
tion may be to prevent phosphorylation of glycerol when ATP concen­
tration is low (e.g. in ischemia, or after a fructose or glycerol 
load). Glycerol effects on hepatic metabolite levels have been exa­
mined by Burch e^ al^ . (1970) who concluded that following a glycerol 
load, large increases in G3P are observed which are not followed by 
a rise in the DHAP levels. These findings have been confirmed by Woods 
& Krebs, (1973).
The limiting step in hepatic glycerol utilization is clearly 
G3P oxidation. This involves the enzyme glycerol-3-phosphate dehydro­
genase (E.C. 1.1.1.8) which exists as two distinct forms. One form 
is associated with the outer part of the inner membrane of the mitoch­
ondria (Green, 1936), whilst the other form is found in the cyto­
plasm (Ho & Pace, 1958). The NADH produced during glycerol metabolism 
by the cytoplasmic enzyme has to be reoxidized if G3P oxidation is to 
be maintained. Thus the limiting factor in glycerol metabolism is the 
rate of NADH reoxidation. Since pyridine nucleotides cannot cross 
the mitochondrial membrane (Lehninger, 1951), cytoplasmic NADH pro­
duced cannot be directly oxidized by the mitochondria. This is par­
tially overcome by the G3P shuttle (figure 5A). Glycerol-3-phosphate 
dehydrogenase in the cytoplasm can reduce DHAP to G3P and oxidize 
NADH to NAD (cytoplasmic glycerol-3-phosphate dehydrogenase at phy­
siological pH favours the production of G3P from DHAP). This G3P 
can then move into the m i t o c h o n d r i a \ B u c h e r ,  1960). Inside 
the mitochondria G3P is oxidised by a flavin - containing glycerol- 
3-phosphate dehydrogenase. The reduced flavin can then be oxidized 
via the respiratory chain. The net result of this shuttle is to trans­
fer excess reduc^^^equivalents from the cytosol to the mitochondria.
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The other possible mechanism for the import of excess NADH 
from the cytosol into the mitochondria is via the malate»aspartate 
shuttle (figure 5B) (Cederbaum et. ±1' * 1973; Rognstad & Clark,
1974). In this shuttle malate enters the mitochondria where oxalo­
acetate can be synthesized in a reaction catalysed by malate dehydro­
genase and coupled to NAD^ reduction. Since the mitochondrial mem­
brane is not freely permeable to oxaloacetate (Haslam & I'jrebs, 1968), 
it is first transaminated to aspartate in the mitochondria and the
products of the transamination (i.e. aspartate and a-ketoglutarate) 
are exported to the cytosol where they re-form oxaloacetate via cyto­
solic glutamate-oxaloacetate transaminase (E.C. 2.6.1.1). The net re­
sult of this shuttle is the transfer of excess cytosolic NADH to the 
mitochondria and its oxidation via the respiratory chain.
F. XYLITOL AND SORBITOL METABOLISM
The liver cell is permeable to both these reduced substrates 
which enter the glycolytic-gluconeogenic sequence after an oxidation 
and a phosphorylation step (figure 3 and figure 6).
In the liver xylitol is first oxidised to D^xylulose by the 
NAD linked xylitol dehydrogenase causing the cytoplasmic (NADH)/
(NAD ) ratio to increase (Williamson al_ , 1971). The next step is 
the phosphorylation of xylulose to xylulose-5-phosphate by xylulose 
kinase (E.C.2.7.1.17). The phosnhorylated product is further metabo­
lised by means of the transaldolase and transketolase reactions of 
the pentose phosphate cycle to D^glyceraldehyde-3-phosphate and Fru- 
6-P. Xylulose has also been shown to be a good substrate for fruc­
tokinase in vitro (Adelman ejt £ l ., 1967; Raushel & Cleland, 1977).
The for the pentose is 0.45 mM (cf to a of 1.0 mM for fructose)
and the V is 65% of the V with fructose as substrate (Barngrover 
max max ^
al_., 1981). The product from this reaction is xylulose-l-Phosphate which 
can undergo aldolytic leavage yielding DHAP and glycolaldéhyde. The
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DHAP produced can thus enter the glycolytic/gluconeogenic sequence 
while glycolaldéhyde is further metabolised to oxalate (Gessner 
et al., 1961; Hodgkinson, 1977; Barngrover e_t al^., 1981) (see also 
figure 6).
Sorbitol is oxidized to fructose in the liver by NAD^ linked 
sorbitol dehydrogenase (E.C.1.1.1.14). The fructose produced is 
then phosphorylated by fructokinase and follows the remainder of 
the fructolysis sequence already discussed (figure 3).
II. PYRUVATE KINASE
Pyruvate kinase (ATP: pyruvate 2-0-phosphotransferase) cata­
lyses an undirectional step in the glycolytic sequence. The reaction 
involves the removal of a phosphate group from PEP and the phospho­
rylation of ADP yielding pyruvate and ATP. This enzyme has a central 
role in the regulation of both glycolysis and gluconeogenesis and is 
regulated by a number of allosteric and covalent modifications 
(Seubert & Schoner, 1971; Engstrüm, 1978; Pilkis e_t , 1978a).
A. MULTIMOLECULAR FORMS OF PYRUVATE KINASE
Kinetic studies of PK from rat and human tissues have led to 
the identification of three classes of isoenzymes with different 
electrophoretic, immunological and kinetic properties (Tanaka et 
al., 1965; Susor & Rutter, 1968; Imamura & Tanaka ££ • > 1972;
Imamura aj^., 1972). These isoenzymes have been designated M-,
A- and L- type PK.
Type M is present in muscle, brain and a small proportion has 
also been found in the liver. Studies on the kinetic properties of 
M-type PK from rat liver have shown that it is similar to the muscle 
enzyme; plots of initial velocities versus PEP or ADP concentrations 
give hyperbolic curves (Jimenez De Asua e_t £_1^ *, 1971; Muirhead 
e_t al^., 1981). Muscle enzyme has been shown to be inhibited by phe­
nylalanine; this inhibition is pH dependent (Gregory & Ainsworth,1981)
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and can be reversed by cysteine, serine and alanine (Rozengurt et al., 
1970; Kwan & Davies, 1981). In contrast to this the liver M-type 
enzyme is inhibited not only by phenylalanine but also by alanine, 
valine, tyrosine, proline, threonine and tryptophan. The inhibition 
by phenylalanine and alanine of the liver M-type PK is only slightly 
pH dependent (Jimenez De Asua e^ £ l ., 1971). The PK from cardiac 
tissue was shown to have physical properties similar to those of 
the muscle enzyme but it displays different kinetic properties 
with regard to activation by Fru^^ BP and inhibition by phenylalanine 
and alanine (Flanders al., 1971).
Type A PK is present as a major component in adipose tissue and 
kidney and is a minor component in the liver. It shows slightly 
sigmoidal substrate saturation curves, is allosterically inhibited 
by alanine and activated by Fru^^BP (Carbonell e_t , 1973); Van 
Veelen et al., 1981).
Type L is the major component of liver PK and a minor component 
in the case of the kidney and intestine. A modified type L PK is also 
present in the erythrocytes (Nakashima, 1974; Lincoln et al., 1975;
Marie e_t al. , 1976; Kahn e^ a^., 1978). Type L PK shows markedly sig­
moidal kinetics with respect to the concentration of PEP; allosteric 
inhibition by ATP and alaninejand allosteric activation by Fru^^BP 
(Tanaka e_t al., 1967a; Seubert & Schoner, 1971). Thus in contrast to 
the type M enzyme, type L is an allosteric enzyme which is under 
hormonal and dietary control.
In order to explain the existence of two different species of 
PK with different regulatory properties in one organ, different com- 
partmentation either within the cells or between the various hepatic 
cell types is postulated. Type L PK was shown to be found exclusively 
in the parenchymal cells while type M was restricted to the non- 
parenchymal cells (Crisp & Pogson, 1972; Van Berkel ejt al., 1972; Bonney 
e£ al., 1973). Furthermore, the capacity for gluconeogenesis and
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glucokinase have also been shown to be confined to the parenchymal 
cells of the rat liver by these workers. Thus, there may be two 
kinds of glycolytic pathways in the liver; one which utilizes hexo- 
kinase and type M PK and has been termed the basal pathway; the other 
involves glucokinase and type L PK and is probably the regulatory 
pathway (Tanaka £££_].*» 1967b; Van Berkel et , 1972). The loca­
lization of these two pathways is further emphasized by the evidence 
that gluconeogenesis,glucokinase, and L-type PK are confined to the 
parenchymal cells and these cells respond to metabolic changes in 
the organ.
B. MOLECULAR PROPERTIES OF L-TYPE PYRUVATE KINASE
A highly purified PK preparation was first obtained by Tanaka 
e£ £1^ . , (1967b) who crystallized the rat liver enzyme. Later, bovine 
(Cardenas & Dyson, 1972); pig (Kutzbach e_t al^., 1973); chicken 
(Eigenbrodt & Schoner, 1975) and human (Marie e£ a_l., 1976) PK's were 
also purified. The molecular weight of the L-type enzyme has been 
reported to be 200,000-228,000 (Tanaka e_t aj^., 1967b; Bischofberger 
e£ al_,, 1970; Ibsen & Trippet, 1972; Cardenas & Dyson, 1973; Riou 
e_t al., 1978). The enzyme has a quaternary structure with identical 
subunits. The molecular weight of the subunits has been estimated 
to range from 54,000 to 62,000 using either an SDS-polyacrylamide 
gel technique or sedimentation equilibrium in guanine hydrochloride 
(Kutzback & Hess, 1970; Cardenas & Dyson, 1973; LjungstrHm et al., 
1974; Riou e_t aj^., 1978).
C. REGULATION OF L-TYPE PYRUVATE KINASE
Recent studies have provided evidence that the pyruvate/PEP 
substrate cycle is very important in the regulation of gluconeogenesis 
(see section I.C.l). PK is also involved in the formation of various 
metabolic products from carbohydrates, thus making its regulation an 
important concept in liver metabolism.
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1. Allosteric Activation
Stimulation of L-type PK by Fru^^BP was first observed by 
Hess ejt a_l., (1966); Tanaka e_t al., (1967a) and Taylor & Bailey, 
(1967). The stimulatory effects of Fru^^BP depend not only on the 
concentration of the effector but also on PEP concentrations and 
pH (Seubert & Schoner, 1971). The interrelationship between PEP 
and Fru^^BP is best illustrated by plotting reaction velocity 
and substrate concentrations. In the absence of Fru^^BP, the curve 
for the initial velocity against PEP concentrations is sigmoidal 
and in the presence of Fru^^BP, the response to PEP concentrations 
is transformed to give a Michaelis-Menten type curve (Rozengurt 
e£ al., 1969; Taylor & Bailey, 1967). This effect of Fru^^BP is 
apparent with both phosphorylated and unphosphorylated enzyme 
(Ekman e£ £ l ., 1976). Changes in the pH strikingly alter the re­
sponse to Fru^^BP. Taylor & Bailey (1967) using a crude preparation 
of PK showed that at pH 6.0 only a small increase in activity was 
observed in response to 0.5 mM Fru^^BP, whereas at pH 8.0 a 20-fold 
increase was observed. The pH optimum for PK activity in the pre­
sence of Fru^^BP lies between pH 7.0 - 7.5 and in its absence is 
about pH 6.5.
Fru-l-P at concentrations which occur in the rat liver during 
perfusion with 10 mM fructose is also an activator of PK (Eggleston 
& Woods, 1970). This activation of PK by Fru-l-P is greatest at 
physiological PEP concentrations (i.e. PEP concentrations which are 
present in fresh freeze-clamped or perfused liver). At a higher PEP 
concentration (0.8 mM), Eggleston & Woods, (1970) found that acti­
vation by Fru-l-P is abolished. Koster e£ £ l ., Ç 1972 )
observed that Glu^^BP also stimulates L-type PK. Maximum stimula­
tion of the enzyme was obtained with 1 mM Glu^^BP. However, it is 
u n l i k e l y h a v e  any physiological significance because of low levels 
of this intermediate Ln vivo.
An effect of Pi on L-type PK has been observed by Koster & 
Hulsman (1970), who found that depending on the substrate concentra­
tions Pi can either stimulate or inhibit the enzyme. When PEP
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concentrations are kept constant and ADP concentrations varied.
Pi can activate PK at high ADP concentrations, whereas at low 
ADP concentrations an inhibitory effect is apparent. The physio­
logical relevance of such effects is doubtful since a relatively 
high concentration of Pi was required to produce these effects.
Only the feed-forward activation of the enzyme by Fru^^BP 
(and possibly Fru-l-P) have been considered to have any physiolo­
gical significance. However, 6-phosphogluconate, an intermediate 
of the pentose phosphate pathway, has recently been shown to acti­
vate L-type PK (Smith & Reedland, 1979; 1981). This activation is 
considered to be a means of communication between the two pathways 
central to fatty acid synthesis. The physiological significance 
to this effect is confirmed by the observations that the stimulato- 
ty effect of 6-phosphogluconate is apparent using concentrations of 
the effector which occur in vivo and that in the physiological range 
of PEP concentrations, 6-phosphogluconate has the greatest effect 
on PK from sucrose-fed rats and the least effect on the enzyme from 
48 h starved rats (Smith & Freedland,1979). Furthermore, incubation 
of isolated hepatocytes with 6-aminonicotinamide, an inhibitor of 
6-phosphogluconate dehydrogenase (E.G. 1.1.1.44) causes the accumu­
lation of 6-phosphogluconate, and also increases the flux of PEP 
through PK (Smith & Freedland, 1981),
L-type PK has also been shown to have an absolute requirement
for mono- and divalent ions (Seubert & Schoner, 1971). K^ is known
to stimulate the enzyme (Irving & Williams, 1973); the optimum
activation is obtained with 50 mM K^. Ekman £t al., (1976) and
LjungstrBm e_t a^., (1976) observed that both the phosphorylated and
unphosphorylated PK were dependent on K^. The stimulatory effect of
K^ is increased by Fru,,BP (Jimenez De Asua et al., 1970). The re-
10   +
quirement of PK for monovalent ions can also be fulfilled by NH^ 
(Jimenez De Asua e£ a_l., 1970). Mg^ has also been shown to be ne­
cessary for PK activity (Carminatti e_t aj^., 1968); the optimum con­
centration which gives maximum activation of PK is about 7 mM
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2+
(LjungstrHm et al., 1976). Higher concentrations of Mg were in­
hibitory and the inhibition is almost complete at concentrations
2+
10-fold higher than the optimum. The activating effect of Ca
2+
(1 mM) is absolutely dependent on Mg concentration (Gabrielli
2+
& Baldi, 1972). In the absence of Mg , PK has no catalytic acti-
2+ . . 2+
vity even in the presence of Ca , The activation by Ca is only
observed at low PEP concentrations. In the presence of Fru.,BP
2+ . . . .  .
(O.I mM), Ca ions are inhibitory at all PEP concentrations.
2. Allosteric Inhibition
ATP is thought to be an important inhibitor of L-type PK in 
vivo, since the enzyme is inhibited by physiological concentrations 
of the nucleotide (Llorente £t aj^., 1970; Seubert & Schoner, 1971). 
The sigmoidal kinetic properties in response to increasing concen­
trations of PEP is enhanced in the presence of ATP, an effect which 
can be reversed by Fru^^BP (Llorente et al., 1970). GTP has also been 
reported to be an inhibitor of chicken liver PK (Williams e_t al., 1969)
A number of amino acids such as alanine, cysteine, proline, 
serine, tyrosine, valine and phenylalanine have been reported to 
inhibit L-type PK. However, of these amino acids, only alanine inhi­
bited the enzyme in the concentration range found under physiological 
conditions (Seubert e£ aT., 1968; Weber et al., 1968b; Schoner et al., 
1970). The inhibitory action of alanine is stereospecific for the 
L-isomer; D-alanine and g-alanine are without effect (Schoner et al., 
1970). Alanine only inhibits PK at subsaturating PEP concentrations; 
the inhibition is competitive with respect to the substrate. The 
inhibitory action of alanine can be counteracted by physiological 
concentrations of Fru^^BP (Llorente e£ £ l ., 1970; Carbonell et al.,
1973).
Llorente e_t a_l., (1970), found that a 50% inhibition of the 
enzyme was observed with concentrations of 0.1 mM alanine and 0.5 mM 
ATP, which are both below their physiological concentration range
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(0.5 to 1.5 idM for alanine; Williamson et al., 1967b; Brosnan ££ 
al., 1970; Schoner e_t £ l ., 1970;and 2 to 3 mM for ATP; Bûcher et 
al., 1964; Schoner et al., 1970). ATP and alanine have also been 
shown to inhibit both the phosphorylated and unphosphorylated PK 
(Ekman et al., 1976; Ljungstrüm e_t £l., 1976).
Therefore it is clear that L-type PK is allosterically inhi­
bited by ATP and alanine and activated by Fru^^BP. The presence of 
physiological concentrations of these effectors can have profound 
effects on the degree of co-operativity displayed by the enzyme as 
well as on the S^ ^ for PEP. With physiological concentrations of 
ATP, alanine and PEP, it can be predicted that the enzyme would be 
completely inhibited in the absence of Fru^^BP, Thus the activity 
of PK vivo probably depends on the concentration of Fru^^BP 
available to bind to PK. However, the concentration of Fru^^BP in the 
cell is such that it would completely activate the enzyme even in the 
presence of physiological concentrations of ATP and alanine. Fru^^BP 
reverses the effects of ATP and alanine on both the phosphorylated 
and unphosphorylated enzyme (Ekman et al., 1976; Ljungstrdm et al., 
1976). Therefore the regulation of L-type PK in vivo is mainly de­
pendent on the concentrations of ATP, alanine and Fru^^BP as well 
as the phosphorylation state of the enzyme.
Other metabolites which have been reported to inhibit PK are 
the free fatty acids (FFA), which also stimulate glucose production 
by the perfused liver (Williamson et al., 1968,; Friedman et al.,
1965). In addition to stimulation of gluconeogenesis, the effect of 
FFA may also be due to a direct inhibition of PK (Lea & Weber, 1968; 
Weber £t al_., 1968a). Quantitative studies by Weber al., (1968b) 
revealed that long-chain FFA were more effective inhibitors than 
medium-chain FFA. The inactivation is time-dependent and irreversible. 
FFA also inhibit the other key glycolytic enzymes (glucokinase and 
PFK 1), but their selectivity was questioned when they were found to 
inhibit a gluconeogenic enzyme (Pande & Mead, 1968). These authors con­
cluded that FFA are unspecific inhibitors and suggested detergent 
properties of the FFA to be the cause of their inhibitory action.
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Acetyl-CoA is an end product of FFA metabolism and its levels 
increase in gluconeogenic conditions (Williamson et al., 1966); it 
seemed possible that it could exert an inhibitory action on some key 
glycolytic enzymes, Weber e£ al., (1968b) studied the inhibition of 
PK by acetyl-CoA and showed that it was time dependent, thus it is 
obvious that a chemical modification of the enzyme rather than an 
allosteric effect is responsible for the alteration of the catalytic 
properties of PK. As with FFA the interaction of acetyl-CoA with 
PK is irreversible.
Oxalate exerts a dual effect on PK.In the absence of Fru ,BP
lo
and at low PEP concentrations, oxalate behaves as an allosteric acti­
vator. In the presence of Fru^^BP and at low PEP concentrations it 
is a powerful competitive inhibitor with respect to PEP (Buc et al., 
1978; 1981).
2+
PK has been shown to be sensitive to Cu (Passeron et al.,
1967; Bailey £t £ l ., 1968a; Carminatti e£ al^., 1968). At low PEP con-
2+
centrations type L is strongly inhibited by Cu . The inhibition pro- 
-3 2+
duced by 6.6 x 10 M Cu can be reversed by chelating agents such
as EDTA and EGTA. Fru^^BP also reverses the inhibition and it is by
far the most effective, since more than 60% reactivation can be ob-
2+
tained at a Fru^^BP concentration five times lower than that of Cu 
This indicates that Fru^^BP is not acting as a simple chelating agent.
but rather has a direct effect on the enzyme. The sensitivity of the 
enzyme towards Cu^* is gre 
(Carminatti et al., 1968).
2+ . 2+
 atly increased at high Cu concentrations
3. Effect of pH
The allosteric properties of L-type PK are strongly affected by 
changes in pH (Rozengurt et al., 1969). The enzyme obeys Michaelis- 
Menten kinetics at pH 5.9 with respect to PEP and there is little 
activation by Fru^^BP. As the pH is raised, the kinetic response to 
increasing PEP concentrations becomes increasingly sigmoidal and 
Fru^^BP activation is more pronounced. This altered kinetic profile
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suggests an activation of an ionizing group (possibly imidazole) 
having a pK value around 7.0 (Irving & Williams, 1973). The inhibi­
tory action of alanine and ATP is also modified by changes in pH; 
the inhibition is reduced at low pH values (Schoner e_t al., 1970).
4. Effect of Temperature
The kinetic behaviour of PK is affected by temperature. If 
crude liver extracts are obtained at room temperature, instead of 
the usual 2-4°C, the extracts show marked sigmoidal kinetics. Storage 
of the enzyme extracts in the cold diminishes the sensitivity of the 
PK to the inhibitory action of alanine and ATP. Resensitization to 
almost 90% of the original activity is observed upon incubation of 
the extracts at 37°C (Llorente £_t £ l ., 1970). Van Berkel et al.,
(1975) observed that ATP and alanine both stabilize PK when assayed 
at 53°C. The sensitivity of PK to Fru^^BP in warmed extracts is lost 
on cooling and can be recovered upon rewarming (Llorente et al.,1970).
5. Hormonal Regulation
The activity of key glycolytic and gluconeogenic enzymes can 
be changed rapidly by administration of hormones (Taunton et al., 1972;
1974; Stifel e£ aj^., 1974).
Administration of glucagon reduces flux through PK, thus dimi­
nishing recycling and increasing the conversion of PEP to glucose.
This effect is consistent with the observations made by Exton & Park
(1969), who found a fall in pyruvate and a rise in PEP steady-state 
concentrations in livers perfused with the hormone or with cAMP, These 
findings indicated that one site of action of glucagon involves the 
regulation of PK. Further investigations performed by independent 
workers demonstrated conclusively that addition of glucagon to the 
perfused rat liver (Blair et al., 1976) or to isolated hepatocytes 
(Feliu e£ al^., 1976; Foster & Blair, 1976; Friedrichs, 1976; Pilkis- 
e_t £ l ., 1976a; 1976b; Riou e_t a_l., 1976; Van Berkel 1^76; 1977a; 1977b) 
results in the inhibition of PK assayed at subsaturating PEP concentra­
tions. When the PK activity was determined at saturating PEP concentrations,
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the hormonal influence was not detected. The regulation of PK by 
glucagon, therefore, does not alter the total enzyme content in 
the liver, but rather appears to influence the dependence of the 
enzyme activity on PEP concentrations. PK inactivated by low glucagon 
concentrations can be rapidly reactivated by the addition of insulin 
(Feliu et al., 1976). In the presence of maximally effective concen­
trations of Fru^gBP (20 pM), 10 nM glucagon has no effect on PK . 
activity (Riou et al., 1976). These workers also reported that the 
maximum stimulation of the enzyme by Fru^^BP in the control was only
I.4-fold but was 6-fold in the extracts of glucagon-treated hepato­
cytes. PK from glucagon-treated hepatocytes is further inhibited by 
ATP and alanine (Riou et al., 1976).
Cyclic nucleotides, such as, cAMP and dibutyryl cAMP have been 
shown to have the same effect as glucagon (Feliu e_t a_l., 1976; Van 
Berkel e£ aj^., 1976; Pilkis eit a_l., l978b). This is consistent with the 
suggestion that cAMP is a second messenger (Robison e_t al., 1971) 
and any changes observed after glucagon administration are due to an 
increase in cAMP levels. There is strong evidence that the effect of 
glucagon is mediated via a cAMP-dependent protein kinase (see section
II.E.l).
Catecholamines have also been reported to inhibit hepatocyte PK. 
The inhibition is quite small compared to that observed with glucagon 
(Feliu e_t a_l., 1976). Inhibition of L-type PK is consistent with sti­
mulation of gluconeogenesis by adrenaline reported by Claus & Pilkis,
(1976). Insulin can suppress, at least in part, the inhibition caused 
by maximally effective concentrations of adrenaline (Feliu et al., 
1976). In this respect, the adrenaline effect is qualitatively diffe­
rent to that of glucagon; in the latter case only the effect of sub- 
maximal concentrations of the hormone can be antagonized by insulin.
The inhibition is associated with an increase in the ^ for PEP 
(Feliu ejt a^., 1976) which suggests phosphorylation of PK. The mecha­
nism is possibly mediated via both a- and 6-receptors (see section
11.5.2).
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Insulin in its role of homeostatic regulator of the blood glu­
cose levels exerts its effects on liver metabolism where several 
enzyme changes are well documented (Pitot & Yatvin, 1973). In general, 
insulin promotes the synthesis of enzymes associated with carbohy­
drate utilization and storage and represses the synthesis of enzymes 
associated with glucose synthesis. The role of insulin in induction 
of PK was studied by Weber et al., (1965b). They observed that PK 
activity was low in alloxan-diabetic rats, but was returned to nor­
mal following insulin injection. Further investigation showed that 
insulin induction of PK was blocked by ethionine (an inhibitor of 
protein synthesis) and actinomycin D (an inhibitor of RNA synthesis), 
suggesting that the insulin-induced rise in this enzyme is due to the 
de novo synthesis of enzyme which is dependent on the synthesis of 
new RNA.
The short term effects of insulin on PK were demonstrated by 
Taunton et al., (1974), who injected insulin into the portal vein 
of experimental animals and detected a rapid effect involving the acti­
vation of henatic PPK 1 and PK. The effect was maximal after 10 min and 
gradually declined over 30 min. Pre-treatment of the rat with acti­
nomycin D and puromycin did not alter the response of the enzymes to 
this hormone, indicating that de novo protein synthesis was not re­
sponsible for the changes in enzyme activities. These rapid effects of 
insulin on PK activity have also been demonstrated in experiments 
using isolated perfused liver (Blair e_t al., 1976) and isolated hepa­
tocytes (Feliu et al., 1976).
Insulin alone, slightly increases the activity of PK in the per­
fused liver compared to the activity found in homogenate from control 
livers. More pronounced effects are observed in livers which have 
been treated with low concentrations of glucagon (Blair et al., 1976).
This effect of insulin could be explained under some conditions by a 
fall in the level of cAMP. Another explanation of the insulin effect 
is that it may increase Fru,,BP levels. However, Claus et al.,(1979) 
reported that even though insulin suppresses the inactivation of PK 
by glucagon and phenylepherine, it did not change Fru^^BP levels.
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6. Dietary Regulation
During starvation, hepatic gluconeogenesis is predominant.
The glucose produced is used as a source of energy by other non- 
gluconeogenic tissues (e.g. muscle). Thus, there is an obvious need 
for hepatic PK activity to be low during starvation (Krebs & Eggleston, 
1965; Tanaka et al., 1965). Meal-trained rats fed on a high carbo­
hydrate diet were used to show maximum induction of hepatic PK after
8 days (Hopkirk & Bloxham, 1979). PK is also subject to a diurnal 
variation. A rapid increase in enzyme activity also occurs as
a response to feeding; this is accompanied by an apparent increase in 
the affinity of the enzyme for PEP which is consistent with the de­
creased phosphorylation of the enzyme.
Kohl & Cottam (1976), made similar observations when they 
starved and re-fed rats on a high carbohydrate and low protein diet. 
Using a precipitating antiserum directed specifically against hepatic 
PK, they found that rats maintained on a high carbohydrate diet 4 
days prior to sacrifice have at least 20 mg of precipitable hepatic 
PK protein per liver. Starving the animal results in a marked reduc­
tion in hepatic PK, so that after 3 days starvation less than 7 mg 
of hepatic PK protein per liver remains.Re-feeding the animals results 
in a return to the normal situation. Furthermore, the specific activity 
of PK purified from liver fasted for 72 to 84 h is approximately one 
third of the specific activity of the enzyme isolated from rats fed on 
a high carbohydrate diet (Kohl & Cottam, 1977). The lower specific 
activity of the enzyme from fasted rats must reflect a modification of 
the enzyme (Van Berkel al_., 1978; Hall et al., 1979). It is sugges­
ted that phosphorylated PK is more susceptible to proteolytic modifica­
tion than the dephosphoenzvme and that this factor plays a role in 
the irreversible deactivation of PK under starvation conditions 
(BergstrHm et al., 1978).
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D. MECHANISM OF ALLOSTERIC CONTROL
The co-operative kinetics of allosteric enzyme can be explained 
using the model of Monod e_t al^., (1965). This postulates that two 
conformational states (R and T) of the enzyme occur which are in 
equilibrium.These can exhibit different affinities for the substra­
tes and effectors (K system) or the same affinities but a different 
catalytic efficiency (V system). According to this model, positive 
effectors, interacting preferentially with the R state, would shift 
the equilibrium in favour of the state with a higher affinity for the 
substrate (K system); or the more active form of the enzyme (V system). 
Negative effectors, interacting preferentially with the T state would 
shift the equilibrium in favour of the state with a lower affinity 
(K system) or a lowered catalytic activity (V system).
In the case of PK, these predictions are fulfilled with respect 
to the interaction of PEP with various effectors(Schoner eJt a_l., 1970). 
In the presence of a positive effector, e.g. Fru^^BP, the homotropic 
interaction of PEP is lowered as indicated by a change in the Hill 
coefficient in the direction of unity (Jimenez Üe Asua et a^., 1970).
On the contrary, the negative effectors, e.g. ATP and alanine, cause 
a strengthening of the homotropic interaction of PEP as indicated by 
the change of the Hill coefficients to a greater value (Schoner et al., 
1970). These findings are compatible with the model of Monod et al., 
(1965), suggesting that PK exists as an equilibrium between two con­
formational states, with various effectors controlling its activity.
ATP, alanine, OH
pyruvate kinase^^^    ^  pyruvate kinase
Fru^^BP,H*
Further investigation of the allosteric model of L-type PK re­
vealed that ATP and alanine both stabilize the enzyme, the degree of 
maximum stabilization for alanine being greater than for ATP (Van 
Berkel et al., 1975). These workers also observed that further
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stabilization occurs when ATP is added to the enzyme maximally
stabilized with alanine or vice versa, indicating additive effects
of alanine and ATP on the stabilization. These observations reinforce
the suggestion made earlier, that alanine and ATP introduce different
conformational states, probably by binding to different sites (Van
Berkel et al., 1974), Rozengurt ejt , (1973) reported that the
allosteric activators and Fru -BP each introduce a different R
io
conformation. These findings on allosteric activation and inhibition 
are difficult to reconcile with a two-state model of Monod et al., 
(1965), and suggests that sequential conformational changes are in­
volved in the allosteric transition (Koshland & Neet, 1968; Koshland, 
1970).
E. MECHANISM OF HORMONAL REGULATION
The intracellular physiological response to glucagon seems to 
be mediated by cAMP (Sutherland, 1972), whose main action at the 
molecular level is to stimulate specific protein phosphorylation 
(Kuo & Greengard, 1969). Such a phosphorylation of enzymes results 
in a change in their kinetic properties, as has been clearly demon­
strated for phosphorylase kinase and glycogen synthetase (Hers, 1976). 
The cAMP-stimulated phosphorylation of enzymes and other proteins is 
reversible because of the presence of phosphoprotein phosphatases. Thus 
metabolic regulation via phosphorylation-déphosphorylation of PK can 
occur iji vivo.
1. Phosphorylation-déphosphorylation
Highly purified L-type PK from rat liver has been shown to be 
phosphorylated by ATP in a reaction catalysed by cAMP-dependent protein 
kinase (LjungstrtJm e£ £ l ., 1974). Phosphorylation appears to modify 
the ease with which the enzyme undergoes conformational changes in 
response to its effectors. The end result is to shift the equilibrium 
between the active and inactive forms. This hypothesis is illustrated 
diagramatically in figure 7a.
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Low PEP
ATP
ADP
Low PEP
High PEP
FrUiôBP
High PEP
ATP
Inactive Active
Figure 7a. Schematic representation of the effect of phosphorylation 
on the equilibrium between active and inactive forms of PK 
(circles - inactive form of PK; squares - active form of PKJ 
other symbols - transitional forms; P represents covalently 
bound phosphate groups) (after Pilkis et al., 1978a).
It is postulated that increasing concentrations of PEP and 
Fru^^BP cause a conformational change in the enzyme leading to a more 
closely associated quaternary structure and to increased activity, 
whereas ATP and alanine have the opposite effect. Phosphorylation 
of the enzyme subunits tends to impede this conformational change, 
resulting in a 'looser* quaternary structure at low PEP concentrations
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and to decreased activity. High PEP and Fru^^BP concentrations can 
overcome the effect of phosphorylation. It is also postulated that 
the active tetrameric form does not undergo phosphorylation 
(Eigenbrodt & Schoner, 1977a; 1977b).
i) Site of Phosphorylation
One major phosphopeptide containing phosphoryl-
serine has been isolated from PK formed by the incubation of
the purified enzyme from rat liver (Edlund e_t a^., 1975) or from pig 
liver (Hjelmquist a_l., 1974) with cAMP-dependent protein kinase 
and P^PJ ATP. This established that a specific seryl residue in 
the PK is phosphorylated. Humble ejt al^., (1975) showed that alkali- 
inactivated pig liver PK and a peptide obtained by cyanogen bromide 
treatment could be phosphorylated by ATP, and in both cases
the rate of phosphorylation was higher than that with the native 
enzyme. The amino acid sequences of the peptides have been determined 
and are shown to have similarities to peptides from other phosphoryla­
ted enzymes (EngstrBm, 1978). The general sequence is that there 
are two basic residues and either one or two neutral amino acids 
preceeding the serine which is followed by another neutral amino acid. 
Hjelmquist et 11., (1974) showed that the minimum structural require­
ments for the phosphorylation of L-type PK were met by the pentapeptide 
Arg-Arg-Ala-Ser-Val. This was confirmed by Humble (1980) who used 
chymotrypsin to remove the phosphorylated site of the enzyme. The 
rate of phosphorylation of these peptides is related to the amino 
acid sequence surrounding the phosphorylation site (Pilkis et. JLL* »
1980). These workers compared the rate of phosphorylation of Fru^^BP- 
ase (which contains only one basic residue preceeding serine) and 
PK (which contains two basic residues preceeding serine).PK is 10 
times better as a substrate for phosphorylation than Fru^^BPase.
ii) Phosphorylation of pyruvate kinase in vitro
Studies to date have revealed that the rat and pig liver enzymeç 
appear to be phosphorylated by a cAMP-dependent protein kinase (Ljungstrüm
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25. fJL" * 1976; Riou e_t al^., 1976; Titanji et al. , 1976; Berglund et 
al., 1977). Phosphorylation has been studied using a homogeneous 
preparation of bovine liver or heart catalytic subunits of cAMP- 
dependent protein kinase and homogeneous rat liver PK (Pilkis et aT., 
1978c). In some cases however, crude preparations of protein kinase 
were used, and it is possible that they contained cAMP-independent 
as well as cAMP-dependent protein kinase. The possible involvement 
of an independent kinase in the phosphorylation of PK was studied 
by Pilkis et. fl." * (1978b), using hepatocyte homogenates that had 
been gel filtered on Sephadex G-25 in order to remove all low-molecu- 
lar-weight compounds. The addition of cAMP and ATP-Mg to these extracts 
produced a time dependent inactivation of L-type PK, whereas the addi­
tion of ATP-Mg alone had no effect. The cAMP-induced inactivation could 
be completely blocked by the addition of a protein kinase inhibitor, a 
compound specific for the catalytic subunit of cAMP-dependent protein 
kinase (Walsh 25. » 1971). These results demonstrated that cAMP-
dependent phosphorylation is linked to enzyme inactivation.
The rate of phosphorylation of PK by a partially purified cAMP- 
dependent protein kinase is increased by alanine (Berglund et al., 
(1977). This stimulation is observed at alkaline pH, but it is not 
clear whether the phosphate was incorporated at the same site or 
if there was any associated alteration in enzyme activity. Evaluation 
of these results clouded by the fact that the protein kinase used 
was not purified. The effect of allosteric effectors on the phospho­
rylation of PK was further studied by El-Maghrabi e2 2L* » (1980) who 
used a purified protein kinase. They reported that physiological con­
centrations of the allosteric effectors PEP and Fru^^BP inhibit the 
rate of phosphorylation catalysed by protein kinase. The negative 
allosteric effector, alanine, only had a small stimulatiory effect 
by itself, but it relieved the inhibition of phosphorylation by PEP 
and Fru^^BP. The ability of allosteric effectors to modify the phos­
phorylation state of PK extends considerably the flexibility and 
sensitivity of its regulation. Thus in addition to the regulation
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of PK directly by allosteric effectors, they also act indirectly by 
modulating the phosphorylation state of the enzyme.
The kinetics of the phosphorylated and dephosphorylated rat 
liver enzyme have been studied. The major kinetic effect of phospho­
rylation is to reduce the affinity for the substrate PEP, the  ^
for this substrate increases from 0.3 mM for the dephosphoenzyme 
to 0.8 mM for the phosphorylated form (Ekman 2L £ l • » 1976). Thus 
the enzyme activity versus PEP concentration curve is more sigmoidal 
for the phosphorylated enzyme. The affinity for the second substrate
ADP is unchanged (Ljungstrüm et al., 1976). Fru^^BP increases the
—"   io
apparent affinity of both enzyme forms for PEP (Ekman 2£ |[_1 •, 1976; 
Ljungstrüm £2 fi* » 1976). At saturating concentrations of this acti­
vator, the kinetics of both enzyme fc^ms are transformed to approxi­
mately identical hyperbolic curves. The negative effectors, ATP and 
alanine,increase even further the ^ for PEP of the phosphorylated 
enzyme. A higher Fru^^BP concentration is necessary for the maximal 
activation of the phosphoenzyme than for the dephosphoenzyme assayed 
in the presence of physiological concentrations of ATP and alanine 
(Ekman et al., 1976). Ljungstrüm e_t al., (1976) reported that hydrogen 
ions are effective in activating the phosphoenzyme. Thus when the pH 
is lowered from 8 to 6.5, the inhibition due to phosphorylation is 
abolished. The requirement for K is unaffected by the phosphorylation 
state, whereas the phosphoenzyme requires a higher concentration of 
Mg^ for maximal activity, compared with the control enzyme.
iii) Phosphorylation of L-type pyruvate kinase in vivo
Experiments using whole animals, perfused livers, liver slices 
and isolated hepatocytes have been performed in various laboratories 
to study the phosphorylation of L-type PK vivo. Ljungstüm & Ekman,
(1977) used liver slices and observed a small but significant phospho­
rylation of the enzyme (about 0.2 mol of phosphate/mol of enzyme).
This value was low, but can be explained by the existence in the cell 
sap of a phosphatase activity (Titanji et al., 1976), which can cause
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rapid déphosphorylation of PK. They observed a decrease in enzyme 
activity parallel to an increase in the phosphorylation of the 
enzyme. A similar decrease in enzyme activity to that observed when 
PK is phosphorylated vitro is also apparent in experiments with 
perfused livers (Blair et al., 1976).and isolated hepatocytes 
(Ishibashi & Cottam, 1978).
A comparison of the kinetic properties of the enzyme in extracts 
of glucagon-treated hepatocytes with those of the purified enzyme 
that has been phosphorylated iji vitro shows several similarities 
(Riou £2 al^., 1976). Firstly, there is an apparent decrease in the 
affinity of the enzyme for PEP. Secondly, both preparations are more 
sensitive to inhibition by ATP and alanine. Thirdly, both enzymes are 
less sensitive to activation by Fru^^BP. Therefore, from the data 
available there is strong evidence that glucagon stimulates phosphoryla­
tion of PK (Garrison & Borland, 1978) which would result in a decrease 
in the enzyme activity.
Furthermore, Riou et al., (1978) used phosphoric acid to
32demonstrate that glucagon stimulates the incorporation of Pi \»0to
32the enzyme in vivo. They injected the rats with Pi, somatostatin
(given to prevent the secretion of insulin in response to glucagon
administration) and either saline or glucagon. The incorporation of 
32
Pi into PK was stimulated 2~to 3-fold by glucagon. This increase in 
enzyme-bound phosphate was associated with an inhibition of PK.and 
an increase in hepatic cAMP accumulation. These results demonstrate 
in vivo phosphorylation of the enzyme and support the hypothesis 
that glucagon regulates L-type PK activity, at least in part, by 
a phosphorylation mechanism.
iv) Dephosphorylation of L-type pyruvate kinase
The enzyme(s) responsible for the dephosphorylation of PK are 
protein phosphatases. A phosphoprotein phosphatase (E.G.3.1.3.16) 
which is capable of dephosphorylating l ^p] -PK has been purified
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from rat liver (Titanji et al., 1976; Titanji, 1977). They observed 
that maximally phosphorylated PK (i.e. the enzyme activity is com­
pletely inhibited when assayed at subsaturating PEP concentrations) 
can be almost completely reactivated by incubation with the phos­
phatase. The PEP saturation curve is nearly the same after dephos­
phorylation of the enzyme as before phosphorylation (Titanji et al^, 
1976). Van Berkel e_t al., (1977a) reported that inactive PK in glu­
cagon-treated hepatocyte homogenates could be reactivated by incu­
bation with divalent ions. This reactivation is completely blocked 
in the presence of 20 mM KF, a well known inhibitor of phosphory- 
lase'b*phosphatase (Stalmans & Hers, 1975) and other protein phos­
phatases (Kato & Bishop, 1972; Siess & Wieland, 1972). These observa­
tions strongly suggest that dephosphorylation of PK is the result 
of the activation of protein '
2. Other Possible Mechanisms of Hormonal Regulation
Another mechanism by which hormones affect PK activity involves 
changes in the intracellular levels of various allosteric effectors, 
particularly Fru^^BP. The addition of glucagon to intact hepatocytes 
lowers the level of Fru^^BP (Blair £t a_l., 1973; Pilkis et al.,1976a; 
1976b), The fall in the concentration of Fru^^BP reduces PK activity 
by inducing a conformational change. This change also converts the 
protein to a more favourable substrate for inactivation by protein 
kinase and/or to a less favourable substrate for activation by pro­
tein phosphatase. The effect of insulin appeals to be unrelated to 
changes in Fru^^BP concentrations (Claus e£ aT., 1979) since the levels 
of this metabolite decline even further in the presence of insulin.
This effect of insulin may be the result of the activation of glycogen 
synthetase (Craig et_ a_l., 1969).
Catecholamine effects are mediated via an a-adrenergic or a 
6-adrenergic mechanism. Adrenaline decreases the PK activity when 
assayed at subsaturating PEP concentrations, and this effect is partly 
blocked by a-adrenergic antagonists (e.g. phenoxybenzamine) and by
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the B-adrenergic antagonists (e.g. propranolol) (Chan & Exton,
1978; Foster & Blair, 1978; Kemp(& Clark 1978). Phenylephrine^an 
a-adrenergic agonist, causes small changes in PK activity and 
the effects are partly inhibited by a-blocking agents and to a 
smaller extent by B-blocking agents (Chan & Exton, 1978; Kemp &
Clark, 1978). In the presence of l-methyl-3-isobutylxanthine, an 
inhibitor of cyclic nucleotide phosphodiesterase (E.C. 3.1.4.17) 
the effect of both these agonists on PK activity is decreased by 
the a-adrenergic antagonists to a greater extent than by B-adrenergic 
antagonists, indicating that the cyclic nucleotide phosphodiesterase 
inhibitor potentiated mainly the a-adrenergic effects of these 
agonists. From these observations Chan & Exton, (1978) concluded 
that adrenaline inhibits PK by an a- receptor mediated, cAMP-inde­
pendent mechanism. In contrast to these observations, Kemp & Clark
(1978) obtained data which suggests that the regulation of PK by adre­
naline is via a cAMP-dependent protein kinase. Furthermore, reports 
by other workers (Blair e_t al., 1979a; Yorek e_t al., 1981) suggest 
that both a- and B-adrenergic control of the enzyme may occur, and 
the relative contribution of these two pathways depends on the age 
of the rat used. Thus, B-adrenergic, cAMP-dependent regulation of PK 
activity and carbohydrate metabolism is consistent with the several 
observations that PK may be phosphorylated by a cAMP-dependent protein 
kinase (Berglund, e£ a^., 1977; Ljungstrüm & Ekman, 1977, Riou et al., 
1978). The mechanism by which cAMP-independent a-adrenergic regula­
tion occurs is not fully understood. However, the a-adrenergic re­
gulation of glycogen metabolism seems to bypass cAMP and cAMP -depen­
dent protein kinase, and intersect the B-mechanism at phosphorylase
kinase via the stimulation of this enzyme as a result of an increase 
2+
in cytosolic Ca concentration (Exton, 1979).
F. THE PHYSIOLOGICAL SIGNIFICANCE OF THE REGULATION OF L-TYPE 
PYRUVATE KINASE
The specific activity of PK in the liver is much higher than 
that of PEP carboxykinase, which suggests that, in order to avoid
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substrate cycling, PK must be substantially inhibited under gluco­
neogenic conditions (Pilkis ejt al., 1978a). Thus the regulation of 
L-type PK in vivo is of physiological importance.
As seen from the discussions earlier in this section, PEP, 
FrUibBP, ATP, alanine and the phosphorylation state of the enzyme 
affect PK activity under physiological conditions, which seems to 
suggest that these are the major regulators of PK.PEP has marked 
effects ,on PK which result in the sigmoidal kinetics of the enzyme 
towards its substrate. At the PEP, ATP and alanine concentrations 
found J_n vivo, PK activity would be negligible unless activated by 
Fru^^BP. Therefore, although there exist- in vivo concentrations 
of ATP and alanine which would completely inhibit PK, the Fru^^BP 
available counteracts this effect. However, it is also clear that 
the concentration of Fru^^BP in vivo is sufficient to maximally stimu­
late the phosphorylated PK assayed at subsaturating PEP concentra­
tions in the presence of ATP and alanine (Ljungstrüm et al., 1976).
The usual explanation for this apparent anomaly * is that the free 
concentrations of Fru^^BP in the cytosol is much lower than the total 
concentration which is normally assayed (Sols & Marco, 1970; Lawson 
ejt a_l., 1976; Feliu e£ a_l., 1977). If these effects have any physiolo­
gical significance, then the balance of the inhibitory and stimula­
tory effects and the phosphorylation state of the enzyme must deter­
mine the flux of carbon through PK.
Under physiological condition^,ATP levels are not altered to 
any great extent which suggests that the interaction of alanine and 
Fru^^BP may be of great physiological importance in the regulation 
of PK. Alternatively, the phosphorylation state of the enzyme may 
be a determining factor or it may be that both types of regulation 
are important. The physiological significance of these effectors is 
apparent when dietary effects are examined. During starvation, PK 
activity is decreased and gluconeogenesis is dominant. Under these 
conditions, the iji vivo concentrations of Fru^^BP decrease (Claus
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e_t aj^., 1979), which would ensure Inactivation of the enzyme by 
ATP and alanine. At the same time there is a hormonally induced 
conversion of the enzyme to alless active phosphorylated form.
The combined effects result in a deactivation of PK. Re-feeding the 
animal on a high carbohydrate diet, on the other hand, leads to 
a change in the liver metabolism from gluconeogenesis to net gly­
colysis. Under these conditions hexose phosphate levels are elevated 
and this leads to an increased synthesis of Fru^^BP which would sti­
mulate PK activity. At the same time the enzyme is dephosphorylated 
with a resulting increase in the affinity for PEP.
From these studies it is clear that these alterations in PK 
activity can account for the physiological changes which occur in 
animals in response to dietary and hormonal factors. A summary of 
the factors which affect PK activity in vivo is shown in figure 7b.
Pi
PEP 
Fru,fBP
PK
(inactive)PK
(active)
Prot^in kinase
Alanine
ATP
ATP
PEP 
Fru,fBP
PEP
FrUigBP
Alanine
ATP
Figure 7b. Factors affecting L-type pyruvate kinase activity 
in liver parenchymal cells.
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III. RESULTS AND DISCUSSION
The L-type pyruvate kinase from rat liver is an allosteric 
enzyme which is inhibited by ATP and alanine and activated by Fru^^BP 
(Seubert & Schoner, 1971). The enzyme can also be regulated by a 
cAMP dependent protein kinase (EngstrUm, 1978).
The glycolysis of various carbohydrate substrates passes a common
regulatory step,which is catalysed by PK (see figure 3). It has been
reported that fructose causes the accumulation of hepatic Fru-l-P
(Woods et al., 1970; Van den Berghe, 1978) a known activator of PK
(Eggleston & Woods, 1970). Dihydroxyacetone has also been reported to
increase Fru^^BP concentrations in the perfused liver (Woods & Krebs, ■
1973) and isolated hepatocytes (Claus et al., 1979). The latter authors
also reported that dihydroxyacetone stimulated PK in isolated hepatocytes
from fasted rats, and this was correlated to the elevated Fru .BP levels.
lo
It was of interest, therefore, to test the hypothesis that the 
activation of PK by accumulated Fru-l-P occurs when isolated hepatocytes 
are incubated in the presence of fructose, and to examine the PK acti­
vity from isolated hepatocytes incubated with other related substrates. 
The physiological importance of these effects was also investigated.
A. REGULATION OF PYRUVATE KINASE ACTIVITY BY CARBOHYDRATES
In this study isolated hepatocytes were incubated with various 
concentrations of carbohydrate substrates, and the PK activity was 
measured at 0.2 mM and 4.0 mM PEP in crude extracts. These values 
were compared to the control activities of PK measured in hepatocytes 
which were untreated.
1. Effect of glucose and fructose on pyruvate kinase activity
The metabolism of fructose by the liver differs from that of 
glucose in several important aspects (Section I.C. and I.D.) The 
conversion of fructose to the triose phosphates does not involve the
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regulatory enzymes glucokinase and PFK 1 (figure 3), thus the only 
regulatory enzyme which is common to the glycolysis of glucose and 
fructose is PK. It is also well known that fructose loading causes 
the accumulation of Fru-l-P in the liver. This accumulation has been 
demonstrated in the livers of several species, using intact organisms, 
including laboratory animals (Kjerulf-Jensen, 1942; GUnther et al.,
1967; Burch a^., 1969; Heinz & JunghMnel, 1969; Van den Berghe 
e^ a^., 1973, 1977b), and normal human beings (Bode et^  , 1973) as 
well as in the perfused organ (Woods ejt £ l ., 1970; Sestoft al^., 1972). 
In addition, it has been reported that hepatic PK is activated by Fru-l-P 
at low substrate (PEP) concentrations, but no such activation occurs 
under saturating conditions (Eggleston & Woods, 1970).
In view of the reports described above, and the observations that 
there is a different rate of conversion of uniformly labelled glucose 
and fructose into various intermediates of carbohydrate and lipid 
metabolism (Bailey et al., 1968b; Bar-On & Stein, 1968; Gale & Crawford, 
1969; Pereira & Jangaard, 1971), further studies of the differential 
effects of glucose and fructose on PK were carried out.
Freshly prepared hepatocytes from fed animals were incubated with 
5 mM glucose and fructose and PK activity examined. A control experiment 
with no added hexose was run in parallel (Methods, section IV.B.2).
Incubation of the hepatocytes in the absence of hexose resulted 
in a gradual decrease in enzyme activity when measured at subsaturating 
PEP concentrations but no change in V^^^ (figure 8). Addition of glucose 
(5 mM) had no detectable effect on the rate of the decrease, but fructose 
(5 mM) caused a rapid fall in enzyme activity during the first 10 min 
of the incubation, followed by a further gradual decrease in activity.
The effect of fructose was unexpected since it was expected that the 
accumulation of Fru-l-P would cause a stimulation of PK activity.
The effect of incubating isolated hepatocytes for 15 min with 
varying glucose and fructose concentrations (up to 50 mM) was studied.
It was clear that glucose had little or no effect on PK activity at
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Figure 8. Time course of the effects of 5 mM fructose ( •  ), 5 mM
glucose ( A  ) or no added hexose ( O  ) on pyruvate kinase 
activity assayed with 0.2 mM PEP. The hexoses were added 
to the hepatocytes at zero time and the reaction stopped 
by freezing aliquots of the cell suspension at the appro­
priate time intervals as described in methods (section IV, 
B.3).
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Figure 9. The concentration dependence of the effect of incubating 
hepatocytes (n=2) with fructose ( •  ) or glucose ) on 
pyruvate kinase activity. The incubation period was 15 min.
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either low PEP concentrations (figure 9) or at saturating levels 
of the substrate (results not shown). Incubating the hepatocytes 
with low fructose concentrations caused a small but consistent acti­
vation of PK assayed at subsaturating PEP concentrations (figure 9) 
but the was unchanged. Since the assay conditions represent a
120-fold dilution of the intracellular contents, the stimulation in 
situ is probably greater than that observed under these conditions. 
However, upon incubation of the hepatocytes with high fructose concen­
trations (5 mM or greater) the enzyme was inhibited at subsaturating
PEP concentrations whereas V was unchanged.
max °
These concentration dependent changes in the effect of fructose 
can be explained by either rapid changes in the levels of effectors of 
PK or by changes in the phosphorylation state of the enzyme. This was 
tested by examining the effects of salting out the enzyme with (NH^)2 S0 ^ 
(Table 1).
Table 1. The effect of (NH^)2S0^ precipitation on the inhibition 
of pyruvate kinase in hepatocytes following fructose 
treatment.
Pyruvate Kinase Activity (v/V ) ■'  ^ max
Untreated
Enzyme
(NH4)2®°4
Treated Enzyme
Control 0.42+0.02 0.34+0.01
Glucose (10 mM) 0.40+0.03 0.35+0.01
Fructose (10 mM) 0.33+0.03** 0.34+0.02
p <.01 fructose versus control.
Hepatocytes were incubated for 15 min with or without substrate and 
aliquots removed as described in methods (Section IV,B.3).An aliquot 
was assayed for enzyme activity and the remainder was treated with 
saturated (NH^)2 ^ ^ 4  Co a final concentration of 50% (NH^)2S0^. The 
precipitated protein was centrifuged at 17,000 g for 20 min, the 
pellet resuspended in 50% (NH^)2S0^ and then recentrifuged. The resul­
ting pellet was then resuspended in suspending medium (see methods
IV.B.4) and used for enzyme assay.
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The effect of this treatment on the activity from control and
glucose treated cells is to decrease the v/V . This is probably
, max
related to the removal of Fru^^^BP from the crude extract. There 
was no such effect when the enzyme from the fructose treated hepa- 
tecytes was precipitated by (NH^)2S0^. Thus it is not possible to 
conclude whether the inhibition is due to a stable change of the 
enzyme or a change in the concentration of effectors. However, when 
perchloric acid extracts of fructose (10 mM) treated heptocytes 
were incubated with a PK preparation which had been desalted by 
(NH^)2S0^, the inhibition was observed (figure 10). This inhibition 
was much less marked when extracts from control and glucose treated 
hepatocytes were examined.
The evidence presented above appears to show that the inhibition 
of PK by fructose is the result of the accumulation of an inhibitor 
or the removal of a stimulator rather than a stable modification of 
the enzyme.
It was checked that fructose had no effect on (NH^)2S0^ precipi­
tated PK under these conditions (results not shown). It was also 
observed that the stimulation of PK which occurs when isolated hepa­
tocytes are incubated with low fructose concentrations is abolished 
by the (NH^)2 S0 ^ treatment (results not shown), suggesting the removal 
of an activator.
While the initial rate of fructose uptake by hepatocytes appears 
to be slower than that of glucose (Baur & Heldt, 1976), the rate of 
phosphorylation of the ketose is considerably greater (Renold et al., 
1954; Pereira & Jangaard, 1971; Bode et al^., 1974; Sestoft & Fleron, 
1974; Vessal et al., 1980). The consequence of the rapid phosphorylation 
of fructose is the accumulation of Fru-l-P and the depletion of ATP and 
Pi (MHenpaa £t £1., 1968; Burch e_t £1., 1969; Woods et al. ,1970;
Sestoft £t £1., 1972; Van den Berghe e£ al., 1977a). Since ATP is 
present mainly as the ATP-JIg complex in the hepatocyte (Veloso et al., 
1973), incubation of the cells with fructose also leads to an increase 
in the free M g 2 +  in the extracts (Van de Werve & Hers, 1979).
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Figure 10. Inhibition of partially purified pyruvate kinase by a
neutralized perchloric acid extract of hepatocytes treated 
with either 10 mM fructose ( #  ) or 10 mM glucose ( A  ) 
for 15 min. A control, with no added hexose C O  ) was also 
tested. The extracts were preincubated for 10 min with pyruvate 
kinase and PEP (0.2 mM) was added to start the enzyme 
assay (100 pi of extract is equivalent to 5.8 mg of 
hepatocytes).
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Increased concentrations of glyceraldehyde, glyceraldehyde—3— 
phosphate, G3P and DHAP have been reported in perfused liver 
(Burch et al., 1969, 1970; Heinz & JunghMnel, 1969; Woods et al.,
1970). Fructose has also been reported to increase allantoin pro­
duction by isolated hepatocytes (Smith e_t al., 1977b; Van den 
Berghe et al., 1980). Therefore there are a number of possible 
candidates responsible for the changes in PK activity observed in 
the present study.
It was of interest,therefore, to attempt to dissociate the 
stimulatory effect of Fru-l-P from the inhibitory effect by introdu­
cing a washing step (methods,section IV.B.3), following the incubation 
of hepatocytes with high fructose concentrations. This should have 
the effect of removing any metabolite which can permeate the cell 
membrane, whereas Fru-l-P should remain associated with the hepatocyte.
2. Pyruvate Kinase activity measured after removing the 
extrahepatocyte medium
i) Glucose and fructose effects
A comparison of the change in PK activity as a function of time 
after the addition of hexose revealed that the inhibition observed 
in the presence of fructose (10 mM) was abolished by the washing 
treatment, and a stimulation was now observed (figure 11 A & B). No
significant change in PK activity in the glucose treated hepatocytes 
was observed following the washing step. These observations were con­
firmed when the concentration dependence of fructose effects were 
examined. Figure 12A shows that stimulation of the enzyme at low 
fructose levels and the inhibition at higher fructose concentrations 
are consistently reproducible. Upon subjecting the hepatocytes to a 
washing treatment (figure 12B), the inhibition was abolished and a 
stimulation of PK activity occurred at all concentrations examined.
This data is consistent with the hypothesis that the stimulation of 
PK by fructose is due to the accumulation of a phosphorylated interme­
diate, possibly Fru-l-P, and that the cell membrane is freely permeable 
to the inhibitor which can be removed by washing the hepatocytes.
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Figure 11. Time course showing the effect of 10 mM fructose ( #  ), 10 mM 
glucose (A  ) or no added hexose ( O  ) on pyruvate kinase 
activity. A, Hepatocytes were extracted with the incubation 
medium. B, Hepatocytes were washed with fresh medium before 
extraction; the cells were rapidly sedimented through ice cold 
KRB ( - C a 2 + )  containing 1.5 g % BSA. The supernatant fraction 
was aspirated and the pellet frozen quickly in liquid N2. The 
cells from A and B were then homogenized in 5 volumes of ice 
cold suspending medium (see methods, section IV.B.3).
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Figure 12. The concentration dependence of the effect of incubating 
hepatocytes with either fructose (4# ) or glucose ( A  ) 
for 20 min on pyruvate kinase activity from; A, unwashed 
and B, washed hepatocytes.
- 82 -
A further examination of the time course of the fructose 
(10 mM) effects on PK activity show that both the inhibitory 
and stimulatory effects, in the unwashed and washed cells respecti­
vely, were very rapid, reaching a maximum level in the case of the 
stimulatory effect within 1 min (figure 13B). This latter change 
is consistent with the data in figure 23 which shows a rapid increase 
of Fru-l-P in the same time period. In the unwashed hepatocytes there 
was an immediate fall in the PK activity, followed by a more gradual 
decline (figure 13A). This suggests that there is a rapid burst in 
the formation of inhibitor, which overcomes the activating effect of 
Fru-l-P, followed by a more gradual accumulation of inhibitor (see 
also figure 8),
The primary events following a fructose load both in the intact 
animal (Burch £l •, 1970; Van den Berghe e^ , 1977a) and the 
perfused organ (Woods £ l ., 1970) are the rapid accumulation of 
Fru-l-P and a concomitant depletion of hepatic ATP. These events would 
be expected to lead to an activation of PK when hepatocytes are incuba­
ted with fructose. However, stimulation of the enzyme is observed only 
when the cells are either incubated with low fructose concentration 
(Figure 9 and 12A) or when cells incubated with a high concentrations 
of fructose are washed before assaying for the enzyme (see figure IIB 
& 12b ). Incubation of hepatocytes with glucose has no significant 
effect on PK under these conditions, presumably because the hexose 
does not deplete ATP. One of the most important metabolic changes 
occurring as a result of fructose administration is the depletion 
of ATP. As a consequence of the depletion of this nucleotide, the 
levels of various intermediates increase (see above). It was thus 
interesting to study the hypothesis that, the difference in- PK activity 
observed after glucose or fructose administration is due to a fall in 
hepatic ATP concentrations, or due to the accumulation of a metabolite 
of Fru-l-P.
ii) Effects of glycerol and dihydroxyacetone on pyruvate kinase
activity in hepatocytes
Glycerol and dihydroxyacetone enter the glycolytic sequence at 
the triose phosphate stage (figure 3). This makes PK the common
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Figure 13. Rapid changes in pyruvate kinase activity from hepatocytes 
(n=2) incubated with ( •  ) or without ( O  ) 10 mM fructose 
Comparison of, A, washed and B, unwashed hepatocytes.
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regulatory enzyme for the glycolysis of these two substrates, and 
thus they share a common pathway to the metabolism of fructose. 
Glycerol is known to deplete ATP levels in the perfused liver 
(Burch et al., 1970; Woods & Krebs, 1973) whereas dihydroxyacetone 
does not cause extensive depletion of the nucleotide (Woods & Krebs, 
1973). Thus the possibility that the effects of fructose are related 
to the ATP depletion could be examined by comparing the effects on 
PK using dihydroxyacetone and glycerol as substrates.
Dihydroxyacetone (10 mM) caused no significant change in PK 
activity (v/V^^^) from unwashed cells whereas ' glyceroldO mM) 
caused a rapid inhibition of the enzyme (figure 14A). Washing the 
cells relieved the inhibition caused by 10 mM glycerol (figure 14B), 
and also revealed a rapid activation of the enzyme when cells were 
incubated with 10 mM dihydroxyacetone. The maximum activation caused 
by dihydroxyacetone (40%) was reached after 20 min incubation 
and this was followed by a steady decline.
These observations indicate that glycerol causes the accumula­
tion of an inhibitor which probably leaves the cell. This observation 
is similar to that made with 10 mM fructose. However, unlike fructose 
there is no activation observed when cells incubated with glycerol 
are washed, indicating that glycerol has little or no effect on the 
concentration of PK activator(s) within the cell , In contrast, dihy­
droxyacetone causes a stimulation of PK in washed cells (figure 14B)« 
probably due to the accumulation of Fru^^BP (Claus e^ al_., 1979; see 
also figure 25B). The activation is not observed with unwashed cells 
(figure 14A) suggesting that incubation of hepatocytes with dihydroxy­
acetone also results in the production of inhibitor(s). However, the 
concentration of the inhibitor in the latter case is not sufficient 
to inhibit the enzyme because of the presence of the accumulated 
activator.
A study of the effect of varying concentrations of dihydroxy­
acetone and glycerol is shown in figure 15. The data confirms the 
observations made with 10 mM substrate and shows that significant 
changes were observed following incubation with 1 mM glycerol. It 
is of interest to note that there is a significant difference between
- 85 -
•45
0 40
0 35
0 30
>  0 65
<  0 55 
>
0 50
0 45
0 40
6040200
TI ME ( m i n )
Figure 14. Time course of the effect of 10 mM dihydroxyacetone ( A  ) , 
10 mM glycerol ( a  ) or no added substrate ( O  ) on 
hepatocyte pyruvate kinase activity. A, Hepatocytes 
extracted with incubation medium. B, Hepatocytes washed 
before extraction.
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Figure 15. The concentration dependence of the effect of dihydroxy­
acetone (A ) and glycerol ( □  ) on hepatocyte pyruvate 
kinase activity. A, Hepatocytes extracted without washing 
B, Hepatocytes washed after incubation. The hepatocytes 
were incubated with substrate for 20 min.
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washed and unwashed cells at all concentrations examined. However, 
when the depletion of ATP was examined it was found that 10 mM dihy­
droxyacetone induced a relatively small change in ATP level 
(Control versus 10 mM dihydroxyacetone: 2.4P+ .11 and 2.0 .09 ymoles
g cells  ^ respectively), whereas glycerol caused a more profound de­
crease in ATP concentration (to 0.8 +_ 0.6 pmoles g c e l l s a  lower 
concentration of dihydroxyacetone (4 nW) had no effect on hepatic ATP 
concentration(2.45 pmoles g cells but as shown in figure 15A & B, 
there was some stimulation revealed after the washing step, again 
suggesting that an inhibitor had accumulated despite the fact that 
ATP was not depleted.
From these observations it is clear that both glycerol and 
dihydroxyacetone cause the accumulation of an inhibitor(s), presumably 
identical, or closely related to the inhibitor(s) produced by fructose. 
On the other hand, in contrast to dihydroxyacetone and fructose, in­
cubating hepatocytes with glycerol does not result in the production 
of an activator of PK.
iii) Effect of ^-glyceraldehyde on hepatic pyruvate kinase activity
g-glyceraldehyde is a product of fructose metabolism resulting 
from the aldolytic cleavage of Fru-l-P. There are three possible routes 
for the metabolism of this triose, but the major route under physiolo­
gical conditions is probably its phosphorylation to give glyceralde- 
hyde-3-phosphate (Burch ejt a_l., 1970). It was therefore of interest 
to examine the effects of D^-glyceraldehyde on PK activity.
Again, at all concentrations of D-glyceraldehyde there was 
a stimulation of PK observed following the washing of the cells which 
was not apparent before washing (figure 16). As with dihydroxyacetone, 
it therefore appears that both the inhibitor and activator are produced 
in response to a D-glyceraldehyde load. However, maximum stimulation
was observed at a relatively lower concentration in the case of the 
latter substrate (cf figure 15 & 16)^The explanation for this is not 
immediately clear since the K and V of triokinase for the trioses
HI
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Figure 16. The concentration dependence of the effect of 
D-glyceraldehyde on hepatocyte pyruvate kinase 
activity in unwashed cells ( 0  ) and washed cells 
( ^  ). The incubation period was 20 min.
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Would favour the metabolism of the ketose derivative. The most 
probable explanation is that a reversal of the aldolase reaction 
is occurring resulting in the formation of Fru-l-P from glyceralde­
hyde and DHAP (see section III.B.2). It is also likely that Fru^^BP 
concentration is raised.
3. Pyruvate Kinase activity in hepatocytes from fasted rats
A study of the dietary regulation of L-type PK has revealed that 
the concentration of the enzyme obtained from fasted animals is de­
creased and that there is an increased proportion of PK in the less 
active form (Feliu £££_!•, 1977; Kohl & Gottam, 1977; Van Berkel et al., 
1977a; 1978). The changes in the kinetic properties brought about by 
fasting are similar to those observed in vitro when the purified ôizyme 
is phosphorylated by a cAMP-dependent protein kinase (Ekman et al.,
1976; Kohl & Cottam, 1977; Van Berkel e£ £l^,, 1977a),
In the fasting animal the stimulation of gluconeogenesis is 
accompanied by a decrease in PK activity (Feliu £t al., 1976 ; Foster 
& 3lair, 1978; Blair e_t £ l ., 1979b; Yorek e£ aj^,, 1981), which results 
in reduced substrate cycling at the PEP-pyruvate stage. Studies of 
gluconeogenesis from various precursors have shown that fructose and 
dihydroxyacetone are very good precursors of glucose (Assimocopoulos- 
Jeannet £j^ * » 1973; Garrison & Haynes, 1973, Veneziale & Lohmar, 1973; 
Brocks e_t al., 1980; Yorek » 1981), It was therefore of interest
to study the effect of these precursors on PK activity in hepatocytes 
from fasted animals.
The v/V for the PK obtained from untreated hepatocytes of fed
THclX
rats was 0.43 + .03 compared to 0.33 _+ ,03 for cells from 24 h fasted 
animals. This difference (p<.02) is probably related to the cAMP-de­
pendent phosphorylation of the enzyme in fasted animals and to a 
lowering of hepatic Fru^^BP in the fasted state together with a 
decrease in the sensitivity of the enzyme to the effector (Claus 
et al,, 1979) (see section II,),
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Incubating hepatocytes from fasted animals with 10 mM 
glucose (figure 17 A & B) had no significant effect on PK activity 
in either washed or unwashed cells. PK in unwashed cells was acti­
vated when isolated hepatocytes were incubated with fructose (10 mM).
A 30% activation compared to the control (p<.02) was observed after 
20 min incubation (figure 17A), This result contrasts with that 
obtained with cells from fed animals (see figure llA), where inhi­
bition was observed. However, washing of the cells incubated with 
fructose resulted in a further stimulation of PK activity (figure 17B), 
suggesting that an inhibitor is produced in the presence of fructose, 
but it is not as effective as in the hepatocytes from fed animals.
There are various possible explanations for this difference, for 
example, it may be that less inhibitor is produced in the fasted 
state or that the enzyme is less susceptible to the inhibitor.
Figure 18 shows a time course for the effect of 10 mM dihydroxy­
acetone on PK in washed and unwashed hepatocytes. Dihydroxyacetone 
activated PK in both preparations. As found with 10 mM fructose, the 
percentage of enzyme activation caused by this substrate in unwashed 
cells (39%) from fasted rats is greater than that in unwashed cells 
from fed animals. Again a greater stimulation was observed in washed 
cells (67%) than in the unwashed hepatocytes (39%). It is also clear 
that the activation of PK caused by this triose in washed hepatocytes 
obtained from fasted animals (67%) is greater than that from fed
animals (40%). This is presumably due to the lower in the
fasted state so that Fru^^BP would have a greater percentage effect. 
There is no evidence that less of the effector is produced in the 
hepatocytes from fed rats than those from fasted animals. The obser­
vations made using fasted cells make it clear that PK from fed rats is 
affected somewhat differently to that from fasted rats.
Thus it is clear that incubation of hepatocytes with fructose 
leads to two distinct effects, depending on the fructose concentration 
used. Low fructose concentrations in the physiological range cause the 
accumulation of an activator of PK. However, a high fructose concen­
tration in addition to causing elevation of the stimulator also results 
in the production of an inhibitor which overcomes the effect of the
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Figure 17. Time course showing the effect of 10 mM fructose ( •  ),
10 mM glucose ( A  ) or no added substrate (<3 ) on 
pyruvate kinase activity in hepatocytes isolated from 
24 h fasted rats. Comparison of A, unwashed'and B, washed 
hepatocytes.
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Figure 18. Time course showing the effect of 10 mM dihydroxyacetone ( ék ) 
and no added substrate ( O  ) on pyruvate kinase activity in 
hepatocytes isolated from 24 h fasted rats; A, unwashed 
hepatocytes and B, washed hepatocytes.
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stimulator. The cell membrane appears to be freely permeable to 
the inhibitor. The inhibitor is either produced to a lesser extent 
in hepatocytes from fasted animals or the enzyme from these hepato­
cytes is less susceptible to the inhibitor. The formation of inhibitor 
in cells from fed rats appeared to be related to the depletion of 
ATP since glycerol also causes an inhibition of the enzyme. On the 
other hand dihydroxyacetone and D-glyceraldehyde appear to cause 
some inhibition of the enzyme since the enzyme from washed cells is 
more active than that from unwashed cells.
B. METABOLITE CONCENTRATIONS IN ISOLATED HEPATOCYTES 
INCUBATED WITH VARIOUS CARBOHYDRATES
The evidence presented in section III.A shows conclusively 
that PK is activated by dihydroxyacetone and fructose when its activity 
is measured after discarding the extrahepatocyte medium, and that an 
inhibitor accumulates especially in the medium of cells incubated with 
high concentrations of fructose. Studies carried out on the nature of 
inhibition caused by various substrates, show that it can be reversed 
either by salting out the enzyme with (NH^)2 S0  ^ or removing the extra­
hepatocyte medium. The activation by fructose can be abolished by 
(NH^)2S0^ treatment but not by washing the cells. It was therefore de­
cided to examine the changes in the level of various metabolites which 
occur in response to different carbohydrate substrates. This was_in 
order to define the nature of the inhibitor and activator of PK and 
to yield some data which may elucidate.the nature of the metabolic 
regulation of glycolysis and gluconeogenesis from substrates which 
enter the glycolytic-gluconeogenic pathways at the triose phosphate 
level.
1. ATP
ATP levels in perfused organ have been reported to be decreased 
by glycerol and fructose but not by dihydroxyacetone (10 mM substrates) 
(Woods et £l., 1970; Woods & Krebs, 1973). It is possible that the 
changes in PK observed in section III.A are related to the depletion
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of ATP. Therefore, the changes in the hepatocyte concentration of 
ATP in response to glucose, glycerol, fructose and dihydroxyacetone 
were measured.
There was no change in ATP levels (over a 60 min incubation 
period) in hepatocytes from fed rats whether or not the cells were 
incubated with glucose (figure 19). ATP levels are considered a 
good indicator of hepatocyte viability and the levels found are 
comparable with the data obtained by other workers (MHenpHM et al.,
1968; Woods ejL a_l., 1970; Bode aj^., 1973; Van den Berghe et al., 
1977a). In addition it was found that when the ATP was measured in 
hepatocytes that had been washed, the level of ATP was identical to 
that found in unwashed cells (results not shown), suggesting that the 
impermeability of the hepatocyte membrane to the phosphorylated 
intermediate^ was maintained during the incubation period.
The most likely explanation for the fact that incubating isola­
ted hepatocytes with 10 mM glucose does not affect hepatic ATP, is 
the comparatively low rate of glucose phosphorylation in the liver 
at this concentration of the hexose, one factor being the limited 
uptake of glucose by the liver cell (Scrutton & Utter, 1968). In 
addition, the activity of glucokinase is considerably lower than 
that of ketohexokinase. (Heinz & Lamprecht, 1967; Zakim £££!•» 1967).
Upon incubating isolated hepatocytes with fructose (figure 19) 
depletion of ATP was detected. The extent to which the hepatocyte 
ATP levels were lowered was concentration dependent; the highest con­
centration of fructose causing the most severe depletion of ATP. The 
minor depletion observed with a physiological concentration of fruc­
tose (2 mM) was reversed by further incubation. The more profound 
depletion measured after incubating with 5 and 10 mM fructose was 
partially reversed by incubation of hepatocytes for up to 60 min, 
but complete restoration of A t P to the pre-fructose value was not 
achieved.
The depletion of ATP is in agreement with the work of Clark 
et al.,(1979) and Van den Berghe ejt £ l ., (1980), but these workers failed
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Figure 19. ATP content of isolated hepatocytes following treatment of 
cells with no added hexose ( O  )» 2 mM fructose ( ^  ),
5 mM fructose ( 0  )» 10 mM fructose ( •  ) or 10 mM glucose 
( ^  ). Hepatocytes were extracted with perchloric acid and 
the ATP determined by an enzymic method (see methods, 
section IV.B.6a).
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to show any recovery in ATP levels during the incubation period. The 
reason for this discrepancy is not clear. However, the former authors 
used hepatocytes from fasted rats and a high level of fructose (25 mM) 
whereas the latter authors used cells from fasted animals but incubated 
for 30 min only. The recovery in ATP levels observed in the present 
study, however, are a further indication of the viability of the hepa­
tocyte preparation used.
The hepatic changes observed following fructose loading can be 
satisfactorily explained on the basis of the properties of ketohexo­
kinase and of the enzymes of adenine nucleotide catabolism. The 
concentration of ATP in isolated hepatocytes incubated with fructose 
(5 and 10 mM) is not completely recovered over the 60 min incubation 
period because of the irreversible catabolism of AMP, which is formed 
by the adenylate kinase reaction with ADP, Fructose administration 
causes a decrease in the concentration of ATP, GTP and Pi (Van den 
Berghe ££  » 1977a, 1980), of which the latter two are inhibitors
of AMP deaminase, whereas ATP is a stimulator (Van den Berghe et al,, 
1977a; see also section I.D.), Thus the total hepatic adenine nucleo­
tide concentrations drop after fructose administration, but ADP and 
AMP levels remain relatively constant (MdenpMM e^ t £l^., 1968; Topping 
and Mayes, 1977; Van den Berghe e_t , 1977a;Yip & Lardy, 1981),
Figure 20 shows that depletion of hepatocyte ATP concentrations 
caused by fructose (10 mM) is rapid and complete after 2,5 min incu­
bation. This data is in agreement with the effect of fructose loading 
in vivo (Van den Berghe e^ , 1977a) and in isolated hepatocytes 
(Van de Werve & Hers, 1979), In the present studies, hepatocytes in­
cubated with fructose (10 mM) showed a 53% fall in ATP concentrations 
after 30 s incubation (figure 20), This is another of
the rapid rate of fructose phosphorylation by ketohexokinase in 
isolated cells.
The effect of glycerol (10 mM) and dihydroxyacetone (4 and 10 
raM)on hepatocyte adenine nucleotide levels was also examined (figure 
21). Dihydroxyacetone (4 mM) caused no significant change in ATP levels
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Figure 20. Rapid depletion of ATP in isolated hepatocytes treated 
with 10 mM fructose ( #  ) compared with no added 
hexose ( O ) .
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Figure 21. ATP content of isolated hepatocytes following treatment
of cells with no « ( O  ) , 4 mM dihydroxyacetone
(n=2) ( B  ), 10 mM dihydroxyacetone ( A  ) or 10 mM glycerol 
( □  ).
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over a 60 min period, but a higher concentration of the substrate 
did cause a small but significant (p<.002) fall in ATP levels for 
up to 30 min. This latter finding is in contradiction to the results 
of Woods & Krebs (1973) who perfused liver for up to 40 min with 
10 mM dihydroxyacetone, but the difference is probably the result 
of using different types of liver preparation. ATP concentrations 
in hepatocytes incubated for 45 and 60 min were not significantly 
different from the control values. On the other hand, incubating 
hepatocytes with 10 mM glycerol caused rapid and profound depletion 
of ATP during the first 10 min incubation, following which there 
was a small recovery of hepatocyte ATP concentration (figure 21).
In this respect, the effect of the metabolism of glycerol is very 
similar to that of fructose (figure 19 & 21). This is in agreement 
with the findings of Woods and co-workers (Woods £2.* * 1970;
Woods & Krebs, 1973) who used perfused liver.
The explanation for the difference between glycerol and di­
hydroxyacetone with respect to ATP depletion is not immediately clear, 
since the latter substrate is thought to be phosphorylated more 
rapidly than glycerol (Woods & Krebs, 1973). The specific activities 
of triokinase and glycerol kinase are known to be similar although 
the relative proportions of the two enzymes are dependent on diet and 
the sex of the animal (Mahmoud, 1979). A possible explanation is that 
glycolysis from the triose phosphate stage to pyruvate involves the 
production of two ATP molecules (see figure 1). Following a dihydroxy­
acetone load the initial step is phosphorylation in a reaction which 
depletes ATP and is catalysed by triokinase (see figure 3). Thus the 
glycolysis of dihydroxyacetone to pyruvate involves no net loss of 
ATP, in fact one molecule of ATP is produced. Gluconeogenesis from 
the triose phosphate stage also involves no net loss of ATP. On the 
other hand, glycerol inhibits glycolysis (see figure 3GB), so that 
regeneration of ATP by glycolysis of the substrate can not occur. 
Therefore, although dihydroxyacetone is phosphorylated more rapidly 
than glycerol, the former substrate restores ATP levels by virtue of
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its metabolism to pyruvate. Such an explanation would require the 
net glycolysis of 50% of the dihydroxyacetone metabolised.
2. Fructose-l-phosphate
The phosphorylation of fructose causes accumulation of Fru-l-P,. 
in vivo (Van den Berghe e_t » 1977a) and in perfused liver (Woods 
e_t a_l., 1970), which is an activator of PK at subsaturating substrate 
concentrations (Eggleston & Woods, 1970). This study was carried out 
to examine the effects of various substrates of Fru-l-P levels in 
isolated hepatocytes and to attempt to correlate this with the stimu­
latory effects of added substrate on PK activity reported in section 
III.A.
When isolated hepatocytes were incubated with fructose (10 mM), 
a rapid accumulation of Fru-l-P was observed (figure 22), concomitant 
with the depletion of ATP (figure 19) and the activation of PK (figure 
IIB). After the initial burst of Fru-l-P production, there was a more 
gradual increase in the level of the intermediate for up to 30 min 
incubation (figure 22). Maximum concentration of Fru-l-P produced 
(about 36 times the endogenous levels) was reached after 30 min incu­
bation, but high concentrations of Fru-l-P were present throughout 
the incubation after the initial 30 s (figure 23).
The build up of Fru-l-P after a fructose load indicates that
the breakdown of the ketose phosphate by aldolase is much slower than
its rate of formation by ketohexokinase. However, since the K^ and
V values of the two enzymes are very similar (Van den Berghe, 1978) 
max
then it must be concluded that ^  vivo fructose phosphorylation is 
much more rapid than aldolytic cleavage. The explanation for this 
phenomenon is not clear. Woods et al.,(1970) concluded that aldolase 
is inhibited by IMP which accumulates in the liver perfused with 
fructose but Smith e_t al^., (1977b) and Van den Berghe et al., (1977a), 
have shown that the accumulation of IMP is subsequent to the accumula­
tion of Fru-l-P. The former authors have suggested that Fru-l-P accu­
mulation is simply the result of the fact that ketohexokinase and
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Time course showing changes in fructose-l-phosphate content 
of isolated hepatocytes incubated with no added hexose ( O ) ,  
10 mM xylitol ( ^  ), 10 mM sorbitol ( ♦  ) , or 10 mM fructose 
( #  ). Hepatocytes were extracted with perchloric acid and the 
fructose-l-phosphate determined by an enzymic method (see 
methods, section IV.B.6e) (for sorbitol and xylitol n=2).
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Figure 23. Rapid accumulation of fructose-l-phosphate in isolated 
hepatocytes treated with no added hexose ( O  ) or 
10 mM fructose ( •  ).
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aldolase act more rapidly than the enzymes of the metabolic pathways 
leading to lactate and glucose (Exton & Park, 1969; Van den Berghe 
et al., 1977a).
Since Fru-l-P is an activator of PK (Eggleston & Woods, 1970), 
the effects of fructose on hepatocyte Fru-l-P can be compared with 
PK activity in isolated hepatocytes incubated with fructose (figure 
IIB). The highest level of Fru-l-P that accumulates after adding 
fructose (10 mM) is 7.8 pmoles g cells  ^ or approximately 20 mM, (it 
is assumed that 1 g of cells contain 380 pi of cytosolic water; Sobell 
^  al^., 1976). Taking into account the dilution factor involved in 
the assay procedure, it is surprising that the stimulatory effect of 
Fru-l-P is observed, in view of the low affinity of PK for Fru-l-P 
(see figure 53).
The pattern of rapid effects of fructose (10 mM) on Fru-l-P 
levels (figure 23) is similar to the activation of the enzyme in 
washed cells (figure 13B), and the concentration dependency of the 
enzyme activation by fructose (see figure 12b ) is also reflected by 
Fru-l-P levels presented in figure 24A. From these observations, it 
seems possible that the activation obtained in washed hepatocytes in­
cubated with fructose may be due to an accumulation of Fru-l-P. On 
the other hand, it is also probable that Fru^^B? also makes a major 
contribution to the activation observed since the affinity of the 
enzyme for this effector is much \\\c^e<rthan for Fru-l-P (see section
III.B.3).
A study of the effects of sorbitol (10 mM) and xylitol (10 mM) 
on Fru-l-P concentrations in isolated hepatocytes is shown in figure 22. 
It is of interest to compare the effects of these two substrates because 
sorbitol is metabolised via fructose in the liver (Fbrster, 1974), 
whereas xylitol is first oxidised to xylulose by the NA^-dependent 
Xylitol dehydrogenase (Smith, 1962; Williamson^ Ï971) and then phospho- 
rylated to xylulose—5—phosphate which is an intermediate of the pentose 
phosphate shunt. After a series of transaldolase and transketolase
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The concentration dependence of the effect of incubating 
isolated hepatocytes with; glucose ( A  ), fructose ( •  ), 
dihydroxyacetone ( A  ), glycerol (O  ) or D-glyceraldehyde 
( W  ) for 20 min, on the fructose-l-phosphate content,
(for glucose and glycerol n=2).
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reactions xylitol enters the glycolytic sequence as Fru-6-P and 
glyceraldehyde-3-phosphate (Froesh & Jakob, 1974). As expected, 
xylitol (10 mM) had no effect on Fru-l-P levels over the 60 min 
incubation period. In this respect this substrate has the same lack 
of effect as glucose. Incubating isolated hepatocytes with sorbitol 
(10 mM) (figure 22), however, caused a time dependent increase in 
Fru-l-P concentrations. In this case, the levels of Fru-l-P accumu­
lating, are somewhat lower than those observed with 10 mM fructose, 
presumably because of the limitation of NAD^required to convert sor­
bitol to fructose via sorbitol dehydrogenase. Thus sorbitol also 
has the effect of increasing (NADH)/(^AD)^ ratio in the hepatocyte (see 
section III.B.8).
Incubating isolated hepatocytes with glycerol (10 mM) and dihy­
droxyacetone (10 mM) revealed that these substrates have no effect 
on Fru-l-P (table 2). Both these trioses are phosphorylated first 
before any further metabolism (figure 3), thus in order to produce 
Fru-l-P from the phosphorylated products, a reversal of aldolase 
fission must occur in the presence of glyceraldehyde. The inability of 
glycerol and dihydroxyacetone to change hepatocyte Fru-l-P levels was 
observed at all concentrations of the substrate tested (figure 24B). Thus 
the activation of PK observed when hepatocytes are incubated with dihy­
droxyacetone is not due to elevated Fru-l-P concentrations. In addition 
the possibility that a substantial amount of glycerol or dihydroxyacetone 
is converted to glyceraldehyde is ruled out.
D-glyceraldehyde increased hepatocyte Fru-l-P levels, an effect 
which was concentration dependent (figure 24B). In contrast to the 
effect of fructose (figure 24A), the increase in Fru-l-P observed after 
incubating hepatocytes with a low D-glyceraldehyde (1 mM) concentration 
was small, but a substantial level was attained in the presence of 
10 mM triose. The formation of Fru-l-P in the presence of D-glyceralde­
hyde must be the result of a reversal of the aldolase reaction resulting 
in the production of the ketose phosphate from DHAP and D-glyceraldehyde.
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Table 2. The effect of glycerol and dihydroxyacetone on fructose-l- 
phosphate levels in isolated hepatocytes.
Fructose-l-phosphate (pmoles g cells )
Substrate Added
Time
(minutes) No Substrate Glycerol Dihydroxyacetone
(10 mM) (10 mM)
0 0.24 + 0.01 - -
10 0.22 + 0.04 0.23 0.26 + 0.03
20 0.23 + 0.01 0.26 0.26 + 0.02
30 0.22 + 0.02 0.23 0.25 + 0.02
45 0.25 + 0.02 0.32 0.28 + 0.02
60 0.26 -»• 0.02 0.32 0.28 + 0.02
Isolated hepatocytes from fed animals were incubated with 10 mM 
substrate for different time periods (up to 60 min). After the 
appropriate time interval, the reaction was stopped using per­
chloric acid and the neutralized supernatant (see methods, section
IV.B.6) was used for Fru-l-P determination.
a = results presented are an average of determinations of 
two different hepatocyte preparations.
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However, it is evident from figure 24B, that the Fru-l-P accumulation 
is not proportional to the triose concentration and that it is not 
a saturable process under these conditions of the experiment. The 
increased rate of Fru-l-P accumulation at high D-glyceraldehyde concen­
tration is probably the result of a saturation of the pathways which 
metabolise the triose, leading to an accumulation of triose phosphates. 
Under these conditions, the accumulated DHAP combines with glyceralde­
hyde to form Fru-l-P.
3. Fructose-1, 6-bisphosphate
Another possible mechanism by which PK from isolated hepatocytes 
is activated after incubating with dihydroxyacetone, D-glyceraldehyde 
and fructose (section III.A) is the accumulation of Fru^^BP, a potent 
activator of the enzyme (Taylor & Bailey, 1967; Llorente et al., 1970; 
Seubert & Schoner, 1971). The levels of this intermediate in the liver 
are under hormonal (Pilkis £l.* » 1976a; 1976b, 1978c) and dietary 
(Lawson > 1976; Claus e£ a_l., 1979) regulation. It was therefore
of interest to examine the effects of various substrates on Fru^^BP.
A time course examination of Fru.,BP concentrations in untreated
lo
isolated hepatocytes (figure 25A) shows that the level of this inter­
mediate are unchanged over the incubation period. Fructose (10 mM) 
caused a two-fold increase in Fru^^BP levels in isolated hepatocytes with­
in 10 min, followed by a small but steady increase of the bisphosphate 
over the 60 min incubation period (figure 25A). This increase in Fru^^BP 
levels is also concentration dependent, but at physiological fructose 
concentrations there was only a small increase observed (figure 26A)
A closer examination of the fructose (10 mM) effect shows that, there 
is a short lag of 30 s followed by a rapid increase in Fru^^BP during 
the next 30 s (figure 27). The concentration of Fru^^BP accumulating 
in hepatocytes (36 nmoles g cells  ^ or 95 yM Fru^^BP after 20 min incu­
bation) treated with fructose would not be expected to cause a signifi­
cant stimulation of the enzyme when the dilution factor is taken into 
consideration. Nevertheless, it is likely, that the high affinity of 
the enzyme for the effector results in the retention of the stimulatory
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Figure 25. Time course showing changes in fructose-1,6-bisphosphate content 
of isolated hepatocytes incubated with no added substrate ( O  ) ,  
10 mM xylitol (n=2) (<} ), 10 mM sorbitol (n=2)(^  ), 10 mM 
fructose ( •  ), 10 mM glycerol ( Q  ) or 10 mM dihydroxyacetone 
( ^  ). Hepatocytes were extracted with perchloric acid and the 
fructose-1,6-bisphosphate determined by an enzymic method 
(see methods, section IV.B.6d).
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Figure 27. Time course showing the rapid accumulation of
fructose-1,6-bisphosphate in isolated hepatocytes 
incubated with no added hexose ((Q) or with 10 mM 
fructose ( #  ).
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effect despite the dilution involved. The short time lag observed 
for the formation of Fru^^BP is presumably due to the time taken 
to increase the triose phosphate pool and, possibly, a slower rate 
of aldolytic condensation compared to the initial phosphorylation 
of the ketose.
After the initial metabolism of fructose to the triose phosphates, 
the products can follow two routes, either gluconeogenesis ot glycolysis. 
In fed animals, glycolysis is the dominant pathway (Pilkis et al., 1978a), 
hence most of the carbon from fructose would be expected to be channel­
led towards pyruvate. This is reinforced by some of the properties of 
the regulatory enzymes concerned (Scrutton & Utter, 1968; Pilkis et al., 
1978a). For example, fructose (10 mM) causes a stimulation of PK by 
Fru^^BP and Fru-l-P assuming that the inhibitor accumulating would nor­
mally be removed ijn vivo. In addition 10 mM fructose is known to lower 
the level of Fru^^BP, the recently discovered regulator of the Fru-6-P/ 
Fru^^BP substrate cycle (Hue, 1981). The result of this would be an 
inhibition of PFK 1 and a stimulation of Fru^^BPase (Claus et al.,
1980; Furuya & Uyeda, 1980; Van Schaftingen & Hers, 1980, 1981a; Pilkis 
e_^  a_l., 1981; Uyeda ejc a^. ,1931a, 1981b) resulting in stimulation of 
gluconeogenesis from triose phosphate. However, at low fructose concen­
tration, FrUg^BP concentration is raised resulting in an inhibition of 
gluconeogenesis. Therefore, it would be expected that at physiological 
fructose concentration, most of the flux from fructose would be direc­
ted to pyruvate and lactate, whereas at high concentration a greater 
proportion of the flux would be directed to glucose.
From an examination of the effect of 10 mM xylitol and 10 mM
sorbitol on Fru,,BP concentration (figure 25A) it is clear that xylitol 
lo
has no significant effect on the levels of this intermediate, whereas 
sorbitol (10 mM) caused an accumulation of Fru^^BP. Once again the effect 
of sorbitol mimicks that of fructose.
A study of the effect of glycerol and dihydroxyacetone indicate 
that,the former substrate had no effect on Fru^^BP level but the latter 
caused a considerable change in hepatocyte Fru^^^BP concentration
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(figure 25B). The maximum level of Fru.^BP accumulating (214 + 23
io —
n moles g cells or 0.6 mM) was observed after 20 min incubation 
with dihydroxyacetone. This indicates that the activation of PK 
in isolated hepatocytes,incubated with dihydroxyacetone,observed in 
the present study (see section III.A) is due to accumulation of this 
allosteric effector of the enzyme. The stimulation of Pk  by dihydroxy— 
acetone (see figure 15B) is concentration dependent as is the accu­
mulation of Fru^gBP (figure 26B). There is a discrepancy between the
relatively small increases in Fru.,BP and the observed activationlo
of PK at 1 mM dihydroxyacetone. This accentuates the care that must 
be exercised in comparing the activation of PK with the concentration 
of Fru^^BP accumulating in the cells. It also suggests that the in­
creased Fru^^BP resulting from fructose utilization by hepatocytes 
may be sufficient to explain the observed activation of PK without 
invoking a Fru-l-P effect. This is especially true if one consider^ 
the high affinity of PK for Fru^^BP and the dilution of the effectors 
during the assay procedure. However, the effect of Fru-l-P on PK 
in vivo must be considered because of the high levels of the ketose 
phosphate present in the cytosol of the hepatocyte.
Incubating hepatocytes with D-glyceraldehyde also causes a con­
centration dependent increase in the Fru^^BP (figure 26A). The effect 
was smaller than that wit^ dihydroxyacetone presumably because of the 
greater affinity of triokinase for dihydroxyacetone (Veneziale, 1976) 
An examination of PK activity in hepatocytes incubated with D-glycer-^ 
aldehyde (figure 16) indicates that maximal activation in washed cells 
is reached with a low concentration of the substrate. The concentra­
tion of Fru^^BP present when cells are incubated with 1 mM D-glycer­
aldehyde (20.4 _+ 1.7 n moles g cells )^ is apparently sufficient to 
cause such activation, if one ignores a possible contribution by 
Fru-l-P. This is further evidence that the increase in PK activity 
observed with low levels of fructose is probably due to an elevation
of Fru.fBP rather than that of Fru-l-P. It also suggests that the
16
changes in Fru^^BP levels which occur in vivo must be fairly small
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compared to those observed in this study with high substrate concen­
trations, if these changes are to have any physiological significance.
4. Dihydroxyacetone phosphate
Most of the substrates examined in this study enter the glyco­
lytic pathway at the triose phosphate stage (see figure 3). Thus an 
examination of the concentration of the triose phosphates in response 
to various substrates may give some indication of the rate of meta­
bolism of the substrates.
The DHAP concentrations were examined in isolated hepatocytes 
incubated with 10 mM substrate for different times (Table 3) and at 
varying concentration of substrates (Table 4). Hepatocytes incubated 
with fructose showed no changes in DHAP concentration within 20 min 
at concentrations of fructose up to 10 mM. A longer incubation time 
resulted in small elevation of the triosephosphate concentration at 
10 m.M fructose. It is perhaps surprising that no change in DHAP levels 
was found at the short time intervals, since the levels of Fru^^BP 
(figure 25A); G3P (figure 28A) and pyruvate and lactate (figure 30A) 
are raised by fructose. The results suggest that once formed, DHAP is 
rapidly converted to these intermediates. The lack of DHAP accumula­
tion is evidence against the theory put forward by Exton & Park (1967) 
and Van den Berghe (1973), that Fru-l-P accumulates in response to 
fructose as a result of high levels of both aldolase and fructokinase 
activity. On the contrary it is further evidence that aldolase is a 
rate limiting step in the metabolism of Fru-l-P. Woods et al.,(1970) 
found an increase in DHAP after 10 min perfusion of the liver with 
10 oM fructose. This discrepancy is presumably related to the type 
of liver preparation used.
In the present study, sorbitol, xylitol and glycerol were also 
without effect on DHAP levels, whereas dihydroxyacetone rapidly ele­
vated DHAP concentrations (up to about 4-fold), an effect which is 
concentration dependent (Table 3 & 4). No elevation was observed when
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hepatocytes are incubated for 20 min with low concentrations of 
dihydroxyacetone, suggesting that under these conditions, the meta­
bolism of DHAP was not a limiting factor, but that at higher concen­
trations of the triose, the rate of synthesis of DHAP exceeded the 
rate of its metabolism, thus leading to an elevation of the triose 
phosphate. The elevation of DHAP is mirrored by the increase in 
FrUfbBP suggesting that the triose phosphate and the hexose diphosphate 
are in equilibrium. The parallel decrease in the levels of these two 
metabolites, which occurs after 20 min incubation (figure 25B & Table 
3) gives an indication of the rate of metabolism of the triose phosphate 
pool.
D-glyceraldehyde at concentrations up to 3 mM had no significant 
effect on DHAP levels (Table 4) despite the fact that this triose 
is phosphorylated to glyceraldehyde-3-phosphate (by triokinase), which 
is readily converted to DHAP (figure 3). Unexpectedly the DHAP levels are 
lowered by high concentrations of D-glyceraldehyde (Table 4). A possible 
explanation for this effect is that at such high concentrations of 
D— glyceraldehyde, the reverse aldolase reaction is occurring. Figure 
24B shows that at these substrate concentrations Fru-l-P accumulates.
Thus it is likely that the high levels of D-glyceraldehyde react with 
DHAP yielding Fru-l-P and therefore, lowering hepatocyte DHAP levels.
At the same time glycolysis is increased by D— glyceraldehyde (figure 
32B) contributing to the fall in DHAP concentration.
5. Glycerol-3-Phosphate
Glycerol-3-phosphate (G3P) is another important triose phosphate 
that may accumulate under various conditions (Burch e_t £l., 1970;
Woods & Krebs, 1973). In order for G3P to enter the glyoolytic se­
quence, NAD^ dependent oxidation to DHAP by glycerol-3-phosphate de­
hydrogenase must occur. An alternative fate of the G3P is its utilisa­
tion in the synthesis of triacylglycerol and phospholipids.
The levels of G3P are unaffected by incubation in the absence 
of substrate or with glucose (up to 1*^ itiM) (figure 28A & 29A). This is 
another indication of the viability of hepatocytes since G3P is elevated
- 116 -
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Figure 28. Time course of the changes in the glycerol-3-phosphate content
of isolated hepatocytes incubated with no added substrate ( O  ), 
10 m!I fructose ( # ) ,  10 mM xylitol ( 0  ). 10 mM sorbitol ), 
10 mM glycerol ( Q ) or 10 mM dihydroxyacetone ( &  ). Hepato­
cytes were extracted with perchloric acid and the glycerol-3- 
phosphate determined enzymatically (see methods, section IV.B. 
6f).
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Figure 29. Glycerol-3-phosphate content in isolated hepatocytes incu­
bated with glucose ( A  ), fructose ( #  ), dihydroxyacetone 
( A  ) , glycerol ( Q  ) or D-glyceraldehyde (D ) for 20 min, 
(for glucose and glycerol n=2).
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considerably immediately following the preparation of the hepatocytes 
(results not shown), but the 10 min preincubation period restores 
the level of the metabolite to those observed in vivo (results not 
shown).
Hepatocytes incubated with fructose (10 mM) contained elevated 
levels of G3P, an effect which is time dependent (figure 28A), The 
increase, although smaller, is also observed at physiological con­
centrations of fructose (figure 29A). The explanation for the increase 
in G3P concentrations caused by fructose is not immediately clear since 
DHAP levels are unaffected (Table 3 & 4). One possible explanation for 
this phenomenon is that the (XADH)/(^AD)^ ratio is altered by fructose. 
However, this is not borne out when the change in (NADH)/(NAD)^ratio 
was measured using (lactate)/(pyruvate) ratios (see Table 8) and 
(G3P)/(DHAP) (Table 10) ratios (Hohorst et al 1959; Berry, 1980).
Another possibility is that an alternative pathway for the metabolism of 
of glyceraldehyde is in operation in addition to the route involving 
triokinase. Thus the D-glyceraldehyde formed by the aldolytic cleavage 
of Fru-l-P, is converted to glycerol by NAD**" linked glycerol dehydroge­
nase, and the glycerol formed is metabolised via glycerokinase to G3P 
and DHAP (Veneziale 1972a; 1972b). This route would not involve a change 
in ('IADH)Z(NAD)^ ratio. Evidence for the occurrence of this pathway is also 
to be found when the effect of D^-glyceraldehyde on G3P levels is con­
sidered (figure 29B). High concentrations of the triose increase the 
G3P levels, but at the same time decreasing the DHAP levels, again 
suggesting that the metabolism of glyceraldehyde via glycerol dehy­
drogenase is possible. However, the effects of fructose were observed 
at low concentrations (figure 29B) while D-glyceraldehyde up to 3 mM 
had no effect on G3P concentrations. The explanation for this discre­
pancy is not clear.
Dihydroxyacetone (10 mM) caused an initial elevation of G3P 
concentrations followed by a gradual decline to control levels over 
the 60 min incubation period (figure 28B). This mirrors the change 
in DHAP (Table 3) and Fru^^BP (figure 25B) during the same period.
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The (G3P)/(DHAP) (Table 10) and (lactate)/(pyruvate) (Table 8) ratios 
are largely unaffected. Therefore the change in G3P observed merely 
reflects the alteration in the size of the triose phosphate pool. The 
effect of increasing dihydroxyacetone concentrations on G3P levels 
(figure 29b ) is the same as on DHAP (Table 4) further reinforcing 
the above hypothesis.
An examination of the time course effect (figure 28B) of gly­
cerol (10 mM) on G3P concentrations in isolated hepatocytes shows 
that there is a 25-fold increase in the levels of the phosphorylated 
product within 10 min followed by a gradual increase over the next 
50 min. These observations are similar to those made by Woods & Krebs, 
(1973), using perfused livers from fed rats and by Berry et al.,(1973) 
using isolated hepatocytes from fasted rats. Glycerol is phosphory­
lated by glycerokinase to G3P, which in turn can be oxidised to DHAP 
in a reaction involving NAD^-dependent glycerol-3-phosphate dehydro­
genase. Considering the vast difference detected in G3P levels accu­
mulating in hepatocytes after a dihydroxyacetone (10 mM) load (0.8
-1
0.1 u moles g cells ) and a glycerol (10 mM) load (5.3 _+ 0.9 ymoles 
-1 . . .
g cells ), it is evident that the oxidation of G3P to DHAP is the 
limiting step in glycerol metabolism. Thus it is clear that the forma­
tion of G3P is more rapid than its catabolism, which is somewhat 
surprising because the activity in liver of glycerol-3-phosphate 
dehydrogenase is higher than that of glycerokinase (Burch et. »
1970; Mahmoud, 1979). It thus seems probable that under these conditions 
the increase in G3P content of hepatocytes is observed because of the 
limited availability of NAD^ in the hepatocyte. A possible mechanism 
for the regeneration of NAD from NADH is the conversion of pyruvate 
to lactate, which is also limiting because of the low levels of pyru­
vate available in the hepatocyte due to a slow rate of glycolysis from 
glycerol (figure 30B). Therefore the overall (NADH)/ (NAd "^ ) ratio in 
the hepatocyte is increased by a glycerol load and this is reflected by 
the (lactate)/(pyruvate) ratio (table 8) and (G3P)/(DHAP) ratio (Table 
10). The concentration of G3P in the hepatocyte was considerably increased 
at all concentrations of substrate examined (figure 29B). A concentration
- 120 -
of 1 mM substrate elevated the concentration of the phosphorylated 
intermediate 17-fold, thus the mechanism described above is also 
valid at lower concentrations of the substrate.
When isolated hepatocytes were incubated with sorbitol (10 mM) 
and xylitol (10 mM) there was a rapid increase in G3P concentrations 
after 10 min incubation (figure 28A). Since the metabolism of these 
substrates involves an initial oxidation step coupled to NAD^ reduc­
tion, it seems probable that the elevated G3P levels occur when DHAP 
is reduced by NADH-dependent glycerol-3-phosphate dehydrogenase in 
order to restore NAD levels. Further evidence that these substrates 
are oxidised in a reaction involving reduction of NAD^ is shown by 
the (lactate)/(pyruvate) ratios and (G3P)/(DHAP) ratios (Table 8 &
Table 10 respectively). The (G3P)/(DHAP) ratios are higher when hepa­
tocytes are incubated with glycerol (10 mM) than when incubated with 
sorbitol or xylitol. This is presumably because in glycerol treated 
cells, there is a greater overall reduction of NAD^ because the initial 
phosphorylation step elevates G3P concentrations, whereas, in hepato­
cytes treated with the latter substrates, there is a certain amount 
of regeneration of NAD^ during the reduction of DHAP to G3P. However, 
the reason why the (lactate)/(pyruvate) ratios for glycerol (10 mM) 
was lower than those for sorbitol (10 mM) and xylitol (10 mM) is 
not clear, since it might be expected that the former substrate would 
deplete the cell of NAD^ more effectively than sorbitol and xylitol.
6. Phosphoenolpyruvate
It is evident from the observations made on metabolite levels in 
isolated hepatocytes incubated with various substrates that, the acti­
vation of PK by these substrates in washed cells (see section III.A) 
is nrobably due to the accumulation of Fru-l-P, Fru^^BP or both. On 
the other hand, when PK activity is measured in unwashed cells incubated 
with high fructose (10 mM) concentrations, an inhibition of the enzyme 
is observed (see figure llA). Thus, in an attempt to obtain a clearer 
picture of the flux through PK under these conditions, the concentrations 
of PEP (a substrate for the enzyme )in hepatocytes were measured.
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An examination of the time course dependency of PEP concentra­
tions in isolated hepatocytes reveals that, in untreated cells as 
well as cells treated with glucose (up to 10 mM) there is no signi­
ficant change in the levels of the phosphorylated substrate (Table 5 &
6). This result is not surprising because glucose has no effect on 
the PK activity in either washed or unwashed cells (figure 12A & B), 
suggesting that all the glycolytic reactions, including that of PK, 
are in a steady state and the rate of glycolysis to PEP is matched 
by the PK activity. Hepatocytes incubated with fructose (10 mM) showed 
no significant change in PEP concentrations during the same time period 
(Table 5), indicating that, although there is increased glycolysis 
from fructose, PK is not rate limiting, presumably because of the 
activation of the enzyme by Fru-l-P and Fru^^BP.
Unexpectedly,dihydroxyacetone caused an elevation of PEP levels 
(Table 5) despite the fact that Fru^^BP levels are raised by this 
substrate (figure 25B). This suggests that the rate of glycolysis 
to PEP from dihydroxyacetone is greater than that from fructose, and 
that in the case of the triose, PK is a rate limiting step in its 
metabolism despite the high levels of Fru^^BP in the cell. However, 
when the rates of glycolysis, as measured by lactate and pyruvate (figure 
30), from dihydroxyacetone and fructose are compared, there is initially 
a greater output of lactate from the former substrate, consistent with 
the above explanation, which slows down with time and is considerably 
less than that from fructose over a 60 min incubation period (figure 
30A and figure 30B). The explanation for this phenomenon is not clear.
It is possible that another inhibitor of PK is accumulating inside the 
hepatocytes incubated with dihydroxyacetone (10 mM), but there is 
little evidence to support this hypothesis. Another possible explana­
tion for the differential effect of fructose and dihydroxyacetone 
can be explained by the inhibitory action of ATP on PK activity (ijbrente 
£t al., 1970; Seubert & Schoner, 1971; Imamura et al., 1972). When 
hepatocytes are incubated with 10 mM dihydroxyacetone there is an 
increase in PEP levels, an effect not observed with 10 mM fructose 
(Table 5), and this is presumably related to the profound depletion of 
ATP in the case of the latter substrate (figure 19), which should re­
sult in releasing the inhibition of PK by the nucleotide triphosphate.
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A further examination of the PEP levels in isolated hepato— 
cytes incubated for 20 min with various substrates (Table 6), shows 
that all concentrations of glucose (up to 10 mM) have no significant 
effect on hepatocyte PEP concentrations. However, although high 
fructose concentrations (5 and 10 mM) had no significant effect on 
the concentration of PEP, physiological concentrations of the hexose 
caused a small but significant increase in PEP concentrations (Table 
6). This seems to indicate that at these concentrations of fructose 
(i.e. 2 and 3 mM) the rate of synthesis of PEP is not matched by PK 
activity. Nevertheless, from the results shown in section III.A (see 
also figure 12), low ketose concentrations are sufficient to cause 
activation of PK, which would seem to indicate that the rate of 
fructolysis to PEP is greater than the PK activity. There is no 
evidence in the literature that the levels of the other substrate 
for PK (ADP) are significantly altered by fructose (MMenpME^ 1968;Van den 
Ferghe e_t a_l. , 1977a; Yip & Lardy, 1931). There is no significant effect of 
low dihydroxyacetone concentrations on hepatocyte PEP levels, but 
higher concentrations of the triose caused a significant elevation of 
this metabolite (Table 6). This may be related to a higher rate of 
glycolysis from fructose than from dihydroxyacetone. However, the deple­
tion of ATP by low concentrations of fructose (2 mM) is much less than 
at higher concentrations (5 and 10 mM) of the substrate (figure 19) 
and this probably results in a significant inhibition of PK by the 
ATP at low fructose concentrations leading to an elevation of PEP. On 
the other hand, after an initial burst of lactate plus pyruvate pro­
duction, glycolysis from dihydroxyacetone proceeds at a much slower 
rate, ATP is not depleted, and as a result of these two factors PEP 
is elevated. Rates of glycolysis from D-glyceraldehyde are similar 
to those from dihydroxyacetone (figure 32B) yet PEP levels are lowered 
by high concentrations of D—glyceraldehyde(Table 6). This difference 
between dihydroxyacetone and ^-glyceraldehyde may be related to the 
raised Fru-l-P levels in the case of the latter substrate (figure 
248).
Glycerol (10 mM) caused a decrease in PEP levels within 10 min 
(Table 5) despite the profound depletion of ATP (figure 21) in this
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time. The decrease in PEP was found at all concentrations of the 
substrate examined (Table 6). Since there is no net lactate plus 
pyruvate production from glycerol (10 mM) indeed the basal rate 
of glycolysis is inhibited by the substrate (figure 3GB), the 
lowering of PEP by glycerol can simply be explained by the change in 
(NADH)/(NAD ) ratio which results in the inhibition of glycolysis 
at the glyceraldehyde-3-phosphate dehydrogenase (Furfine & Velick,
1965)step. This is borne out by the evidence that while PEP levels drop 
in response to a glycerol load, G3P and DHAP levels rise (figure 28 &
29), Since glyceraldehyde-3-phosphate is in equilibrium with DHAP 
and 1, 3 PGA is in equilibrium with PEP (Jakob £ l ,, 1971) this 
suggests that the control is imposed at the glyceraldehyde-3-phosphate 
dehydrogenase step,Such an explanation is consistent with the effect 
of xylitol in perfused liver (Jakob £ l ,, 1971) where PEP levels are 
severely lowered by this substrate whereas triose phosphate and G3P 
levels are raised,
7, Total glycolytic flux in isolated hepatocytes incubated 
with various substrates
The substrates studied in this thesis are mainly metabolised via 
the glycolytic and gluconeogenic sequences (see introduction section I, 
also see figure 3), The rate of accumulation of the major end products 
of glycolysis (i,e, pyruvate and lactate) gives an estimation of the 
glycolytic flux, and thus the flux through PK. However, it must be noted 
that the contribution of gluconeogenesis from lactate, pyruvate de­
hydrogenase activity and alanine aminotransferase activity, would result in 
an underestimation of the glycolytic flux.
An examination of the time course of total pyruvate plus lactate 
produced by isolated hepatocytes shows that, there is a slow but sig­
nificant rate of glycolysis in glucose (10 mil) treated cells as well 
as in untreated cells (figure 30) over a 60 min incubation period.
There is no statistical difference between the rate of glycolysis in 
the presence and absence of added glucose (up to 10 nul) (figure 30A 
and 32A), Presumably the pyruvate and lactate arises from the breakdown
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Figure 30. Time course of the total lactate plus pyruvate content in
isolated hepatocytes incubated with no added substrate ( O  ) ,
10 mM glucose ), 10 mM fructose ((* ), 10 mM glycerol 
( Q )  or 10 mM dihydroxyacetone (A )• A perchloric acid 
extract was obtained after the incubation period and pyruvate 
and lactate were determined enzymatically (see methods, section 
IV.B.bh and IV.B.Si).
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of glycogen since the addition of glucose has no effect on the output 
of the glycolytic products. Therefore, this must mean that glucose 
at these concentrations (approximately 12 mM)makes no significant 
contribution to the glycolytic flux or that the limiting step is 
subsequent to the hexose phosphate pool. One of the important rate 
limiting steps in glycolysis is thought to be the PFK 1 reaction 
(Stadtman, 1966; Mansour, 1972; Bloxham & Lardy, 1973; Ramaih, 1974; 
Hofmann, 1976; Uyeda, 1979), now known to be regulated by Fru^^BP 
(Van Schaftingen £t al_., 1980b, 1980c; Claus £t al. , 1980) which in 
turn is regulated by the size of the hexose phosphate pool and the 
hormonal state of the animal (Van Schaftingen e^ , 1980b; Van 
Schaftingen & Hers, 1981b). Presumably the Fru2 ^BP levels in the hepa­
tocytes treated with glucose (10 mM) are not altered sufficiently to 
result in a modification of PFK 1 activity in the cell (Van Schaftingen 
fJL* » 1980b, observed elevated levels of the stimulator of PFK 1 
after incubating hepatocytes with 20 mM glucose).
The result of incubating isolated hepatocytes with 10 mM fructose, 
is to increase (by 4-fold compared to the control) the production of 
pyruvate and lactate over a 60 min incubation period (figure 30A).
The simplest explanation for this phenomenon is that fructose meta­
bolism bypasses the main regulatory step in glycolysis (see figure 3) 
and it can be postulated that the maximum flux through PK is 4-fold 
greater than through PFK 1. It is possible, however, that flux through 
PFK 1 is also increased because of the increased glycogenolysis known 
to occur in response to fructose (Van de Werve & Hers, 1979), and 
also the lowering of ATP levels (figure 19) by the ketose would be 
expected to relieve the inhibition of PFK 1 (Brand & Sbling, 1974). 
However, fructose (10 mM) is also known to lower Fru^^BP levels (Hue, 
1981) which would also compensate for this effect. A similar effect 
on total glycolytic flux is also observed in hepatocytes from fasted 
animals (figure 31), with a minimal rate of pyruvate and lactate output 
in the control and glucose (10 mM) treated hepatocytes whereas the 
glycolytic rate in the presence of fructose (10 mM) is comparable to that
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Figure 31. Time course showing the total lactate plus pyruvate content 
in hepatocytes isolated from 24 h fasted rats. The cells 
were incubated with no added substrate (O ), 10 mM glucose 
( ^  ) » 10 mM dihydroxyacetone ( A. ) or 10 mM fructose ( #  ) ,
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in the fed animals (compare figure 30A and figure 31). This is further 
evidence that the pyruvate and lactate output reflects the activity 
of PK in the hepatocyte. There was a concentration dependent increase 
in pyruvate and lactate output by hepatocytes from fed animals in 
response to fructose (figure 32A). However, the curve appears to be 
biphasic, this correlates well with the PEP levels in the hepato­
cytes under identical conditions (see Table 6). Thus, at low con­
centration of fructose, glycolysis to PEP is more rapid than flux 
through PK as a result PEP accumulates, but with increasing fructose 
concentrations, the increase in Fru^^BP (figure 26A) and more notably 
the lowering of ATP concentrations (figure 19) would result in the 
deinhibition of PK, and thus a more rapid output of pyruvate and lactate 
This is accompanied by diminished PEP concentrations (Table 6).
An initial rapid output of pyruvate and lactate (equivalent to 
that observed with fructose) is evident after incubation^isolated 
hepatocytes with dihydroxyacetone (10 mM), but after this time there 
is a return to the rate of output observed in control hepatocytes 
(figure 30B). This effect was also observed in hepatocytes from fasted 
rats (figure 31). The explanation for this phenomenon is not clear 
since glycolysis to PEP is not inhibited because elevated PEP levels 
are observed in the presence of 10 mM dihydroxyacetone after 20 min 
(Table 6). This suggests that PK is rate limiting under these condi­
tions despite the elevated Fru^^BP levels found (figure 26B). In con­
trast to fructose, dihydroxyacetone (10 mM) depletes the hepatocyte 
ATP level by only a small amount which would result in the inhibitor 
reducing flux through PK. This mechanism would explain the diminished 
pyruvate plus lactate output after 10 min but does not explain the 
initial rapid flux of carbon with the triose.
At low concentration of substrate, the pyruvate and lactate out­
put in response to dihydroxyacetone, fructose and D-glyceraldehyde is 
very similar (figure 32A & B), but at a concentration of fructose of 
5 mM and above there is a further increase in the output of pyruvate 
plus lactate whereas this does not occur with the trioses. This is 
possibly related to the fact that dihydroxyacetone does not deplete
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Figure 32. Total lactate plus pyruvate output by isolated hepatocytes 
incubated with varying concentrations of glucose ( A  ), 
fructose ( • ) ,  glycerol ( Q ) ,  D-glyceraldehyde ( I B )  or 
dihydroxyacetone ( A  ). The hepatocytes were incubated with 
substrate for 20 min.
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ATP levels. Presumably D-glyceraldehyde does not deplete ATP to the
same extent as fructose either, since the K and the V of trio-
m max
kinase would favour phosphorylation of dihydroxyacetone rather than 
D-glyceraldehyde (Frandsen & Grunnet,1971). The effect of D-glyceral­
dehyde on pyruvate and lactate output is virtually identical to that 
of dihydroxyacetone which is not surprising since the trioses are 
metabolised via triokinase and the same glycolytic enzymes. In general, 
none of these substrates altered the (NADH)/(NAD^) ratio as estimated 
by the (lactate)/(pyruvate) ratio (Table 9), Therefore,the effects 
observed cannot be attributed to changes in cytonlasmic redox poten­
tial which could affect the rate of glycolysis (Furfine & Velick,
1965).
In contrast to the substrates discussed above, incubation of 
hepatocytes with glycerol (10 mM) caused no net formation of the 
glycolytic products compared to the control (figure 30B). Indeed, 
when compared to the control the pyruvate plus lactate output was 
significantly inhibited. This suggests that basal glycolysis is 
inhibited by this substrate, and this is borne out by an examination 
of the concentration dependence of the effect of glycerol (figure 32B). 
The mechanism of this inhibition is probably related to the change 
in (NADH)/(NAD^) ratio as indicated by (lactate)/(pyruvate) ratios 
(Table 8). The accumulation of G3P in response to a glycerol load 
results in severe depletion of NAD^ which is also required by glycerol- 
3-phosphate dehydrogenase. Since there is a limited supply of NAD in 
the cell, there are various mechanisms in operation in order to re­
store the level of the coenzyme (see introduction I.E). Further con­
firmation that glyceraldehyde-3-phosphate dehydrogenase is inhibited 
by a glycerol load comes from the fact that PEP levels are lowered 
(PEP is in equilibrium with 1, 3 PGA) and the metabolites of the triose 
phosphate pool are increased.
The reduced substrate xylitol (10 mM) had similar effects to 
that of glycerol (Table 7). The initial step in the metabolism of 
xylitol involves its conversion to D-xylulose in an NAD dependent 
reaction (see figure 6). This substrate increased the (NADH)/ (NAD )
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Table 7. The effect of sorbitol and xylitol on total lactate plus 
pyruvate in isolated hepatocytes.
Time
(minutes)
Lactate plus Pyruvate (umoles g cells ^)
Substrate added (10 mM)
No Substrate Sorbitol Xylitol
0 8.9 + 0.9 - -
10 16.5 + 1.2 17.3 +0.8^^ 12.0 + 1,0**
20 24.4 + 1.6 21.0 +2.7^^ 16.4 + 0.9***
30 29.9 + 1.5 26.8 + 1.4^S 19.1 + 1, 5***
45 36.8 + 2.9 50.0 + 0.9*** 20.2 + 2.2***
60 41.1 + 2.4 72.6 + 1.6*** 27.8 + 1.7***
Hepatocytes isolated from fed animals were incubated with 10 mM 
substrate for varying time periods. After the incubation period, 
the reaction was stopped using perchloric acid and the neutralized 
extracts used to estimate lactate and pyruvate concentrations as 
described in methods (Section IV.B.6).
Substrate versus control: NS = not significant;
* *  = p < 0 . 0 1 ;  * * *  = p < 0 . 0 0 1 .
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ratio (Table 8 & 10) as well as inhibiting pyruvate plus lactate 
output (Table 7). This observation is consistent with the results 
of Jakob 25. fJL" * (1971) who found similar effects of this substrate 
on metabolite levels in perfused liver. Furthermore, xylitol has 
been reported to cause the accumulation of oxalate (see figure 6)
(Rofe et al., 1977; Barngrover et al., 1981), a potent inhibitor 
of hepatic PK (Buc 2 5 . a_^., 1978, 1981). Another possible explanation 
for the apparent inhibition of glycolysis by xylitol and glycerol is 
an increased rate of gluconeogenesis from lactate, but Jakob et al., 
(1971) found that xylitol is an inhibitor of gluconeogenesis.
The results obtained with sorbitol are an interesting contrast 
to those observed with xylitol and glycerol (Table 7). Sorbitol is 
metabolised via the N AD— dependent sorbitol dehydrogenase, to fructose. 
The (NADH)/ (NAD ) ratio, as estimated by (lactate)/(pyruvate) ratio 
is increased initially to a greater extent by sorbitol (10 mM) than 
by glycerol and xylitol (Table 8). After 45 and 60 min there is 
little difference, in (lactate)/(pyruvate) ratio, between the effect 
of sorbitol and xylitol but the effect of sorbitol is more profound 
than that of glycerol at all times indicated (Table 8). Thus the pyru­
vate plus lactate output would be expected to be inhibited to below 
control values if the (NADH)/(NAD^) ratio is critical as suggested 
previously. However, in the case of this substrate there is apparently 
no stimulation or inhibition of glycolysis up to 30 min, but after 
30 min there is a stimulation so that the rate of pyruvate and lactate 
output approach that observed with fructose.
It is well known that sorbitol is rapidly converted to fructose 
in hepatocytes (Berry e^ £l., 1973), and the fructose is rapidly phos- 
phorylated by ketohexokinase, resulting in the high levels of Fru-l-P 
observed using sorbitol as a substrate (figure 25A). Thus it would 
be expected that ATP would be depleted by this substrate and in 
addition (NADH)/ (NAD*^) would be increased. Therefore, the situation 
might be expected to be analagous to that with glycerol and an inhibi­
tion of glycolysis might be expected. However, in contrast to glycerol, 
sorbitol raises Fru-l-P and Fru^^BP levels in the cell and this may
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account for the increased glycolytic flux. The depletion of ATP and 
the increase in Fru-l-P and Fru^^BP may activate PK sufficiently 
to convert PEP, present at low concentrations, to pyruvate. This, 
coupled to the regeneration of NAD"^  by the LDH reaction and by the 
conversion of DHAP to G3P may be sufficient to relieve the inhibi­
tion of glycolysis at the glyceraldehyde—3-phosphate dehydrogenase 
step. This hypothesis is further reinforced by the observation that 
as (lactate)/(pyruvate)and (G3P)/(DHAP) ratios (Table 8 & Table 10 
respectively) fall there is an increased rate of pyruvate and lactate 
output from sorbitol (Table 7).
8. An estimation of hepatocyte 'redox state*
Glycolysis to lactate from the triose phosphates involves an 
NAD utilizing and an NAD producing step (figure 3), thus there is 
no net depletion of NAD . However, upon subjecting the liver to a 
reduced substrate load this steady state ceases to exist (because 
these substrates are initially oxidised by NAD^ coupled enzymes), 
resulting in a raised (NADH)/(NAD^) ratio. Thus, a net decrease in 
}{AD may cause inhibition of glycolysis at the glyceraldehyde-3-phos- 
phate dehydrogenase step resulting in decreased pyruvate and lactate 
production (see previous section). This study was carried out in an 
attempt to correlate the metabolic effects of various substrates with 
the changes in the cytoplasmic 'redox state' in the hepatocyte.
The (NADH)/ (NAD^) ratios in the cytoplasm have been measured
using various methods, one of the oldest methods being the assay of 
(G3P)/(DHAP) ratio (Hohorst e£ al., 1959), which is generally con­
sidered to give valid results because of the high activity of gly- 
cerol-3-phosphate dehydrogenase. Williamson et al.,(1967a) also re­
ported that the components of the LDH system in the liver are main- '
tained in a constant state apparently close to thermodynamic equilibrium,
thus (lactate)/ (pyruvate) ratios are also considered to be a true 
reflection of the 'redox state', the ratio of free (NADH)/ (NAD ) within 
the hepatocyte (Williamson e^ . fLl" * 1967a; Bûcher 25. £ji.* * 1972). The 
other redox couple that has been used as a measure of (NADH)/(NAD )
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ratio is sorbitol and fructose because although there is considerably 
less sorbitol dehydrogenase activity than LDH in the liver (Gibson 
GC a 1., 1953; Leissing & McGuinness, 1978), fructose can also be 
reduced to sorbitol at substantial rates (Berry & Werner, 1973), thus 
making (sorbitol)/(fructose) a valid indicator of (NADH)/(NAD*^) ratios.
In this study (G3P)/(DHAP) and (lactate)/(pyruvate) were used as a 
measure of (NADH)/ (NAD ) ratios since sorbitol and fructose were used 
as substrates.
A study of the (lactate)/(pyruvate) ratios shows that the ratios 
are not altered in untreated hepatocytes over a 60 min incubation period 
(Table dA). The values obtained are in agreement with those obtained by 
various workers(Woods & Krebs, 1973; FBrster, 1974) which is another 
indication that the hepatocyte preparations used in this study were 
viable. Incubating hepatocytes with glucose, fructose, dihydroxyacetone 
or D-glyceraldehyde (up to 10 mM of each substrate) had no significant 
effect on the (lactate)/(pyruvate) ratios (Table 8A & B). This lack 
of effect is also anparent in cells from 24 h fasted animals treated with 
dihydroxyacetone, glucose or fructose(Table 9). This phenomenon is easily 
Explained by the fact that these substrates are in the oxidised form 
and therefore their metabolism does not involve a net utilization of 
NAD (see also figure 3). Incubation of isolated hepatocytes with 10 mM 
of the reduced substrates glycerol, sorbitol or xylitol caused a 
rapid elevation of (lactate)/(pyruvate) ratios within 10 min (Table 
8A), followed by a gradual decrease over the next 50 min in the case 
of glycerol and sorbitol. The effect of glycerol on (lactate)/(pyruvate) 
ratios was concentration dependent, and this effect was apparent at 
all concentrations of substrate (up to 10 mM) tested (Table 8B). An 
explanation for the elevation of (lactate)/(pyruvate) ratios caused 
by reduced substrates can be offered by a study of the metabolism of 
these substrates (figure 3 & 6). In order to enter the glycolytic- 
gluconeogenic pathway, the above substrates are oxidised in reactions 
coupled to NAD^, thus resulting in depleted NAD in the hepatocytes.
In an attempt to restore NAD levels, reduction of pyruvate to lactate 
occurs. However, since there is limited glycolysis with these substrates 
(see figure 30 B & Table 7), the cell is unable to completely compensate
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for the depleted NAD and hence the (lactate)/(pyruvate) ratio is 
increased. The reduction of (lactate)/(pyruvate) ratios observed 
with longer incubation time is presumably due to slow restoration 
of NAD concentrations in the hepatocytes by the shuttle mechanism 
described in section I.E.
A time course study of (G3P)/(DHAP) ratios shows that in un­
treated hepatocytes there was no significant change over a 60 min 
incubation period (Table 10). Incubating isolated hepatocytes with 
up to 10 nM dihydroxyacetone or glucose caused no significant changes 
in (G3P)/(DHAP) ratios (Table 10 A & B). This lack of effect of the 
substrates was similar to that observed when (lactate)/(pyruvate) 
ratios were examined. However, high concentrations of fructose (Table 
10 A & B) caused a significant elevation of (G3PY(DHAP) ratios which 
was not mirrored by parallel changes in (lactate)/(pyruvate) ratios.
A further study of (G3P)/(DPAP) ratios reveals that low D-glyceralde­
hyde (up to 3 mM) concentrations also have no effect whereas 5 and 
10 clM substrate caused substantial increases in the (G3P)/(DHAP) ratios 
(Table lOB). Once again this effect is not reflected by a similar 
effect on (lactate)/ (pyruvate) ratios.
Berry (1980) also found discrepancies between (G3P)/(DHAP) and 
(lactate)/(pyruvate) ratios in isolated hepatocytes. He concluded from 
his observations that (G3P)/(DHAP) are not good indicators of the 
cytoplasmic (NADH)/(NAD^) ratios, possibly because the two enzymes 
involved, i.e. LDH and glycerol-3-phosphate dehydrogenase do not equi- 
libriate with the same cytoplasmic pool of NAD and NADH. The effects on 
(G3P)/(DHAP) of fructose and D-glyceraldehyde may be related since 
the latter is a product of the metabolism of the former. Nevertheless, 
it must be noted that in the case of the triose the level of G3P is 
increased (figure 29B) and the DHAP levels are decreased (Table 4).
A possible explanation of the effect of D-glyceraldehyde is that at 
low concentrations, the triose is metabolised via glyceraldehyde-3- 
phosphate and DHAP whereas at high concentrations, the metabolism via 
glycerol, G3P and DHAP may become significant. The involvement of the 
latter pathway may result in the elevation of G3P at the same time
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as DHAP- becomes depleted as the result of Fru~l—P synthesis by the
reverse aldolase reaction. This may result in a lack of equilibrium
state of glycerol-3-phosphate dehydrogenase despite the availability
of NAD . This is supported by the evidence that the K of triokinase
m
for D-glyceraldehyde is much lower (0.019 mM) than the K of NAD
m
linked glycerol dehydrogenase (11 mM) for the same substrate (Leuthardt 
and Wolf, 1954; Sillero eit al., 1969; Frandsen & Grunnet, 1971; 
Veneziale, 1972b). Alternatively it is possible that Fru-1—P accumu­
lating with both ^-glyceraldehyde and fructose is affecting the level 
of G3P via an effect of one of the enzymes involved in its metabolism. 
The reduced substrates, glycerol, sorbitol and xylitol tested raised 
(G3P)/(DHAP) ratios at all concentrations (Table 10). The explanation 
for this phenomenon is discussed above.
9. Glucose
The evidence available from the studies in previous chapters 
indicat^Sthat fructose activates PK in washed cells, in addition in­
creasing the net glycolytic flux. However, a closer examination of the 
glycolytic flux (figure 30) from various substrates suggest that fruc-
tolysis is occurring at a linear rate over the 60 min incubation
period, whereas after dihydroxyacetone administration there is a 
burst of glycolysis followed by a slower rate of pyruvate plus lactate
production comparable to the control rate. It was thus of interest to__
study glucose output in the presence of these two substrates.
An examination of the time course for glucose production in
isolated hepatocytes from fed animals (figure 33) shows that there 
is a slow rate of glucose production in untreated cells (0.6 umoles 
min"^ g cells~^). Incubating with dihydroxyacetone (10 mM) and fructose 
(10 mM) caused a significant increase in glucose production during 
the first 30 rain incubation, but there was no significant difference 
in the rate of gluconeogerj^is from either substrate (figure 33). 
Further incubation (for up to 60 min) resulted in a decrease in the 
rate of glucose output with both substrates. The decrease in the
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Figure 33.
TIME (min)
Time course showing changes in the glucose level of isolated 
hepatocytes incubated with no added substrate ( O ), 10 mM 
dihydroxyacetone ( A  ) or 10 mM fructose ( •  ). Hepatocytes 
were extracted with perchloric acid and the glucose deter­
med by an enzymatic method (see methods, section IV.B.6g).
4
CF*
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o
o
6040200
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Figure 34. Time course showing the glucose produced when hepatocytes 
isolated from 24 h fasted rats were incubated with 10 mM 
fructose or dihydroxyacetone (symbols as in figure 33).
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rate of glucose output observed with both substrates may be related 
to the depletion of added substrate especially in the case of dihy— 
droxyacetone, The total glucose produced from dihydroxyacetone during 
the first 30 min incubation period is approximately 3.5 mM, and since 
2 moles of dihydroxyacetone are used to form 1 mole of glucose, this 
amount of glucose produced is equivalent to 7 mM substrate. Conside­
ring the dihydroxyacetone is also metabolised to pyruvate plus 
lactate (figure 30B) it is not surprising that the rate of glucose 
production from this substrate slows down with time. It must be 
noted that fructose effects cannot be easily explained because this 
substrate also stimulates glycogenolysis by activating phosphorylase, 
secondary to the depletion of ATP (Van de Werve & Hers, 1979). Thus 
the effect of fructose observed above may be due to increased glyco- ■ 
genolysis, increased gluconeogenesis or both, whereas the effects ob­
served with dihydroxyacetone are probably due to increased gluconeo­
genesis. Thus the burst of glycolysis, followed by a slower rate 
observed with dihydroxyacetone (figure 30B), may also be due to li­
mited substrate since a considerable amount is converted to glucose. 
With fructose no such effect is apparent (figure 30A) presumably 
because glycogenolysis is also stimulated.
There is no significant production of glucose in untreated hepa­
tocytes from 24 h fasted rats (figure 34). The basal glucose concen­
tration is also considerably less than that observed in fed animals 
presumably due to lack of glycogen. Incubating with 10 mM dihydroxy­
acetone and fructose (figure 34) reveals that both these substrates 
cause increased glucose production, the substrate producing
more glucose over the whole incubation period. After the initial burst 
of glucose production, there is a gradual decrease of glucose concen­
trations with time. A possible explanation for this effect is that 
the glucose produced is used to restore glycogen depleted during 
fasting or alternatively it undergoes glycolysis.
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In agreement with the reports by Foster & Blair (1978) and 
Claus 6^ * » (1979); who used hepatocytes from fasted rats, the
major products of dihydroxyacetone metabolism in hepatocytes from 
fed animals were glucose, lactate and pyruvate. The former authors 
reported that dihydroxyacetone (10 mM) doubled the output of lactate 
by cells from fed animals while increasing glucose output by 33%.
The former finding is in line with the results in the present study 
but a much greater stimulation of glucose output was observed.
C. INVESTIGATION INTO POSSIBLE INHIBITORS OF PYRUVATE KINASE
Incubation of isolated hepatocytes with high fructose (10 mM) 
concentrations causes inhibition of PK in unwashed cells. Experi­
ments from the previous section (III.A) provide strong evidence that 
the inhibition caused by fructose is reversible by either salting 
out the enzyme with (NH^)2 S0  ^or removing the hepatocyte medium.
Thus, this rules out inhibition by a change in the phosphorylation 
state of the enzyme. A wide variety of substances have been reported 
(see section II.C) to inhibit PK, and such inhibition is of phy­
siological importance (section II.F) since this enzyme occupies 
an important strategic position in glycolysis. This section dis­
cusses the inhibition of PK in isolated hepatocytes incubated with 
fructose and investigates the possible role played by some of the 
inhibitors discussed in the introduction (see section II.C). The 
role of other as yet undiscovered inhibitors and their physiological 
importance is also discussed.
1. Effect of pH on pyruvate kinase activity
Evidence that PK is strongly affected by pH has been previously 
discussed (see section II.C.3). The intracellular pH of perfused 
liver has been quoted as 7.24 while the perfusate pH was 7.4 (Cohen 
et al.,1971; Lloyd et aT., 1973; Cohen & lies, 1975). A further 
study of intracellular pH by lies e^ £!.• ♦ (I960) showed that the 
fall in intracellular pH after addition of fructose is rapid and
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follows a similar time course to the fall in ATP. Perfusion with 
10 mM substrate caused a decrease in pH (0.1 - 0.2 units) within 
6 min. Therefore, it was of interest to study the pH in the final 
assay conditions.
An examination of the pH of the reaction mixture, either before 
or after the assay, reveals that the pH is not altered significantly 
under these conditions. This finding is not surprising since the 
buffers used are both at pH 7.4 and the cell preparation is diluted 
120 times during the preparation of the reaction mixture. These 
findings rule out the possibility that a change in pH is causing 
the inhibition observed.
2. Effects of adenine nucleotide catabolism
Intravenous injection of fructose in normal humans significantly 
increases uric acid concentration in the plasma, with concomitant 
increases in urinary excretion of urate (Ferheentupa & Raivo, 1967). 
Although there is evidence of de novo purine synthesis, (Emmerson, 
1974; Raivo ££  a_l., 1975), the major sources of the extra uric acid 
seem to be preformed purine nucleotides, which, following fructose 
administration are known to undergo extensive breakdown in the liver 
(MMenpMH ejt , 1963; Burch e^ , 1969, 1970). Increased formation 
of the end product of purine catabolism, allantoin (Raivo et al., 
1968), and the depletion of adenine nucleotides (Woods e^ aT., 1970) 
have also been reported to occur in the perfused rat liver system. 
Smith ££ a_^.,(1977b) reported that incubating hepatocytes with 28 mM 
fructose causes an accumulation of allantoin which is not observed 
in the presence of glucose. Thus a study was carried out to observe 
the effects of the products of adenine nucleotide catabolism on PK 
activity.
i) Effect of A2ÎP metabolic products on pyruvate kinase activity
High fructose concentrations cause inhibition of PK in unwashed 
cells and this effect is not apparent after incubating with low 
fructose concentrations (section III.A). The inhibition caused by
- ]_45 -
high fructose concentrations is probably due to the accumulation of 
an inhibitor. As a consequence of depletion of ATP by fructose 
the rate of AMP catabolism is known to increase. Thus a number of 
AMP catabolic products were tested for their effects on the activity 
of a partially purified PK preparation.
The results obtained (Table 11) indicate that the only adenine 
nucleotide catabolic products that affect PK activity significantly 
were uric acid and allantoin. Of the metabolites which had no effect 
on PK activity, the use of higher concentrations (up to 4 mM) had 
no significant effect on PK activity (results not shown), A closer 
examination of the uric acid and allantoin effects was carried out 
as shown in Table IIB. The results obtained provide further evidence 
that the end products of A2IP catabolism inhibit PK whereas the inter­
mediary metabolites do not.
ii) Effect of allopurinol on fructose induced inhibition of
ELruvate kinase
Xanthine oxidase the enzyme which produces uric acid in the 
catabolism of AMP, is inhibited by allopurinol (Massey e_t , 1970a; 
Spector & Johns, 1970; Fain & Shepherd, 1977; Nifhaolain & Goughian, 
1978). Allopurinol is an analogue of hypoxanthine which is converted 
to oxipurinol (4, 6-dihydroxypyraxolo (3,4-d) pyrimidine) by xanthine 
oxidase (Elion e_£ al., 1966; Massey e_t aT., 1970a, 1970b).
The results presented in table 11 seem to indicate that uric 
acid and allantoin may be causing the inhibition of PK activity 
observed in unwashed hepatocytes after incubating with high fructose 
concentrations. It was, therefore, of interest to examine the combined 
effects of fructose and allopurinol on PK activity in unwashed cells. 
The results shown in table 12 give the indication that allopurinol 
(20 uM) does in fact reverse the inhibition observed with high fruc­
tose concentrations to some extent, but the stimulation observed in 
washed cells (figure 12B) was not apparent. This reversal of the 
effect of fructose by allopurinol appeared to strengthen the hypothesis 
that the end products of AMP catabolism inhibit PK activity.
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Table 11. The effect of AMP breakdown products on partially purified 
pyruvate kinase from isolated hepatocytes. The v/V
max
for the control is assumed to represent 100% activity (n = 2)
A - Effect of various metabolites (* n =7 )
Metabolite Concentration
mM
Enzyme
Activity
%
Inhibition
%
Control* - 100 -
Adenosine 1.0 97 —
AMP 1.0 98 —
Allantoin* 1,0 69 + 2.4 31
Hypoxanthine 0.5 97 —
LMP 1.0 103 —
Urea 1.0 99 —
Uric Acid* 0.5 78 + 4.0 22
Xanthine 0.5 98
B - Effect of different concentrations of uric acid and allantoin
Metabolite
Uric Acid Allantoin
Concentration
mM
Enzyme
Activity
%
Concentration
mM
Enzyme
Activity
%
0 100 0 100
0.1 92 0.5 97
0.2 90 1.0 73
0.3 88 2.0 70
0.4 85 3.0 70
0.5 75 4.0 65
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Table 12. Pyruvate kinase activity in isolated hepatocytes 
incubated for 20 minutes with increasing fructose 
concentrations in the presence and absence of 20 pM 
allopurinol. The enzyme was assayed at 0.2 mM PEP. 
(n=2).
Fructose
mM
Pyruvate Kinase Activity
”1 -1 
Immoles min g cells
+ 20|a.M Allopurinol
0 24.7 + 0.8 25.0 + 0.6
1.0 29.8 + 1.0 29.8 + 2 . 1
2.5 27.1 + 0.9 27.9 + 1.2
5.0 20.2 + 1.2 25.5 + 1.1
10.0 16.7 + 0.5 24.8 + 1.6
20.0 15.6 + 1.3 25.2 + 0.5
50.0 15.73+ 2.6 25.5 + 0.8
(V (62.5 + 0.5) was unaffected under these conditions 
max —
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There are a number of other possible explanations for the 
lack of enzyme activation in the unwashed hepatocytes incubated 
with allopurinol and high fructose concentrations. For example, 
allopurinol may prevent the accumulation of the activator, but 
a study of the effect of low concentrations of fructose (figure 35) 
on the activation of PK shows that allopurinol had no effect. Another 
possibility is that allopurinol is affecting PK activity, but it 
was found that concentrations of up to 10 pM allopurinol had no 
effect on the enzyme (results not shown). A third possibility is 
that the concentration of allopurinol used is not sufficient to 
prevent accumulation of uric acid and allantoin. A study of allo­
purinol effects reveals that higher concentrations (up to 500 pM) 
of the xanthine oxidase inhibitor did not reverse the inhibition 
caused by fructose to a greater extent than that observed with 10 pM 
allopurinol (results not shown). This is in agreement with the data 
of Fain & Shepherd, (1977), who reported a 98% inhibition of xanthine 
oxidase with 10 pM allopurinol. A fourth possibility is that allopu­
rinol prevents the accumulation of uric acid and allantoin, but 
not the accumulation of another inhibitor which may also have some 
effects on the stimulation of PK by endogenous Fru^^BP.
A comparison of the effects on PK of glycerol (10 mM), fruc­
tose (5 mM) and hypoxanthine (1.75 mM) in the presence and absence 
of allopurinol is shown in Table 13. The inhibitory effect of fruc­
tose was partially reversed by allopurinol at short time intervals, 
but the activity observed after 60 min incubation was identical. 
Glycerol mimicked the effect of fructose but with this substrate 
the reversal by allopurinol was only observed after 10 min incuba­
tion. The similarities between glycerol and fructose effects presumably 
reflects the depletion of ATP by these substrates, but the fact that 
the allopurinol effect was only observed at shorter time intervals, 
suggests that there are two factors involved, one being the accumu 
lation of allantoin and uric acid which is blocked by allopurinol, 
and another factor which is unaffected by the drug. However, incu­
bating isolated hepatocytes with hypoxanthine (1.75 mM) did not
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Figure 35. The effect of 20 uM allopurinol ( #  ) on pyruvate kinase 
activity extracted from unwashed hepatocytes following in­
cubation with fructose for 15 min. Controls, without 
allopurinol ( O  )•
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significantly affect PK activity (Table 13). This lack of effect 
was also apparent when the cells were incubated with 1 mM xanthine 
(results not shown), despite the fact that this is an immediate 
precursor of uric acid and allantoin (figure 4), The conclusions 
drawn from this experiment were that either hypoxanthine and xanthine 
do not raise the uric acid and allantoin levels in isolated hépa­
tocytes or that the allantoin and uric acid accumulating in response 
to glycerol and fructose are not sufficient to explain the inhibi­
tion of PK by these substrates.
iii) Uric acid and allantoin concentrations in isolated hepatocytes
This was tested by examining the allantoin and uric acid levels 
in isolated hepatocytes incubated with 10 mM fructose, which depletes 
ATP severely,or 10 mM dihydroxyacetone, which depletes ATP to a much 
lesser extent (figure 19 & 21). Uric acid levels in isolated hepato­
cytes were assayed by both the colorimetric and the U.V. method, 
but no urate could be detected under any conditions. This is in agree­
ment with the results obtained by Van den Berghe ejt aT., (1980) and 
is presumably the result of a high uricase activity present in the 
rat liver.
Allantoin levels in the extrahepatocyte medium were also mea­
sured in the presence and absence of added fructose and dihydroxy­
acetone (figure 36). Relatively high levels of allantoin (0.16 mM) 
were found with the preincubated cells, presumably arising from the 
catabolism of adenine nucleotides during the isolation procedure 
and in the preincubation period. Incubation with 10 mM fructose, re­
sulted in a rapid output of allantoin within the first 1 0  min (corres 
ponding to the rapid degradation of ATP) followed by a more gradual 
increase over the next 60 min (figure 19). A lesser but substantial 
increase in allantoin levels was also observed in hepatocytes incu­
bated with dihydroxyacetone (10 mM). This output was comparable to 
that observed in the control cells (figure 36). Similar results were 
also obtained when the total allantoin, in both the hepatocyte and
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Figure 36. Allantoin output by isolated hepatocytes incubated with 
10 clM fructose ( •  ), 10 mM dihydroxyacetone ( ^  ) or no 
added substrate ( O  )• Allantoin was determined colori- 
metrically in neutralized perchloric acid extracts of the 
incubation mixture (see methods, section IV.B.6 c).
(n=2 ).
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the medium was assayed, suggesting that the plasma membrane is 
freely permeable to allantoin.
Thus, it appears that treatment with fructose does cause an 
increase in allantoin output by the isolated hepatocytes and that 
the hepatocyte membrane is permeable to this end product. Therefore, 
it could be a candidate for the inhibition of PK observed with 
fructose in unwashed cells. However, a consideration of the con­
centration of allantoin attained in these experiments (figure 36) 
and the concentration dependence of the inhibitory effect of allan— 
toin on PK (Table IIB) render it unlikely that the inhibition is 
due directly to allantoin accumulation. However, when the procedure 
used is examined, another possible explanation can be considered.
PK activity as assayed by the spectrophotometric method is raised 
by fructose and dihydroxyacetone in washed cells despite the large 
dilution of the intracellular factors involved. This suggests that 
FRu^^BP is tightly bound to the PK during the extraction and assay 
procedure. Allantoin may cause some dissociation of the Fru^^BP 
from the PK at the stage where the hepatocyte preparation is frozen 
and thawed prior to its dilution and assay.
3. Alanine
The free amino acids are key gluconeogenic precursors. Alanine 
and glutamine have been shown to be the predominant amino acids re­
leased from rat skeletal muscle (Ishikawa e_t , (1972; Ruderman & 
Lund, 1972; Snell, 1976; Snell & Duff, 1977), where they are synthe­
sized de novo (Ruderman & Berger, 1974; Garber e^ * 1976). The 
uptake of alanine by the liver exceeds that of other amino acids 
(Ishikawa, 1976) and the carbon of alanine is rapidly incorporated 
into blood glucose making this amino acid an effective gluconeogenic 
carrier (Mallette e_t al., 1969a; Snell, 1979). Changes in the steady 
state concentrations of intermediates in the gluconeogenic pathway 
observed using perfused liver, suggest that glucagon acts to enhance 
gluconeogenesis from alanine by increasing the transport of this amino
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acid into the hepatic cell and by stimulating the conversion of 
pyruvate to PEP(Mallette e£ al,, 1969a; 1969b). Other factors that 
affect hepatic alanine levels are; insulin, which inhibits gluconeo— 
genesis from this substrate by reducing its uptake by the liver 
(Felig, 1973) and sterôi<â hormones, which have been shown to increase 
hepatic alanine concentrations (Betheil et al., 1965).
Hepatic alanine levels are important because this amino acid 
plays a major role in maintaining blood glucose homeostasis; inhibi­
tion of PK being one of its important regulatory functions (see section 
II.C.2). A low alanine concentration (0,1 mM) is sufficient to produce 
a 50% inhibition of PK, when the enzyme is assayed at 0.3 mM PEP and 
1 m^-I Mg ADP in the absence of other effectors (Seubert & Schoner, 1971). 
This concentration of alanine is far below the values (0.5 - 1.5 mM) • 
calculated for physiological conditions (Williamson e£ £l.,1967b ;
Brosnan e^ , 1970; Schoner al^., 1970). It was of interest, therefore, 
to study the effect of various substrates on the levels of alanine in iso­
lated hepatocytes in order to examine the possibility that the inhibition 
of PK observed with fructose (section III.A) was the result of alanine 
accumulation.
i) Effect of various substrates on alanine concentration
in isolated hepatocytes
The de novo synthesis of alanine in muscle involves the transfer 
of amino groups to the carbon skeleton of pyruvate (Snell, 1979). Thus, 
the availability of pyruvate may determine the rate of alanine forma­
tion in the liver. Decreasing the availability of pyruvate by dichloro- 
acetate (which promotes pyruvate oxidation by activating pyruvate dehy- 
drogenase)diminishes alanine release in vivo (.Blackshear et al., 1975), 
and in vitro (Snell, 1976; Snell & Duff , 1977). Conversely, increasing 
the availability of pyruvate by perfusing rat hind limb preparations with 
glucose (Pozefsky & Tancredi, 1972) or lactate (Ruderman & Berger, 1974) 
or by incubating isolated muscle preparations with glucose (Odessey £l_« » 
1974; Snell, 1976; Snell & Duff, 1977) or pyruvate (Garber £ l ., 1976) 
increases alanine release. These observations were all made using muscle
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preparations. The present study was done to find out if fructose and 
other pyruvate oroducing substrates would have the same effect in 
isolated hepatocytes.
An examination of alanine concentrations in isolated hepatocytes, 
reveals that there was a basal rate (0 . 0 2  ymoles min”  ^ g cells'^) 
of alanine formation in the hepatocytes with no added substrate (figure 
37), presumably as a result of endogenous glycolysis. Cell preparations 
incubated with glucose (10 mM) showed a small increase in alanine 
levels when compared to the control. However, incubating with fru— 
tose (10 mM) caused a 3-fold increase in alanine levels during the 
first 10 min, followed by a gradual increase (figure 37A).
The hepatic synthesis of alanine from pyruvate involves a .
transamination from glutamate catalysed by alanine aminotransferase. 
The glutamate required for transamination reaction presumably arises 
from several sources. Firstly, from a pool of free glutamate in the 
liver; secondly, by transamination reactions involving other amino 
acids and .a-ketoglutarate and thirdly, as a result of the direct 
amination of a-ketoglutarate in a reaction catalysed by glutamate de­
hydrogenase. The latter enzyme can utilize either NAD or NADP and 
is inhibited by GTP (Dieter e_t £ l • i 1981). Since GTP levels are re­
ported to be low in isolated hepatocytes and GTP is depleted by a fruc­
tose load (Van den Berghe et.fl», 1980) this should result in a higher 
activity of the enzyme in fructose treated cells.
The ammonium ions required for the direct amination by gluta­
mate dehydrogenase can arise from various sources. For example, adenine 
nucleotide catabolism involves a deamination reaction which would 
result in release of free NH^ . Thus the increased rate of pyruvate 
accumulation in the case of fructose (figure 38A) is accompanied by 
the release of NH^ as a result of the AMP deaminase reaction. A second 
possibility postulated by Sainsbury (1980), is that, normally NH^ in
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Figure 37 » Alaninfî output by isolated hepatocytes incubated with no
added substrate (O ), 10 nùl glucose ( A  ), 10 mM fructose 
( ^  ), 10 mM glycerol ([}) or 10 mM dihydroxyacetone (jL ) 
Hepatocytes were extracted with perchloric acid and alanine 
determined colorimetrically (see methods, section IV.B.Sb).
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Figure 38. Pyruvate output by isolated hepatocytes incubated with 
10 mM glucose, 10 mil fructose, 10 m.4 glycerol or 10 mil 
dihydroxyacetone (symbols as in figure 37),
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hepatocytes is present in the form of NH^MgPO^. Thus the effect of
a fructose load would be to decrease Pi, which in turn would lead
to the dissociation of the complex and an increase in the free NHt.
4
This seems to suggest that the increase in alanine observed with 
fructose (figure 37A) is the result of increased pyruvate accumula­
tion (figure 38A) and increased NH^ availability. This is borne out 
by the evidence in Table 14, which shows that the effects of 
fructose on alanine output are only observed at 5 and 10 mM. Since 
stimulation of pyruvate output is observed at low concentrations 
of fructose (figure 39A), this suggests that NH+ may be a limiting 
factor in alanine production at these concentrations.
Further evidence for this hypothesis was obtained from the results 
on a study of the effect of added NH^C1(10 mM) on the output of alanine. 
In the absence of KH^Cl, the usual stimulation of alanine output 
was observed, but on addition of NH^Cl both the basal and the fruc­
tose induced increase in the output of alanine were considerably 
elevated (figure 40). This increase is probably due to the increased 
availability of glutamate as the result of glutamate dehydrogenase 
activity. These observations are in accordance with the results of 
Hems ejt aj_., (1975), who found that lactate raised alanine concen­
trations in hepatocytes from 48 h - starved animals, and at the 
same time glutamate levels were increased. The addition of NH^Cl 
resulted in an increase of both glutamate and alanine. Thus the rapid 
rise in alanine concentrations occurring after fructose administra­
tion is the result of pyruvate accumulation. The much smaller rise 
observed in the absence of NH^Cl suggests that the level of intra­
cellular may also be a limiting factor.
An examination of the fructose—induced alanine production over 
a 10 min incubation period (figure 41) revealed that a significant 
effect of fructose (10 mM) was observed after 1 min, whereas pyruvate 
output was only significantly increased after 5 min (figure 42). This 
observation coupled to the fact that ATP levels are significantly
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Figure 39. Pyruvate output by isolated hepatocytes incubated with
glucose (A ). fructose ( #  ), glycerol (o)» dihydroxy­
acetone ( 4 k) or D-glyceraldehyde ( O  ) 2 0  min
(glucose n=2 ).
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Figure 40. Alanine output by isolated hepatocytes treated with no 
added substrate (C )» 10 mM fructose (4# ), 10 mM 
NH^Cl ( 0  ) or 10 mM fructose and 10 mM NH^Cl ( ♦  ).
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Figure 42. Rapid pyruvate output by isolated hepatocytes incubated 
with or without 10 mM fructose (symbols as in figure 41)
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reduced within 30 s (figure 20) is further evidence for the involvement 
of an increased NH^ availability during synthesis of alanine. In 
general, however, the time course for pyruvate accumulation parallels 
that for alanine production suggesting that the level of pyruvate 
is also an important factor.
This hypothesis was tested further by comparing the effects 
of glycerol (which causes a substantial depletion of hepatocyte ATP 
(figure 21), but inhibits pyruvate production (figure 38B)) and 
dihydroxyacetone (which does not deplete hepatocyte ATP severely 
(figure 21) but increases pyruvate formation (figure 38B)), on ala­
nine production. A time course examination of the effect of these 
substrates on hepatocyte alanine concentration (figure 37B) revealed 
that both the trioses caused a small but significant increase in 
alanine production during the first 2 0  min of incubation, but this 
was much less than that observed with fructose. Initially there 
was no difference in the rate of alanine output in the presence of 
dihydroxyacetone (10 mM) and glycerol (10 mM), but after 20 min 
the rate of alanine output in the presence of the latter substrate 
was much reduced compared to dihydroxyacetone. An explanation for 
this phenomenon can be put forward by considering the effects of 
the two substrates on ATP and pyruvate levels. Glycerol depletes 
the hepatocyte ATP (figure 21), decreases the pyruvate levels (figure
38B) and inhibits the formation of total lactate plus pyruvate (figure
+
30B). The elevation of NH^ caused by the phosphorylation of glycerol 
would cause a rapid conversion of pre-existing pyruvate to alanine 
initially; but then the supply of pyruvate would become limiting be­
cause of the inhibition of glycolysis. In the case of dihydroxyace­
tone, pyruvate output is increased (figure 38B), but in this case 
+
is the limiting factor in alanine production. With fructose, the 
ATP depletion and pyruvate accumulation would result in the high rate 
of alanine production observed. The effect of dihydroxyacetone and 
glycerol on alanine production was also found to be concentration de­
pendent (Table 14). There appears to be no significant difference in 
the rate of alanine output in the presence of either glycerol or
- 164 -
dihydroxyacetone. However, it is likely that in the case of the 
former substrate pyruvate accumulation is limiting, whereas in the 
case of the latter substrate, NH^ concentration is limiting.
ii) Effect of aminooxyacetate on alanine concentrations in-
isolated hepatocytes
It is evident from the above results that fructose (10 mM) 
causes an increase in alanine production by hepatocytes. The pro­
posed mechanism for this effect is that fructose increases the 
concentration of both NH^ and pyruvate in the hepatocyte and this 
leads to transamination of glutamate and pyruvate to yield alanine.
It was of interest, therefore, to study the effect of aminooxyacetate, 
an inhibitor of aminotransferases (Hopper & Segal,1962; Otto, 1965; 
Blackshear et al., 1975; Garber et^  al^., 1976 ; John £t al ., 1978) on 
alanine levels in isolated hepatocytes and also to examine PK acti­
vity under these conditions.
An examination of alanine levels in isolated hepatocytes re­
veals that aminooxyacetate inhibits the basal alanine production by 
untreated hepatocytes (Table 15). Similarly the raised alanine output 
due to fructose is also inhibited by aminooxyacetate. The simplest 
explanation for this phenomenon is the inhibition of pyruvate trans­
amination, but an examination of the lactate and pyruvate levels in 
the aminooxyacetate treated cells revealed that, while the rate of 
glycolysis as estimated by lactate and pyruvate output was unaffected, 
the pyruvate levels fell considerably following treatment of the cells 
with the inhibitor (Table 16). This is a consequence of a change in 
the (lactate)/(pyruvate) ratio. An explanation for the change in 
the (lactate)/ (pyruvate) ratio can be found in the work of Rognstad 
& Clark,(1974) who suggested that aminooxyacetate may inhibit the 
malate-aspartate cycle which serves to remove excess cytosolic NADH. 
From the results in Table 16, it would appear that basal glycolysis 
from glycogen and glycolysis from fructose to pyruvate would generate
— 165 —
Table 15. The effect of aminooxyacetate on alanine levels in
isolated hepatocytes incubated for 2 0  min in the presence 
and absence of 10 mM fructose.
Concentration
of
Aminooxyacetate
(mM)
Alanine (pmoles g cells ^)
No Substrate Fructose
0 0.75 + 0.09 1.75 + 0.15
0.25 0.62 + 0.08 0.91 + 0.09
0.5 0.65 + 0.04 0.75 + 0.07
1 . 0 0.61 + 0.04 0.81 + 0.03
2 . 0 0.57 + 0.02 0.77 + 0.14
Isolated hepatocytes were incubated with or without fructose 
and aminooxyacetate for 20 min. The reaction was stopped using 
perchloric acid and the neutral extracts used for alanine 
estimation as described in methods (section IV.B.6 ).
- 166 -
SI
3
t3
U
f3
3
U
c
tfj
<u
>>
u
o
a;
cn
0
4-1
u
3W
Vm
1  
O
0
(J
c
01 
aj 
XI 
CO
•3
C
CO
3 O 
3: u
"3
OJ
3
>
3
u
CL.
-3
C
CO
(U
CO
4-1
a
CO
►J
o
CN
o
CO
0>
3
CO
> ,
%
Oo
c
*S
CO
XI
COo o 14-1 X 'O’ a)•r-( cO4-1 04 CN 1—4 m 1—4 cn 3
CO WL4 O + 1 + 1 + 1 + 1 + 1 4-44-4 c(U u m o r—4 r-4 cr> CO4-1 3 4-4
CO i-i cr» o cr> o cn CO
> k CN CN <r C
3 Li
04 04
>, 4-4 CL
C_ 3 304 4-4 aj X4J cn un cr> un 04
CO O "3 «Ol 4-1 *—4 cn CN r-4 m CO 044-1 4J >- N >
CO CO + 1 + 1 +1 + 1 + 1 X •H M4-4 X o rH
O 3 m 00 CT\ ON CO o CO cCO c Li orÀ o <r (T> CN 4-4 •r4
o »—4 CN cn cn »a- s 3 4-4z rO 04 Uc 04
a)
<4-4 04
1 o Xcn 04 <Tl un f—^ CN r—t 4-1 (0r—* a: 04 nor-4 O o o O O o U •3 O01 4J c C X
u u +1 +1 + 1 + 1 +1 04 CO 4-1
3 </i 04
00 1-4 CN X 04 EU4 W "3cn <r CN f—4 r-4 O CL •H 04
01 u 04
04 CO a)
o X
E 04 4-4 o4-4 <rH a)
CO X c Li C
04 w o o o o •H o O4-4 4.4 t—1 •H
CO cn o O o o o -o X 4-4
> X 04 u CO
3 +1 +1 +1 +1 +1 4J Li LiL, CO to 04 4-4
>, <r C7\ r«v X X X CL c
CU o 3 04
z CN O O o o u W) U
c c c
•r-l •l-l o
a) u<r o cn o 1-^ 04 3
1 04 >-i 04
a) n •«a- •a- cn NT <r 04 TJ 4Jo 3 04 CO4J + 1 + 1 + 1 +1 +1 CL >
04 o a) CL 3
U 3 o CN CN C7> O W
L, CO 4J
CO U4 m <T CN 'a- E ai CL
•vT a^- 'C 'T NT •H
V) c a)
01 CO 3 "3
04 3 C
O 4J *o 3s CO CN CN X 04 C
u 14-1 o
4-4 cn CN cn CN CN •iH 04
<3 aj E 4J 4-44J X + 1 + 1 + 1 + 1 + 1 0 u 3
CO 3 W CO 4-4
4-1 CO 00 C?4 f—4 r-4 L-l 04 CJ
u Li 3
CO o cn CN cn <r in TJ r—1
.-J 2 CN CN CN CN CN 04 04
4-4 X 3
CO H CI—4
o
04 aj
C 4J •r4 X 04o CO 4-4
•r4 4-1 a) 3
4-4 04 04 o no
CO U 4-4
u CO >» CN
4-1 C4-I m u o
c o X CN in O o o O 4-4
04 o O 4J 4-4
U o o O 1—4 CN CO no
c c CL CL 3
0 04 3 a)
a I 3
- 167 -
excess NADH at the glyceraldehyde-3-phosphate dehydrogenase step.
Some of the NADH is removed by the action of LDH, but since some 
pyruvate is converted to alanine, then an excess NADH is produced. 
Normally this is removed by malate-aspartate shuttle (figure 5E), 
but if this is inhibited by aminooxyacetate then excess NADH will 
alter the (lactate)/(pyruvate) ratio in the direction shown in 
Table 16. Such a mechanism, however, would imply that the pyruvate- 
glutamate transaminase is not completely inhibited by aminooxyace­
tate and that the effect of the inhibitor on alanine output is the 
result of a lack of availability of pyruvate.
An examination of the effect of aminooxyacetate on the inhibi­
tion of PK caused by incubation of hepatocytes with 10 mM fructose 
(Table 17), showed that although the transaminase inhibitor reversed 
the inhibition due to fructose, no stimulation was observed as 
might be expected from the accumulation of Fru^^ BP and Fru-l-P 
and the depletion of ATP in the hepatocytes exposed to fructose (see 
section III.B). This is evidence that alanine accumulation may 
account for some of the inhibition of PK observed after a fructose 
load, but other factor(s) must also be involved.
iii) Alanine concentrations in isolated hepatocytes from
fasted rats
A study of the PK activity in isolated hepatocytes from rats 
fasted for 24 h (figures 17 & 18) indicated that fructose (10 mM) and 
dihydroxyacetone (10 mM) caused activation of the enzyme in unwashed 
cell preparations. There are a number of possible explanations for 
this phenomenon. One possibility is that in hepatocytes from fasted 
animals the inhibitor(s) do not accumulate to the same extent after 
administration of a high fructose load as in cells isolated from fed 
animals. Alternatively, the concentration of the other effectors 
may change upon fasting such that the enzyme is rendered less suscep­
tible to the inhibitor. Another possibility is that the phosphorylated
— 168 -
Table 17. The effect of aminooxyacetate on pyruvate kinase
activity in isolated hepatocytes incubated with or 
without 10 mM fructose for 20 min (n = 2).
Concentration
of
Aminooxyacetate
(mM)
Pyruvate Kinase Activity (v/y^^^)
No Substrate Fructose
0 0.42 0.32
0.25 0.39 0.36
0.5 0.39 0.35
1 . 0 0.40 0.40
2 . 0 0.41 0.40
Isolated hepatocytes were incubated in the presence and absence 
of 10 mM fructose and increasing concentrations of aminooxyacetate 
The reaction was stopped by freezing samples in liquid and PK
assayed as described in methods (see section IV.B.3).
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enzyme,which is found upon fasting, is inhibited to a lesser extent 
by the inhibitor. Phosphorylated PK is known to be more sensitive to 
ATP and alanine inhibition (Ekman aj[., 1976; LjungstrHm et al., 
1976). This suggests that the latter possibility is invalid or that 
the inhibition has a totally different effect to that of ATP and ala­
nine. Williamson e^ aT., (1967b) have reported a 65% decrease in hepatic 
alanine levels as the result of fasting. It was, therefore, of interest 
to examine the effects of various substrates on alanine levels in he­
patocytes from fasted rats in an attempt to further examine the possi­
bility that the inhibition of PK is caused by alanine.
A time course study revealed that in the absence of substrate, 
very little alanine accumulation occurred in hepatocytes from fasted 
animals (figure 43). This can be correlated with the low rate of gly­
colysis by these cells and is a further indication that alanine output 
is dependent on pyruvate availability. Glucose (10 mM) caused very 
little accumulation of alanine (figure 43) or pyruvate (figure 44) 
in cells from fasted animals, but fructose (10 mM) again stimulated 
alanine output to the same extent as it did in the cellsfrom fed rats 
(figures 37A & 43). This stimulation is again reflected by the rate of 
lactate and pyruvate output observed under these conditions (figure 31). 
There was no significant difference in the elevation of alanine produc­
tion caused by dihydroxyacetone (10 mM) in hepatocytes from fed and 
fasted animals over a 60 min incubation period (figure 43). Again the 
changes in alanine levels mirror the changes in pyruvate (figure 44).
The lack of difference in the effect of fructose on alanine output 
in fed and fasted animals is evidence against the involvement of alanine 
in the inhibition of PK which occurs when hepatocytes from fed animals 
were incubated with 10 mM fructose.
iv) Intrahepatocyte alanine concentrations
The observations made above indicate clearly that alanine accumu­
lation in isolated hepatocytes from both fed and fasted animals occurs
+
as a consequence of NH^ and pyruvate availability. These studies also
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Figure 43. Time course showing the alanine content of hepatocytes 
isolated from 24 h fasted rats and incubated with no 
added substrate ( O  )» 10 mM glucose ( A  ), 1 0  mM 
dihydroxyacetone ( A  ) or 10 mM fructose ( #  ).
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Figure 44. Time course showing the pyruvate content of hepatocytes 
isolated from 24 h fasted rats and incubated with 10 mM 
glucose, 10 mM dihydroxyacetone, 10 mM fructose or no 
added substrate (symbols as in figure 43).
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show that the greatest output of alanine occurs in the presence of 
fructose and that elevation of this anino acid is inhibited by amino­
oxyacetate. From the results in section III.A , it is clear that the 
inhibitor which accumulates in isolated hepatocytes after a high fruc­
tose load is removed by discarding the extrahepatocyte medium. Since 
alanine was considered a possible candidate for the inhibition of 
PK, the distribution of the alanine between the hepatocyte and the 
medium was investigated.
A comparison of the total alanine accumulating and alanine con­
centrations inside the hepatocyte from fed rats (Table 18) shows 
that some of the alanine formed leaves the cell. The amount of alanine 
inside the untreated hepatocytes is about 40% of the total alanine.
The uptake and subsequent metabolism of amino acids in liver paren­
chymal cells has been subjected to intensive research (Ishikawa, 1976). 
The presence of specific amino acid transport systems in the paren­
chymal cell membrane has been demonstrated both in whole cells (Edmondson 
e_t^ a^., 1977; 1979; Le Cam & Freychet, 1977; Sips f_l • » 1980b) and 
in isolated plasma membrane vesicles (Van Amelsvoort a^., 1978;1980; 
Sips » 1980a). Thus there is a distribution of alanine against a
concentration gradient by the hepatocytes as evidenced by the results 
in this study (Table Id). A rough calculation of the ratio of the con­
centration of alanine inside and outside the cell yields a result of 
approximately 30, which is in agreement with the evidence of Hems et al.,
(1975) for alanine levels in isolated hepatocytes incubated with lactate.
A quantitative study of the alanine levels in isolated hepatocytes 
shows that the total alanine in both the cells and medium increases from
0.03 to 0.10 mM in the 60 min incubation period. However, if the alanine 
levels inside the hepatocytes are examined (0.55 to 1.42 mM - assuming 
1 g cells contains 380 yl cytosolic water - Sobell e^ , 1976) 
it seems that the intracellular alanine concentrations are similar to 
those reported in the literature (0.5 - 1.5 mM) (Brosnan et_ al., 1970; 
Schoner et al., 1970). In the case of fructose total alanine increases 
from 0.03 to 0.11 mM whereas the intracellular alanine changes from
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0.55 to 1.95 mM in 20 min. Thus when the dilution factors are taken 
into account the inhibition of PK by high concentrations of fructose 
cannot be accounted for by changes in total alanine concentrations.
The lack of change in the medium alanine concentrations in response 
to fructose is evidence against the involvement of the amino acid
in the inhibition of PK, since the evidence points to the presence 
of the inhibitor in the extrahepatocyte medium. However, it is 
possible that the localized alanine level inside the hepatocyte may 
extert a regulatory effect on PK r^i situ and thus alter the glycolytic 
flux.
D. KINETIC STUDIES ON PYRUVATE KINASE EXTRACTED FROM 
ISOLATED HEPATOCYTES
The results from the previous section(III^) indicate that a
high concentration of fructose leads to a depletion of intracellular 
ATP and an accumulation of Fru^^BP and Fru-l-P within the cell. Taken 
together this should result in the activation of PK Ln situ as measured 
by glycolytic flux and the activation of the enzyme as measured in a 
cuvette. However, while it is evident that total glycolytic flux is 
increased by fructose (figure 30A), the activation of PK is only 
apparent in hepatocytes washed after treatment with fructose (figure 
IIB). This seems to suggest that an inhibitor is present in the extra­
hepatocyte medium, which causes a profound inhibition of PK. Two 
possible candidates to explain this inhibition are alanine and allan­
toin. The following experiments were performed to study the kinetic 
properties of PK in order to examine if the changes detailed above 
could be explained by the kinetic properties of the enzyme.
1. The effect of fructose treatment on the kinetic parameters of a 
crude pyruvate kinase preparation isolated from hepatocytes
A comparison of the kinetic properties of PK from hepatocytes in­
cubated with fructose (10 mM) with those of PK from untreated hepatocytes 
clearly shows the inhibition observed in unwashed cells (figure 45A) and
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the stimulation which occurs when the washed cells were assayed
(figure 45B). These effects were only apparent at subsaturating
PEP concentrations, while V is unchanged by fructose treatment.max ° ^
A kinetic analysis of PK activity (using Hill plots) from washed 
or unwashed cells, treated or not treated with fructose ( 1 0  mM), 
showed that the changes in activity observed were mainly as a 
result of the changes in the affinity of the enzyme for PEP, as 
estimated by the  ^values (figure 46). The Sq ^ values in the 
control cells were unaffected by the washing treatment (unwashed 
cells Sq  ^ = 0.25 mM, washed cells 5 ~ 0.29 mM) but both values 
were lower in the crude hepatocyte preparation (figure 46A & 46B) 
than in the (NH^)2 S0 ^ purified enzyme (S^ ^ = 0.59 mM, figure 46C).
This is presumably because (NH^)2 S0 ^ treatment removes the tightly 
bound Fru^^BP, resulting in the inactivation of the enzyme. This 
effect is also apparent when the  ^ value for PK from washed cells 
treated with fructose (S^  ^ = 0.16 mM) is compared to the (NH^)2 S0 ^ 
purified enzyme (S^  ^ = 0.69 mM). However, it is apparent that the 
Sq  ^ value for the enzyme from unwashed cells (S^ ^ % 0.50 mM) 
treated with 10 mM fructose is higher than the value for the com­
parable enzyme from washed cells (S^ ^ ^ 0.15 mM)•
The kinetic analysis of the crude enzyme preparation from hépa­
tocytes indicates that the changes in affinity for PEP observed when 
hepatocytes are treated with fructose are due to changes in the level 
of activator (s) and inhibitor(s) since (NH^)2 S0 ^ treatment abolishes 
the difference between the fructose-treated and the untreated cells.
Thus the changes in enzyme activity occurring as a result of fructose 
treatment are not due to a stable change in the enzyme. The fact that 
in the control, the (NH^)2 S0 ^ treatment results in an increase in the 
Sq ^ value is evidence that there is a carry-over of activator (s) 
(presumably Fru^^BP) in the extraction and assay procedure. This 
must be borne in mind when interpreting results obtained with the 
assay of PK from hepatocytes. The effect of Fru^^BP and Fru-l-P are 
also apparent in figure 45B. The difference between the fructose-treated
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and untreated hepatocytes is presumably related to the high level 
of these effectors found in the treated cells (see figures 22 & 25). 
Similar effects were also found with hepatocytes from fasted rats 
(results not shown).
The explanation for the inhibition of the PK in the extracts 
of cells from fed rats incubated with fructose is more problematical. 
The simplest explanation is that an inhibitor has accumulated which 
overcomes the stimulatory effect of Fru^^BP and Fru-l-P. Alternatively, 
it is possible that the reversal of the stimulatory effect is due to 
a dissociation of the tightly bound activator from PK during the 
extraction and assay procedure. Thus the carry-over of Fru^^BP may 
be much reduced in the presence of the increased concentration of 
alanine and/or allantoin. The fact that the ^ value for the fruc­
tose-treated enzyme from unwashed cells is lower than the  ^
value for the (NH^)2 S0 ^ treated enzyme lends further support for 
this mechanism. Therefore, it is possible that the inhibition of PK 
activity observed with fructose is the result of a decreased carry­
over of Fru^^BP rather than the accumulation of an inhibitor since the 
changes in the known inhibitors are not sufficient to explain this in­
hibition (see section III.C).
2. Effect of magnesium ions on partially purified pyruvate kinase
It has been reported that free Mg^^ levels are increased by
a fructose dependent depletion of ATP-IIg in the liver (Levin et al.,
1963; Van de Werve & Hers, 1979; Sainsbury, 1980). Thus the effect 
2+
of Mg on a partially purified PK preparation was studied and pre-
2+
sented in figure 47. The Mg concentrations shown are those of added 
MgCl 2 . It is evident from these results that PK has an absolute 
requirement for this divalent ion. The maximum activity was ob­
tained with 10 mM Mg^* whereas higher concentrations were inhibitory 
as shown by changes in both v and V^^^. Normally 10 mM Mg^* ions 
were used in the assay medium (see methods, TV.B.5). The ratio of
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2+ 2+
is unaffected by Mg and the possible change in Mg level
caused by fructose in the isolated hepatocytes is very small compared
to the total Mg^ in the assay. Thus it is very unlikely that the
2+
inhibition of PK caused by fructose is due to changes in free Mg
The presence of Fru ,BP and Fru-l-P did not normally change the 
2+
effect of Mg on the PK activity (results not shown).
3. Effect of PEP and ADP concentrations on partially purified 
pyruvate kinase
The effect of varying PEP concentrations on the (NH^)2S0^ puri­
fied enzyme is shown in figure 48 • • The sigmoidal relationship 
observed by other workers is evident. The ^ values for PEP as
determined by a Hill plot, for the enzyme from fed animals is 0.58 mM 
(figure 48B). This is within the range of value> reported in the 
literature for phosphorylated and unphosphorylated PK (Ekraan et al., 
1976; Claus ££ » 1979). The  ^ for ADP was 0.2 mM (cf Ekman
et al., 1976) and was obtained at 1 mM ADP (figure 49). Thus
throughout the present study PK has been assayed at saturating ADP 
concentrations.
Fru^^BP decreases the  ^ value of the enzyme for PEP to 45 pM 
(figure 48). This compares well with the values obtained by Ekman et al.,
(1976) (Sq ^ % 40 pM) and Claus et al^., (1979) (S^  ^ % 50 pM). Simi­
larly, Fru-l-P is a stimulator of PK (cf Eggleston & Woods, 1970); in 
this case the  ^ of the enzyme is reduced to 240 pM in the presence 
of 1 mM Fru-l-P (figure 48). The possibility that the effect of Fru- 
1-P could be due to contamination by Fru^^BP was tested by purifying 
the hexose phosphate by paper chromatography and no significant change 
in the stimulating power of Fru-l-P was observed after this treatment.
4. Inhibitors of pyruvate kinase
Alanine is a known inhibitor of PK (Seubert & Schoner, 1971) and 
this was confirmed in the present study by examining the activity of 
the partially purified enzyme in the presence and absence of Fru^^BP
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(figure 50A) and Fru-l-P (figure 50B). Physiological concentrations 
of alanine (0,5 - 1,5 mM) caused a substantial inhibition of the 
enzyme in the presence and absence of Fru^^BP. Alanine (1 mM) in­
creased the half maximal stimulation of the enzyme from 0,4 yM to 2,0 
y’l Fru^^BP (figure 51).However,the concentration of Fru^^BP used is 
much less than that observed iri vivo suggesting that PK may be 
maximally activated in vivo. However, it is possible that the enzyme 
in situ is more sensitive to the allosteric inhibitors than the 
purified enzyme (Llorente e^ , 1970; Seubert & Schoner, 1971),
The evidence in the present study (see section III,B) indicates that 
while Fru^^BP may regulate flux through PK, the depletion of ATP may 
play a more important role in the increased glycolytic flux observed 
with fructose. In this case the increase in alanine levels in the 
isolated hepatocytes do not substantially affect the enzyme activity, 
since this would be expected to inhibit glycolytic flux.
The inhibitory effect of alanine is a result of a change in the
S. c for PEP with no corresponding change in V . The effect of 0,5 r o o max
alanine on the partially purified PK is shown in figure 52, The in­
hibitor exerts its effects both on the enzyme incubated in the absence 
of Fru^^BP and in the presence of Fru^^BP, The ^ values for PEP vary 
from 45 yM with Fru^^BP only,to 1,0 mM with alanine. Since the con­
centration of PEP in isolated hepatocytes found in the present study
-1
(0,15 ymoles g cells ) clearly lies within this range then it is 
evident that these changes in enzyme activity could obviously regulate 
flux through PK, but the high level of Fru^^BP in the cell may prevent 
such a regulation. Thus it may be that the intracellular ATP concen­
tration plays an important role in determining PK activity.
The stimulation of PK by Fru-l-P is also reversed by alanine (figure 
53 & 54), The half maximal stimulation of the control enzyme was ob­
tained at 0,34 mM Fru-l-P, whereas for the alanine treated enzyme 
the value was 3,3 mM, Once again the 5^ ^ values for PEP vary from 
0,24 mM with Fru-l-P only,to 1,0 mM with alanine (figure 54B),
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partially purified pyruvate kinase preparation assayed in 
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alanine ( O  ) •
•6
u
•2
20 3 51 4
F R U C T O S E - 1 -  PHOSPHATE ( m M  )
Figure 53. Effect of Fru-l-P concentrations on the activity of a
partially purified pyruvate kinase preparation assayed in 
the presence ( ^ ) or absence ( ) of 1 mM alanine.
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pyruvate kinase preparation assayed in the presence of 
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data obtained with low PEP concentrations.
B, Hill plots of data in figure 54.A.
- 188 -
ATP is also known to be a potent inhibitor of PK (Seubert & 
Schoner, 1971), The effect of increasing ATP concentrations on the 
partially purified enzyme is shown in figure 55. In the absence 
of effectors, 5 mM ATP-Mg almost completely abolished the enzyme 
activity. The addition of Fru-l-P (1 mM) relieved the inhibition 
to a small extent, but a concentration of Fru^^BP lower than physio­
logical concentrations(see section III.B) was much more effective 
in relieving the inhibition caused by ATP-Mg. However, the inhibitory 
effect of ATP was noticeable even when a high concentration of Fru^^BP 
was present (see also figure 56A). Thus, it is clear that the increase 
in Fru^^BP and the decrease in ATP which occur together when the 
hepatocyte is treated with fructose (see figure 19 & 25) would result 
in the increased glycolytic flux observed (see figure 30). However, 
it is clear that the fall in ATP concentration appears to be more 
important in determining glycolytic flux since dihydroxyacetone raises 
Fru^^BP but does not affect ATP levels to any great extent (see section
III.B). These observations seem to suggest that Fru-l-P accumulation in 
the hepatocyte does not play an important role in the high rate of fru- 
ctolysis. This is in agreement with the results in figure 57A, which 
shows that in the presence of 1 mM ATP-Mg, Fru-l-P exerts only a small 
stimulatory effect on the enzyme.
Earlier in the present study, it was found that allantoin was 
an inhibitor of PK activity measured at 0.2 mM PEP (Table 11). The 
effect of allantoin on the enzyme appears to be very similar to the 
effect of alanine and also appears to be equally potent (cf figure 
52 & 58). Allantoin (1 mM) inhibited the control enzyme, the  ^
value for PEP in the absence of inhibitor was 580 yM and in the pre­
sence of allantoin the value was 930 yM. Inclusion of Fru^^BP (50 yM) 
in the assay medium resulted in these values changing to 45 yM and 
370 yM respectively. It was also found that allantoin (1 mM) causes 
inhibition of the enzyme at all concentrations of Fru^^BP (figure 56A) 
and Fru-l-P (figure 57A) examined. Urate (0.5 mM) also exerted a 
similar effect on PK (results not shown), but since this metabolite
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pyruvate kinase preparation assayed with no added effector 
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does not accumulate in isolated hepatocytes treated with fructose, 
it is clearly not involved in the inhibition of the enzyme observed 
in the present study. However, it is possible that allantoin accu­
mulation observed in the presence of 10 mM fructose (figure 36) is 
sufficient to cause an inhibition of PK not by direct inhibition in 
the assay, since the dilution would be too great for the accumulated 
allantoin to exert an effect, but possibly by altering the confor­
mation of the PK thus making it easier to remove the tightly bound 
Fru^^BP which is carried over in the control extracts.
This was tested by incubating hepatocytes with 10 mM fructose
for 20 min, removing the extracellular medium and then adding fresh 
2+
KRB (plus Ca and BSA), containing either allantoin or alanine or 
both effectors before freezing the samples as in the previous ex­
periments. Table 19 shows that the inhibition of the fructose-treated 
PK occurs with the unwashed hepatocyte preparation and stimulation 
with the washed cell preparation. The stimulation was reversed by 
adding allantoin (1.0 mM) or alanine (1.0 mM) to the washed cells.
A lower concentration of alanine (0.1 nM) partially reverses the 
stimulation. Concentrations of the metabolite comparable to those 
which occur in hepatocytes treated with fructose i.e. 1.0 mM allan­
toin and 0.1 mM alanine produced an inhibition comparable to that
which occurs in unwashed cells. It is clear, therefore, that the
'inhibition' of PK which occurs is the result of the loss of bound
Fru^^BP from the PK during the freezing-thawing treatment, enzyme di­
lution and assay procedure. This is also apparent in the kinetic study 
of the enzyme from the fructose treated hepatocytes and control hepa­
tocytes (figure 45 & 46). It is clear that the intracellular ATP 
does not interfere with the binding of Fru^^BP to PK since the 
enzyme becomes activated after the washing step.
The physiological significance of the inhibitory effect of 
allantoin is somewhat doubtful since the normal plasma level of allan­
toin in rats is about 0.12 mM and that of urate is about 0.06 mM 
(MüenpMÏ et al.,1968). However, on fructose infusion in vivo these 
values rise to 0.5 mM and 0.22 mM respectively (MMenpMM et al.,1968).
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Table 19. Pyruvate kinase activity in isolated hepatocytes treated 
with allantoin and/or alanine.
Pyruvate Kinase Activity (v/^^^)
No Substrate
Fructose 
(10 mM)
Unwashed Hepatocytes 0.44 0.36
Washed Hepatocytes 0.47 0.60
Washed Hepatocytes 
+ 1.0 mM Allantoin 0.39
0.38
Washed Hepatocytes 
+ 1.0 niiM Alanine
0.38 0.38
Washed Hepatocytes 
+ 0.1 mM Alanine
0.46 0.45
Washed Hepatocytes 
+ 1.0 mM Allantoin 
+ 1.0 mM Alanine
0.36 0.33
Washed Hepatocytes 
+ 1.0 mM Allantoin 
+ 0.1 mM Alanine
0.39 0.41
Isolated hepatocytes were incubated for 20 min in the presence and
absence of 10 mM fructose. After the incubation period, an aliquot was
frozen in liquid ^ 2  to stop the reaction, at the same time samples
were removed and washed as described in methods (section IV.B.3).
2+
After the washing step, the cells were resuspended in KRB (+Ca and 
1.5g% BSA) containing allantoin and/or alanine and then frozen in 
liquid N2 for enzyme assay (section IV.B.3).
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This suggests that under these conditions the effect of allantoin 
and urate on PK at least partially compensates for the fall in 
ATP levels which occurs following a fructose load.
The interaction of physiological concentrations of alanine,
ATP-Mg and allantoin on partially purified PK activity was studied 
(figure 56b & 57B). The greatest inhibition was observed with 3 mM 
ATP-Mg at all Fru^^BP concentrations examined (cf Figure 56, 57A & B). 
The inhibition observed with 1 mM ATP was considerably less than that 
observed with the higher concentration of ATP, but the addition of 
alanine (1 mM) to ATP-Mg (1 mM) appeared to have little further inhi­
bitory effect over that observed with ATP-Mg (1 mM) on its own, whereas 
a combination of ATP, allantoin and alanine (concentration of all 
effectors 1 mM), produced an inhibition similar to that found with 
3 mM ATP. Thus, under these conditions,found in the hepatocyte after 
a fructose load, i.e. low ATP, high alanine and allantoin, it is 
possible that the PK is in an inhibited form. However, since the 
latter inhibitors leave the cell freely while the ATP remains in the 
cytoplasm, it is evident that the inhibitory effect of the ATP re­
mains the most important factor which determines PK activity.
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E. GENERAL DISCUSSION AND CONCLUSIONS
It is clear from the data presented in section A - D that 
hepatic PK is subject to a number of diverse control mechanisms, 
involving changes in the concentrations of the allosteric effectors 
in addition to the control by phosphorylation - dephosphorylation 
observed by others (Engstrbm, 1978). Fructose administration is 
well known to cause lactic acidosis in humans (BergstrHm et al.,
1968), and it has also been shown that high rates of lactate output 
occur when perfused liver (Exton & Park, 1967) and isolated liver 
cells (Seglen, 1974) are subjected to high fructose concentrations. 
However, it is unlikely that liver cells are exposed to such high 
concentrations of the ketose jji vivo since in animals ingesting 
fructose the concentration of the ketose in the hepatic portal vein 
has been shown not to exceed 2.5 mM (Topping & Mayes, 1971). In the 
present studies when the effects of fructose on hepatocyte metabolism 
were examined both at,high fructose concentrations and physiolo­
gical concentrations of the ketose considerable discrepancies were 
observed. Such differential effects of fructose have also been obser­
ved on other biochemical parameters. For example, fructose concen­
trations (up to 5 mM) stimulate glycogen deposition by isolated 
hepatocytes whereas higher concentrations cause increased glycogen 
mobilization (Wood a_l,, 1981). Lipogenesis from ^H^O is stimulated 
by low concentrations of fructose but inhibited at high concentrations 
(Clark D.G. et. fLl' * 1974). Hepatic pyruvate dehydrogenase activity 
is not significantly affected by low fructose concentrations whereas 
higher concentration of the ketose increases the enzyme activity 
(Topping & Mayes, 1977). Gluconeogenesis from fructose is stimulated 
by glucagon at low substrate concentrations but the hormone has no 
effect when the ketose concentration is increased (see section I.D.3).
The effect of fructose on PK activity measured iji vitro in the 
present study appeared to fit in with the pattern of the differential 
effects of fructose. However, a closer examination revealed that the 
effect observed did not reflect the in vivo changes in enzyme activity.
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but rather was an artefact of the hepatocyte extraction and PK assay 
procedure. This procedure has been employed successfully to show 
the effects of insulin and glucagon (Feliu £l.* , 1976) and dihy­
droxyacetone on PK activity in isolated hepatocytes (Claus aT., 
1979).
From the present study, it is clear that a number of factors
could alter the v/V value observed with this assay technique. The
max ^
results indicate that the value observed is not a reflection of the
phosphorylation state of the enzyme but that it is affected by the
carry-over of Fru^^BP and/or Fru-l-P associated with PK during the
extraction and assay procedure.This carry-over of Fru^^BP and/or
Fru-l-P is dependent on a number of factors. Firstly, the level of
the hexose phosphate in the hepatocytes after incubation is clearly
important since dihydroxyacetone, fructose and D-glyceraldehyde all
increase the level of one or both these intermediates and PK activity
Secondly,the accumulation of the inhibitors, alanine and allantoin,
causes the dissociation of the stimulator - enzyme complex resulting
in a lowering of the v/v . Thus the dissociation probably occurs
max
during the freeze-thaw procedure for the extraction of the PK, since 
addition of alanine or allantoin to the washed hepatocytes incubated 
with fructose also results in a lowering of the enzyme activity. A 
kinetic analysis shows that the concentrations of alanine and allan­
toin in the assay medium are unlikely to substantially inhibit PK 
directly. Further evidence for the dissociation of the Fru^^BP - PK 
complex, comes from comparing the kinetics of the (NH^)2 S0 ^ treated 
enzyme with the enzyme from the washed and unwashed fructose treated
hepatocytes. The effect of fructose in the unwashed cells is to
decrease the  ^ for PEP to a similar value as that observed in the
(NH^)2 S0 ^ treated enzyme.
Therefore, the use of a spectrophotome trie assay for examining 
the effects of substrates on PK activity is associated with a number 
of problems such as the dilution of the enzyme preparations. Thus, 
the activity of the enzyme found by this method does not necessarily
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reflect the activity of the enzyme in the cytosol of the hepatocyte. 
Perhaps a better indicator of the latter parameter is the measure­
ment of lactate and pyruvate output which is a measure of the net 
glycolytic flux. This assay, however, ignores the potential contri­
bution by pyruvate to amino acid synthesis, gluconeogenesis and mito­
chondrial pyruvate metabolism. Thus some care must be taken in the 
interpretation of the results.
The effect of fructose at all concentrations is to increase
the lactate and pyruvate output by isolated hepatocytes suggesting
that the apparent inhibition of PK by high fructose does not occur
in the cell. The large accumulation of Fru-l-P even at low fructose
K-eVcV«'jtoV.vtva.se
concentrations indicates that is operating at its maximum
velocity under these conditions.If it is assumed that the aldolytic clea­
vage of Fru-l-P to DHAP and D^glyceraldehyde is not affected by changes 
in fructose concentration, then the output of lactate and pyruvate 
must reflect the state of activity of the only regulatory enzyme 
(i.e. PK) in the glycolysis of fructose. Thus the increased glycolytic 
flux in response to increasing concentrations of fructose must be 
related to the intracellular accumulation of Fru-l-P and Fru^^BP, both 
allosteric activators of PK. That PK is rate limiting under these con­
ditions is indicated by the accumulation of PEP at low fructose con­
centrations. At high concentrations of the ketose, a further factor 
must be taken into account, that is the depletion of ATP which results 
in a further increase in the glycolytic flux with a concomitant de­
crease in PEP levels.
The relative importance of the ATP-depleting effect and the 
increase in Fru^^BP is apparent when the glycolytic flux with dihy­
droxyacetone is examined. Here again an increase of lactate output, 
reflected an increased concentration of Fru^^BP in the cell, but 
in this case PK appeared to be rate limiting since PEP accumulated 
at all concentrations of dihydroxyacetone examined. This substrate 
does not substantially deplete ATP which could account for the lower 
rate^lycolysis from the triose. The physiological significance of
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this observation is that,normally changes in PK would probably be 
mediated via changes in Fru^^BP, but under conditions where ATP is 
depleted, then glycolytic flux is enhanced.
Thus it may be postulated that glycerol could have a similar 
effect to fructose since ATP is depleted by this substrate. However, 
an examination of the glycolytic flux in this case indicates that 
there was an inhibition of endogenous glycolysis from glycogen in 
hepatocytes from fed rats. The explanation for this phenomenon is 
probably related to the redox changes induced by the metabolism of 
glycerol. Therefore, in the presence of glycerol, the deficiency 
of NAD probably limits glycolysis. This was borne out by the inhi­
bition of lactate and pyruvate output by xylitol which has a similar 
effect on the (NADH)/(NAD^) ratio in the cell.
The effects of sorbitol, another reduced substrate, were more 
complex. Initially, the sugar alcohol caused little or no effect on 
the glycolytic flux, whereas at a later time there was a stimulation 
of f,lux. Sorbitol has a number of different effects which could possi­
bly account for this apparent contradiction.The metabolism of sorbitol 
is via fructose (see figure 3), therefore it shares with fructose a 
number of effects (for example, increases in Fru^^BP and Fru-l-P levels 
and , probably depletion of ATP). Thus the stimulatory effect of 
sorbitol on glycolytic flux is probably due to these factors which 
overcome the effect of the NAD^ depletion caused by this substrate.
The time lag in the stimulatory effect of sorbitol probably reflects 
the slower rate of Fru-l-P accumulation. The lack of inhibition of 
glycolysis by sorbitol may be the result of reoxidation of NADH by 
pyruvate accumulating as the result of the stimulation of PK. Thus the 
increased metabolism of the triose phosphates in this case is the re­
sult of a ’pull’ mechanism which does not involve any net change in
NAD^ levels. Thus the increased Fru_,BP and Fru-l-P levels caused by
lo
sorbitol, but not by glycerol, stimulate glycolysis irrespective of 
the depletion of ATP by the latter substrate.
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It is well documented that the effect of fasting is to increase 
phosphorylation of L-type PK by a cAMP-dependent protein kinase 
which results in the inactivation of the enzyme (see section 11.C.6). 
This was confirmed in the present study and the effect of this in­
activation on the glycolytic rate of the hepatocytes in the presence 
of fructose and dihydroxyacetone examined. A high glycolytic rate 
was observed in hepatocytes incubated with fructose and this was 
comparable to that by cells from fed animals. Dihydroxyacetone sti­
mulated lactate and pyruvate output but to a much lesser extent than 
fructose despite the fact that Fru^^BP concentrations are raised to 
a much greater extent by the triose.
A comparison of the PK activity assayed iji vitro shows that 
dihydroxyacetone stimulates PK at least as efficiently as fructose. 
However, it is clear from the low glycolytic rate observed, in the 
presence of the triose that PK must be inhibited in the cytoplasm 
of the isolated hepatocyte. The explanation for this discrepancy must 
be related to the phosphorylated state of the enzyme and the ATP con­
centration in the cytoplasm. The enzyme is mainly phosphorylated
in the fasted state and thus the effect of Fru,,BP is not so marked
I d
and that of ATP is enhanced, hence the low rate of glycolysis from 
dihydroxyacetone. Fructose however, lowers ATP levels and allows gly­
colysis to proceed. Thus a similar, but more marked, effect of fruc­
tose compared to dihydroxyacetone is observed with hepatocytes from 
fasted rats compared to cells from fed animals. Again the discrepancy 
between the activation of PK observed iji vitro and the low rate of 
glycolysis from dihydroxyacetone emphasises the problems of extrapo­
lating the results of enzyme assays on crude extracts to explain the 
changes which occur i_n vivo.
Another approach to the problem of determining, enzyme activity 
in vivo is to examine the levels of substrates and effectors under 
various conditions and to attempt to examine the regulation of the 
purified enzyme under conditions which are as close to physiological
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situation as possible. Thus at the levels of ATP, alanine and PEP 
found under physiological conditions; Fru^^BP is a far better 
stimulator of PK activity than Fru-l-P if one compares the effects 
of the levels of the hexose phosphates which accumulate in the hepa­
tocytes. At lower ATP levels, Fru-l-P and Fru^^BP stimulate the 
enzyme to a greater extent, suggesting a possible synergistic effect 
of ATP depletion and Fru^^BP and/or Fru-l-P accumulation resulting 
in an increased glycolytic rate.
One other consequence of increased glycolysis and decreased 
ATP levels is the accumulation of alanine as a result of increased 
synthesis of the amino acid by the transamination of glutamate and 
pyruvate. This transamination is stimulated by nH^ formed during 
the catabolism of AIIP. The increased level of alanine which occurs 
in the hepatocytes might be expected to impose an inhibitory effect 
on glycolysis via its effect on PK. This would be expected to counter­
act the decreased inhibitory effect due to the depletion of ATP. How­
ever, there is little evidence in the present study that the increased 
alanine content of the hepatocytes substantially counteracts the acti­
vating effect of ATP depletion on PK.
The evidence described above suggests that the rate of glycolysis 
from the triose phosphates is normally limited by L-type PK activity 
in the liver cell from both fed and fasted animals. This is despite 
a concentration of Fru^^BP which would normally be expected to fully 
stimulate the enzyme. The current belief is that much of the Fru^^BP 
in the cell is protein-bound and thus not available to stimulate PK. 
However, the possibility remains that there is as yet another undis­
covered regulator of PK which further inhibits the enzyme. The inhibi­
tion by allantoin and urate may provide part of the explanation, but 
the concentration of these catabolic products iji vivo would not impose 
a physiologically important inhibition on PK under normal conditions. 
Another possibility is that the levels of Fru^^BP are over-estimated 
by the enzymatic assay mechanisms normally used.
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From a physiological viewpoint it is important that the regu­
lation of PK by fructose is not considered in isolation. For example, 
fructose is generally regarded as a lipogenic precursor presumably 
because of the ease of its conversion to lactate (also regarded as 
a good precursor for fatty acids) (Hopkirk & Bloxham, 1979). Thus 
the regulation of PK may be important in determining the flux of 
carbon from carbohydrate to fatty acids. This allied to the observa­
tion that pyruvate dehydrogenase is activated at high fructose con­
centrations (Topping & Mayes, 1977) should result in an increased 
provision of acetyl CoA for lipogenesis . However, lipogenesis is 
inhibited at high fructose concentration (Clark, D.G. e_t a_l., 197(%f 
suggesting that there is an inhibition of the lipogenesis at a point 
subsequent to the provision of intramitochondrial acetyl CoA. However, 
fructose does stimulate lipogenesis from acetate and
lactate at physiological concentrations of the substrate (Davies & 
Daneshmand, unpublished results).
Another aspect of the present study which may be important is 
that the depletion of ATP caused by fructose may cause activation of 
PK. In this context it has been reported that the hypoglycemia caused 
by administrating fructose in patients with hereditary fructose into­
lerance is caused by inhibition of gluconeogenesis in addition to in­
hibition of phosphorylase 'a' by Fru-l-P (Van den Berghe, 1978). This 
decreased gluconeogenesis may be the result of a stimulation of gly­
colysis via PK and, possibly, by the relieving of ATP inhibition of 
PFK 1; which is also inhibited at physiological concentrations of ATP 
(Van Shaftingen eJl fA' * 1981b).
In conclusion it is evident from the work presented in this 
thesis and from a considerable amount of the published data that, 
the effects of fructose on hepatic metabolism are many and varied.
It is clear that the effects of the ketose are concentration dependent 
and thus a clear distinction must be made between the effects of phy­
siological levels of fructose, such as those found in animals given 
fructose in the diet (Topping & Mayes, 1971), and the toxic effects
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of the high levels of fructose which are sometimes administered 
intraveneously in certain clinical conditions (Van den Berghe, 1978).
It is apparent that low concentrations of the sugar stimulate 
glycolysis and flux through PK. This is probably related to the ele­
vation of Fru-l-P and Fru^^BP. The depletion of ATP by higher con­
centrations of fructose causes a further increase of the glycolytic 
rate. The ATP depletion is followed by a number of changes in the 
levels of metabolites, e.g. alanine and allantoin, which would also 
influence PK activity.
This study also shows that the vitro assay of an enzyme in 
a crude extract does not necessarily represent the activity of the 
enzyme in vivo and that artefacts can arise as the result of effects 
which are apparently unrelated. However, it should be emphasised that, 
only changes which involve a covalent modification are seen when pu­
rification of the enzyme is performed and thus there is a valid reason 
for using crude extracts to examine the effects of various substrates 
and hormones on enzyme activity. Therefore, a careful and critical 
analysis of the data from such studies is important.
M A T E R I A L S  A N D  M E T H O D S
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IV. MATERIALS AND METHODS
A. MATERIALS
1. Animals and diets
All rats used for this project were mature male rats (200 - 
300 g) of the Wistar strain bred in this laboratory. Unless other­
wise stated all animals were fed a^ libitum on a normal laboratory 
chow diet (PRD). The animals were maintained on a 12 h light and 
12 h dark cycle and all experiments were commenced 2 h after the 
start of the light cycle. Fasted animals were deprived of food 
24 h before the start of the experiment.
2. Reagents
All enzymes and substrates were obtained from Sigma Chemical 
Company or Boehringer Mannheim. All phosphorylated substrates used 
were in the form of their sodium salts. Inorganic chemicals and 
solvents were of the Analar grade from BDH. All solutions and buffers 
were prepared using glass distilled, deionized water.
B. METHODS
1. Isolation of hepatocytes
Isolated hepatocytes were prepared from adult male rats by the 
method described by Berry & Friend (1969); with some modifications 
(Krebs e_t a^. , 1974; Wagle & Ingebertson, 1975). Mature rats were 
anaesthetized with nembutal (60 mg of pentabarbitone/ml; Abbot, UK, 
0.1 ml/100 g rat) and placed on a dissecting tray. The peritoneal 
cavity was opened by making incisions starting at the midline of the 
lower abdomen and proceeding upwards until the diaphram was reached 
but not penetrated. The muscle and skin was then lifted to expose the 
peritoneal cavity where the portal vein and the inferior vena cava
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can be located. Two ligatures were loosely placed around the portal 
vein and a third ligature was placed loosely around the inferior 
vena cava just anterior to the branch point of the right renal vena 
cava.
A sterile luer cannula (Braunula sterile luer; Armour Pharma­
ceutical Co.Ltd.) was used to cannulate the portal vein. The two liga­
tures around the portal vein were then tied to secure the cannula. 
Krebs-Henseleit bicarbonate medium (ICRB) (Krebs & Henseleit, 1932) 
minus Ca^* (preincubated at 37°C, gassed with 95% 0^ and 5% CO^ 
and already circulating in the perfusion cabinet) was connected to the 
cannula to allow a continuous flow into the liver. Immediately follo­
wing this the inferior vena cava was severed to prevent the liver 
from swelling. When the blood had been cleared from the liver, the 
rib cage was cut exposing the thoracic cavity. A fourth ligature was 
placed loosely around the inferior vena cava, and then a cannula 
was placed via the right atrium of the heart into the inferior vena 
cava. The ligature around the cannula was then tied. To ensure that 
the KRB (-Ca^*) was flowing from the portal vein through the liver 
to the inferior vena cava, the ligature adjacent to the kidney was 
tied. The liver was perfused with KRB (-Ca^ ) at a rate of approxima- 
terly 25 ml/min until the perfusate was free of blood cells.
The liver was then perfused with 30 mg crude collagenase in 
100 ml KRB (+Ca^*). The buffer was maintained at 37°C and was gassed 
continuously with 0^ + CO^ (95:5 v/v). The perfusion was continued 
for about 15-20 min and any leaky perfusion fluid appearing in the 
abdominal cavity was collected and returned to the reservoir. The 
rate of digestion of the tissue was reflected by the degree of leak­
age of the medium and when this was rapid, the liver was removed and
2+
placed in a beaker containing KRB (-Ca ).
The liver was then finely cut with a scissors and gently gassed 
with O 2 + CO^ (95:5 v/v). A plastic funnel with a nylon mesh (Nybolt 
No. 10; 132 micron, J.Staniar & Co., Manchester) placed over the top
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of centrifuge tubes (MSE 50 ml) was used to filter the cells. The
samples were centrifuged at 50 g for 60 s in a bench centrifuge
2+
and the cells resuspended in KRB (+Ca ), containing 1.5 g% of 
essentially fatty acid free-bovine serum albumin (BSA) (fraction V, 
Sigma Chemical Co.).
The cell suspension was examined microscopically for trypan 
blue exclusion; 85-95% of hepatocytes isolated in this way excluded 
trypan blue indicating that under these conditions a high proportion 
of the cells were viable.
2. Incubation procedure
All flasks used for incubating hepatocytes were siliconized 
to give them water repelling properties. This was done by rinsing 
the flasks thoroughly with dimethyldichlorosilane solution (about 
2% v/v in 1, 1, 1-trichloroethane) and leaving them to dry in an 
oven overnight. Cells suspended in KRB(+Ca^ ) with 1.5g% BSA (8-10 ml) 
were placed in the siliconized conical (25 ml) flasks and preincubated 
in a shaking water bath (100 stroLes/min) at 37°C with continuous gassing 
with O 2 + CO2 (95:5 v/v). After a period of 10 min the cells were used 
for various metabolic studies.
Aliquots of the cell suspension were then transferred to a
25 ml conical flask containing an equal volume of substrate dissolved 
2+
in KRB (+Ca ) containing 1.5g% BSA. The final cell concentration was 
between 6 and 8 x 10^ cells/ml (48-64 mg wet wt/ml). The cells were 
incubated in a shaking water bath at 37°C (gassing with O 2  + CO 2  (95:5 
v/v). After the desired time interval, aliquots of the incubation 
mixture were removed and stored appropriately before being used for 
metabolite and enzyme assays. Duplicate incubations were carried out 
for every experiment. Unless otherwise stated all experiments were 
done on at least three different hepatocyte preparations.
3. Sampling procedure for pyruvate kinase assay
Following incubation, an aliquot of cell suspension was taken 
and the reaction stopped by freezing in liquid N 2 , and these samples
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were used as a source of 'unwashed' cells. The washing of the hepa­
tocytes was done by the following procedure! the cell extracts were
taken at the appropriate time and rapidly sedimenttt^tl through ice 
2+
cold KRB + Ca containing BSA (1.5g%). After spinning the suspen­
sion for 60 s (at 50g), the supernatant was discarded and the pellet
2+
resuspended in KRB + Ca containing 1.5g% BSA and then frozen in 
liquid and stored at -70°C before use for PK assay.
4. Partial purification of pyruvate kinase from isolated hepatocytes
One vol. of the cell suspension was frozen in liquid N 2  and 
thawed by adding 4 volumes of ice cold suspending medium (containing 
0.1 M KF, 15 mM ethylene glycol bis(S~aminoethyl ether) -N, N, N', 
N'-tetraacetic acid (EGTA) and 50 mM glycyfIglycine, pH 7.4) PK was 
precipitated by adding one vol. of extract to one volv of saturated 
ammonium sulphate (Carbonell al_., 1973; Feliu » 1977). The
mixture was kept for 30 min in the cold and the precipitate was collec­
ted by centrifugation at 17,000 g for 30 min. The pellet was dissolved 
in one vol. of suspending nediur.i and aliquots stored at -70°C. When re­
quired the samples were thawed by the addition of five vol. of suspen­
ding medium and ?K was assayed.
5. Measurement of pyruvate kinase activity
PK was measured using a coupled reaction system (Feliu et al., 
1976). The incubation mixture (total volume 1 ml) containeA50 mM gly- 
cyglycine, pH 7.4, 0.1 M KCl, 10 mM MgCl 2 , 1.3 mM ADP, 0.15 mM NADH 
and 2 units of LDH, 50 pi of homogenate was added to the mixture and 
preincubated at 25°C for 10 min. The reaction was started by the 
addition of PEP and the PK activity was measured by following the 
oxidation of NADH at 340 nm. In all cases the rate of reaction was 
followed for 5 min. The enzyme activity was calculated using 6.22 x 
10^ L.mole ^cm  ^ as the molar extinction coefficient of NADH at 340 nm,
6. Metabolite assays
For the measurement of metabolite levels in hepatocytes, ice 
cold perchloric acid (0.05 vol.of 4.2M HOlO^)was used to terminate
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the reaction at the appropriate time intervals. The resulting extract 
was blended on a Vortex mixer and the protein precipitate removed 
by centrifugation at 3,000g for 10 min. The supernatant fraction 
was neutralized with K^CO^ and any precipitate of KCIO^ formed 
was removed by centrifugation at 3,000g for 10 min. The metabolite 
levels in the neutralized supernatant were assayed as described below.
a) Adenosine triphosphate
ATP levels were measured using a U.V. method. The principle 
of the test was the conversion of glycerate-3-phosphate to glycerol- 
1-phosphate in a sequence of reactions catalysed by glyceraldehyde-3- 
phosphate dehydrogenase, phosphoglycerate kinase, triose phosphate 
isomerase and glycerol-3-phosphate dehydrogenase with the utilisation 
of ATP and NADH oxidation. The incubation mixture (total vol. 1.2 ml) 
contained 0.41 M triethanolamine, pH 7.6, 3.3 mM MgSO^, 5 mM glycerate- 
3-phosphate,0.21 mM NADH and the deproteinized supernatant. The de­
crease in absorbance at 340 nm was followed after the addition of an 
enzyme mixture (10 ul) containing glyceraldehyde -3- nhosphatej,^330 U/ 
ml; phosphoglycerate kinase 450 U/ml; triose phosphate isomerase SCO 
U/ml; glycerol-3-phosphate dehydrogenase 60 U/ml.
b) Alanine
The method of Williamson, (1974) was used to measure L-alanine 
levels. Hydrazine-tris buffer (prepared fresh daily) containing 12.9 
mM tris, 0.2 mM hydrazine, 0.45 m>t EDTA, pH 10.0, was placed in a 
cuvette containing 0.8 mM NAD and the deprotqpized samole (final vol 
1.55 ml). The reduction of NAD^ was recorded spectrophotometrically at 
340 nm after addition of 5 yl dialysed L-alanine dehydrogenase. This 
enzyme preparation was dialysed against 20 mM phosphate, pH 7.4 to 
remove NH^ ions. The enzyme was diluted with the same buffer to give 
an activity of 15 U/ml before use.
c) Allantoin
The allantoin in the perchloric acid extracts was first subjected 
to alkaline-acid hydrolysis. 1 ml of sample was mixed with water (2 ml)
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and 0.5 M NaOH (1 ml) and heated for 8 min at 100°C. After cooling,
0.65 M HCl (1 ml) was added and the mixture was heated for 4 min at 
100°C. The mixture was cooled once more and 0.4 M phosphate buffer, 
pH 7.0 (1 ml) and 1 ml phenylhydrazine (3.3 mg /ml) were added and 
the mixture allowed to stand at room temperature for at least 5 min. 
After' this hydrolysis procedure the standard method for assaying 
glyoxylate derivatives was used (Vogels & Van der Drift, 1970).
The tubes containing the hydrolysed samples were cooled to 0°C 
in an ice-water bath and concentrated PCI (5 ml) precooled to 0°C as 
well as 1 ml of ferricyanide solution (16.5 mg/ml) were added. The 
tubes were then kept at room temperature for 15 min and the absor­
bance was measured spectrophotometrically at 535 nm. A standard curve 
using commercial allantoin was prepared.
d) Dihydroxyacetone phosphate and fructose-1, 6-bisphosphate
These two metabolites can be measured in the same reaction mix­
ture using a method described by Michal & Beutler, (1974). The reac­
tion mixture (total vol. 1.5 ml) containing 200 mM triethanolamine, 
pH 7.6, 17 yM NADH and 0.75 ml of the deproteinized sample were placed 
in a cuvette. The decrease in absorbance at 340 nm was followed using 
a recording spectrophotometer after the addition of various enzymes 
(5 y 1 of each enzyme). Glycerol-3-phosphate dehydrogenase (1 mg protein/ 
ml) was added initially and the decrease in absorbance was quantita­
tively related to the amount of DHAP present in the extract. A further 
decrease in absorbance was observed when triose phosphate isomerase 
(50 yg protein/ml) was added and this was related to the glyceralde- 
hyde-3-phosphate levels in the extract. Muscle aldolase (1.5 mg protein/ 
ml) caused a further decrease in the absorbance which is equivalent 
to the amount of Fru^^BP in the sample. Contamination of the enzymes 
with LDH and with each other should be minimal to achieve accurate 
results with this method. Enzyme preparations from Boehringer Mannheim 
were found to be sufficiently pure.
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e) Fructose-l-phosphate
The method described by Eggleston (1974), was used to deter­
mine Fru-l-P levels in the neutralized supernatants. In this method 
liver aldolase is used to convert Fru-l-P to DHAP and D-glyceralde- 
hyde. The DHAP produced can be reduced to G3P by glycerol-3-phosphate 
dehydrogenase coupled with the oxidation of NADH to NAD*.
Liver aldolase was prepared from 3-5 rats killed by cervical 
fracture. After insertion of a hypodermic syringe needle into the 
hepatic portal vein, the inferior vena cava was severed and the 
liver was slowly perfused with 0.15 M KCl at 2°C to wash out the 
blood. The combined livers were homogenized with 4 volumes of KCl 
at 2°C, and centrifuged at 30,000g for 20 min. (NH^)2S0^ (27.7g/
100 ml of supernatant) was added to the supernatant with stirring 
and the final pH was adjusted to 7.8 with 2 M NaOH. This mixture was 
left in an ice-bath with stirring for 60-90 min then it was centrifuged 
at 30,000 g for 20 min. A further portion of (NH^)2S0^ (6.5g/100 ml 
of supernatant) was added with stirring. After 90 min. in an ice-bath 
the mixture was centrifuged at 30,000 g for 20 min and the resulting 
precipitate dissolved in a small volume of water (0.3 ml for every 
g of original liver). This solution was dialysed against 200 volumes 
of distilled water at 2°C, changing the water every h, for 4 hours to 
remove the (NH^)2S0^ as completely as possible. The cloudy protein 
solution was cleared by centrifugation at 30,000 g for 20 min and 
0.1 M EDTA, pH 7.4 added to give a final concentration of 2.5 mM 
EDTA. The mixture was allowed to stand at room temperature for 1 h 
to completely inactivate any polyol dehydrogenase present.
To assay Fru-l-P, the decrease in absorbance was measured at 
340 nm and this is proportional to the amount of Fru-l-P present. The 
deproteinized cell extracts contain Fru^^BP and triose phosphates 
which can be removed using muscle aldolase, triose phosphate iso­
merase and glycerol-3-phosphate dehydrogenase. The assay mixture
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(total volume 1,4 ml) contained 50 mM Tris, pH 7.4, 70 yM NADH,
50 yl of the enzyme mixture (i.e, LDH 15 units; aldolase 0.42 units; 
triose phosphate isomerase 4.2 unitsf glycerol-3-phosphate dehydro­
genase 0.3 units) and the sample (0.575 ml), The enzyme mixture
was first dialysed against 200 volumes of water at 2°C to comple- 
+
tely remove NH^ ions before use. Fru-l-P was measured from the 
change in absorbance observed after adding 0,1 ml of liver aldolase 
to the reaction mixture. There was a slow rate of NADH oxidation 
observed even in the reaction mixture with no sample. This was over­
come by subtracting the change in absorbance observed in blank cu­
vettes from the sample values.
f) Glycerol-3-phosphate
The formation of NADH as measured by the increase in optical 
density at 340nm was used as a measure of G3P present (Michal & Lang, 
1974). The reaction mixture (total volume 1.05 ml) contained hydrazine- 
glycine buffer pH 9.5 (i.e. 0.189 M hydrazine, 0.47 M glycine and 
2.7 mM EDTA); 2.31 mM NAD and the deproteinized sample (0.5 ml).
The reaction was started by adding 10 yl of glycerol-3-phosphate 
dehydrogenase (10 mg/ml) and the formation of NADH was followed using 
a recording spectrophotometer.
g) Glucose
Glucose levels were determined using a colorimetric method invol­
ving glucose oxidase and peroxidase (Bergmeyer & Bernt, 1974). A sample 
of deproteinized cell extract was placed in the reaction tube and the 
volume adjusted to 1 ml using distilled water. To each sample, 2 ml 
of glucose oxidase reagent (i.e. 75 mg glucose oxidase, 7.5 mg pe­
roxidase and 25 mg 0-dianisidine HCl in 250 ml Tris-glycerol buffer 
pH 7.0) was added. After shaking thoroughly, the tubes were incubated 
at 37°C for 1 hour in a water bath. At the end of this period, 9 M 
H^SO^ (2 ml) was added to stop the reaction.A standard curve was si­
multaneously prepared using 0-50 yg glucose. The optical density was 
read at 540 nm.
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h) Lactate
This metabolite was measured using a method described by 
Gutmann û Tahlefeld,(1974). The enzyme used is LDH which catalyses 
the conversion of lactate to pyruvate. The reaction product (i.e. 
pyruvate) is removed by trapping with hydrazine. The assay mixture 
(total volume 1.0 ml) contained hydrazine-glycine buffer pH 9.5 
(i.e.0.178 M hydrazine,0.45 M glycine, 2.55 mM EDTA); 2.47 mM 
NAD and the neutralized supernatant (0.5 ml). The reaction was 
started by adding 10 yl of . Lcxc-roJce dehydrogenase (10
mg protein/ml) and the oxidation of NAD* followed at 340 nm. Lactate 
levels in the cell extracts are proportional to the NADH produced.
At the end of the assay a standard amount of lactate was added to 
check the assay method.
i) Phosphoenolpyruvate and pyruvate
PEP and pyruvate levels were determined by the method described 
by Czok & Lamprecht,(1974). In this assay system, pyruvate and PEP 
can be assayed sequentially, in the same cuvette. The reaction mixture 
(total volume 1.10 ml ) contained 45 mM triethanolamine, pH 7.6;
0.7 mM MgSO^; 67 mM KCl; 0.2 mM ADP; 89 yM NADH and the sample (0.75 
ml). The decrease in absorbance was measured spectrophotometrically 
after the addition of the enzymes. Initially 10 yl of LDH (130 units) 
was added and the decrease in absorbance was quantitatively related 
to the pyruvate present in the extract. A further decrease in absor­
bance was observed when 10 yl of PK (60 units) was added and this was 
related to the PEP levels present.
j) Uric Acid
Uric acid was assayed using both the colorimetric and U.V. method 
(Scheibe e_t £ l ., 1974). The test principle for the U.V.method is the 
conversion of uric acid (which absorbs at 293 nm) to allantoin and
H 2 O 2  which do not absorb at this wavelength. Borate buffer (0.1 M;
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pH 9.5) was used to dilute the sample. Then 3.5 ml of the diluted 
sample was placed in a quartz cuvette containing 45 mU uricase (20yl) 
and the change in absorbance at 293 nm measured against a blank.
The change in optical density is due to the degradation of uric acid.
The colorimetric method was carried out using uricase and ca- 
talase. The reaction product of uricase (i.e. H2 O 2 ) oxidizes methanol 
to formaldehyde. The latter reacts with acetylacetone and ammonia to 
give a yellow product 3,5-diacetyl-l, 4-dihydrolutridine, which has 
an absorption maximum at 410 nm (Kageyama, 1971). 5 ml of uric acid 
reagent (0.57 M ammonium phosphate buffer, pH 7.0; 1.7M methanol;
20 mM acetylacetone; 670 U/ml catalase) was placed in a test tube 
containing 0.5 ml of sample. After mixing thoroughly, 2.5 ml of the 
mixture was put in a cuvette containing 5 U/ml uricase (20 yl). The 
sample and sample blanks were incubated for at least 60 min at 37°C 
and the absorbance of the sample was measured against a sample blank 
at 410 nm.
7. Expression of results
The enzyme activity is expressed as v/v , where v is the
max
enzyme activity at 0.2 mM substrate (PEP) concentration and V is •' max
the enzyme activity at 4.0 mM PEP. The use of this activity ratio
eliminates any slight variations of v and V which are due to non­
max
uniform cell distribution during sampling. In cases where the enzyme 
activity is not expressed as v/V^^^, the activity is given in ymoles min 
g cells ^. Metabolite levels are expressed as yraole (or n moles) 
per g cells. The weight of hepatocytes was calculated from the 
total number of cells counted (Krebs et al., 1974).
8. Statistical Analysis
Unless otherwise stated all data presented is the mean _+ standard 
error from at least three different cell preparations. The standard 
error of mean was calculated from the standard deviation.
-1
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SD
i.e. SEM = r 
/n
where n = number of observations
SD = standard deviation 
SEM = standard error of the mean
The standard deviation was calculated using the formula
SD
n~l
where _ ^L - sum of
X = observation or observed value
_   ^ Y.X
X = mean of the sample (i.e. — )
A t-test for small population was used to test the significance 
of the results. The formula used was
t =
Xi - Xj
OW
degrees of freedom n^+n^-2
where
t = test of significance 
X^;X2 - mean of sample
d w  -  Ô  /  — — -  
^ 1^ 2
=  * 1^ 1 * ^ 2^ 2 
"l*"2 ■ 2
n - number of observation 
s^- standard error of mean
(Ballentine, 1974),
B I B L I O G R A P H Y
- 217 -
RIRLIOGRAPHY
Adam, P.A.J. and Haynes, R.C.Jr. (1969), J.Biol.Chem. 244, 6444-6450.
Adelman, R.C., Ballard, F.J, and Weinhouse, S. (1967), J.Biol.
Chem., 242, 3360-3365.
Arinze, I.J. and Rowley, D.L. (1975), Biochem.J., 152, 393-399.
Arion, W.J., Wallin, B.K., Carlson, P.W. and Lange, A.J. (1972),
J.Biol.Chem. 247, 2558-2565.
Assimacopoulos-Jeannet,F.D., Exton, J.H and Jeanrenoud,B., (1973),
Am.J.Physiol. 225, 25-32.
Assimacopoulos-Jeannet,F.D., Blackmore,P.F. and Exton,J.H., (1977),
J.Biol.Chem., 252, 2662-2669.
Bachelard,H.S., (1970), in "Handbook of Neurochemistry" (Leytha A.ed,), 
vol.4, pp.1-12, Plenum, New York.
Baer,H.P., Drummond,G.I, and Duncan,E.L., (1966), Mol.Pharmacol.,
2, 67-76.
Bailey,E., Stripe,F. and Taylor,C.B., (1968a), Biochem.J., 108, 427-436.
Bailey,E., Taylor,C.B. and Bartley,W., (1968b), Nature (London)
217, 471-472.
Ballard,F.J., (1970), Biochem.J., 120, 809-814.
Ballentine,R.B., (1974), in "Experimental Techniques in Biochemistry" 
(Brewer J.M., Pescoe A.J. and Ashworth R.B., eds). pp 10-31, 
Prentice-Hall, New Jersey.
Bar-on,H. and Stein,Y. (1968), J.Nutr.. 94, 95-105.
Barngrover,D.A., Stevens,K.C. and Dills,W.L. Jr., (1981), Biochem.
Biophys.Res.Commun., 102, 75-80.
Barritt,G.J., Zander,G.L. and Utter,M.F., (1976), in "Gluconeogenesis:
Its Regulation in Mammalian Species", (Hanson R.W. and Mehlman 
M.A., eds.), pp 3-46, J.Wiley & Sons, New York.
Baur,H. and Heldt,H.W., (1976), in "Use of Isolated Liver cells and 
Kidney Tubules in Metabolic Studies", (Tager J.M., Soling H.D. 
and Williamson J.R., eds.), pp 357-362, North-Holland Publishing 
Company, Amsterdam.
Beaufay,H. and de Duve,C., (1954), Bull.Soc.Chim.Biol., 36, 1525-1537.
Bender,A.E. and Damji,K.B., (1971), in "Sugar:Chemical Biological and
Nutritional Aspects of Sucrose", (Yudkin J., Edelman J. and Hough L., 
eds.,) pp 172-182, Butterworths, London.
- 218 -
Berglund,L., Ljungstrüin,0. and Engstr8m,L., (1977), J .Biol.Chem.,
252, 613-619.
Bergmeyer,H.U. and Bernt,E., (1974) in "Methods in Enzymatic Analysis", 
(Bergmeyer,H., ed.), Vol.3, pp 1205-1212, Academic Press, New 
York.
Bergstr8m,G., Ekman,P., Humble,E. and Engstr8m,L., (1978), Biochim.
Biophys. Acta., 532, 259-267.
Bergstrbm,J., Hultman,E. and Roch-Norlund,A.E., (1968), Acta Med.
Scand., 184, 359-364.
Berry,M.N., (1980), FEBS Lett., 117, K106-K120.
Berry,M.N. and Friend,D.S., (1969), J.of Cell Biol., 43, 506-520.
Berry,M.N. and Werner,H.V., (1973), Biochem.Soc.Trans., 1^, 190-193.
Berry. M.N.. Kun. E. and Werner. H.V.. (1973). Eur.J.Biochem..
33, 407-417.
Betheil,J.J., Feigelson,M. and Feigelson, P., (1965), Biochim. Biophys.
Acta, 104, 92-97.
Bischofberger,A., Hess, B., Rdschlau, P., Wieker, H.J. and Zimmarmann-
Teschow, H., (1970), Hoppe-Seyler's Z.Physiol.Chem., 351, 401-408. 
Blackmore,P.P., Brumley,F.T., Marks, J.L. and Exton, J.H., (1978), J.
Biol.Chem., 253, 4851-4858.
Blackmore,P.F ., Dehaye,J-P., Strickland, W.G . and Exton, J.H., (1979),
FEBS Lett., 100, 117-120.
Blackshear,P.J., Holloway, P.A.H. and Alberti,K.G.M.M., (1975),
Biochem.J,, 150, 379-389.
Blair,J.B., Cook,D.E. and Lardy,H.A. (1973), J.Biol.Chem., 248, 3601-3607 
Blair,J.B., Cimbala,M.A., Foster,J.L. and Morgan,R.A. (1976), J.Biol.
Chem., 251, 3756-3762.
Blair,J.B., James,M.E. and Foster, J.L., (1979a), J.Biol.Chem., 254, 
7579-7584.
Blair,J.B., James,M.E. and Foster,J.L., (1979b), J.Biol.Chem., 254, 
7585-7590.
Bloxham,D.P. and Lardy,H.A. (1973), in "The Enzymes", (Boyer P.B.ed.),
3rd Edition, vol. 8, pp 239-278, Academic Press, New York. 
Bode,J.C., Zelder,0., Rumpelt,H.J. and Wittkamp,U., (1973), Eur.J.
Clin.Invest., 2* 436-441.
Bode,J.C., Bode,C., Rumpelt,H.J. and Zelder,0., (1974), in "Regulation 
of Hepatic Metabolism" (Lundquist F . and Tygstrup N.,eds)., 
pp 267-281, Munksgaard, Copenhagen.
- 219 -
Bold,A.M. and Wilding,?., (1975), in "Conversion scales for SI
Units with normal values in Clinical Chemistry", Blackwell 
Scientific Publication, Oxford.
Bollman,J.L. and Mann,F.C. (1931), Am.J.Physiol., 96, 683-695.
Bonney,R.J., Walker,P.R. and Potter,V.R., (1973), Biochem.J., 136, 
947-954.
Brand,I. and Süling,H.D., (1974), J.Biol.Chem., 249, 7824-7831.
Brand,I. and Süling,H.D., (1975), FEBS Lett., 57, 163-168.
Brand,I., Muller,M.K., Unger,C. and S8ling,H.D., (1976), FEBS Lett.,
68, 271-274.
Brocks,D.G., Siess,E.A. and Wieland,0., (1980), Eur.J.Biochem.,
113, 39-43.
Brosnan , J.T., Krebs,H.A, and Williamson,D.H., (1970), Biochem.J.,
117, 91-96.
Brown,S.S., Forrest,J.A.H. and Roscoe,P., (1972), Lancet, 2, 898-900.
Buc,H.A., Demaugre,F. and Leroux,J-P., (1978), Biochem.Biophys. Res. 
Commun., 85, 774-779.
Buc,H.A., Demaugre,F., Moncion,A. and Leroux,J-P., (1981), Biochimie,
63, 595-605.
Bûcher,Th., Krejci,K., Rüssmann,W., Schnitger,H. and Wessemann W. ,
(1964), in "Rapid Mixing and Sampling Techniques in Biochemistry", 
(Chance,B., Eisenhardt,R.H., Gibson,Q.H. and Lonberg-Holm,K.K., 
eds.). Academic Press, New York.
Bûcher,Th., Brauser,B., Conze,A., Klein,F., Langguth,0. and Siess,H., 
(197%), Eur.J.Biochem., 27, 301-317.
Burch,H.B., Max,P.Jr., Chyu,K. and Lowry,O.H., (1969), Biochem.Biophys. 
Res. Commun., 34, 619-626.
Burch,H.B., Lowry,O.H., Meinhardt,L., Max,P.Jr. and Chyu,K.J., (1970), 
J.Biol.Chem., 245, 2092-2102.
Burke,V., (1971), in "Sugar: Chemical, Biological and Nutritional
Aspects of Sucrose", (Yudkin,J., Edelman,J. and Hough,L., eds,), 
pp 203-220, Butterworths, London.
Cahill,G.F.Jr., Ashmore,J., Earle,A.S. and Zottu,S., (1958a), Am.J. 
Physiol., 192, 491-496.
Cahill, G.F.Jr., Hastings, A.E,, Ashmore, J. and ZottR, S., (1953B), 
J.Biol.Chem., 230, 125-135.
Carbonell, J., Feliu, J.E., Marco, R., and Sols, A., (1973), Eur.J. 
Biochem., 37, 143-156.
- 220 -
Cardenas ,J.M. and Dyson,R.D., (1973), J.Biol.Chem., 248, 6938-6944. 
Carlson,C.W., Baxter,R.C., Ulm,E.F. and Pogell,B.M., (1973), J.Biol.
Chem., 248, 5555-5561.
Carminatti,H., Jim/nez De Asua, L., Recondo, E., Passeron,S. and 
Rozengurt, E ., (1968), J.Biol.Chem., 243, 3051-3056.
Castana, I.K., Nieto,A. and Feliu,D.E., (1979), J.Biol.Chem., 254, 
5575-5579.
Cederbaum,A.I. and Dicker,E., (1979), Arch.Biochem.Biophys., 197, 
415-423.
Cederbaum,A.I., Lieber,C.S., Beattie, D.S. and Rubin, E., (1973), Arch.
Biochem.Biophys., 158, 763-781.
Chan,T.M. and Exton,J.H., (1978), J.Biol.Chem., 253, 6393-6400. 
Chen,J.L.J., Babcock,D.F. and Lardy,H.A., (1978), Proc.Natl.Acad.
Sci., USA., 75, 2234-2238.
Cherrington,A.D., Assimacopoulos,F.D., Harper,S.C., Corbin,J.D.,
Park,C.R. and Exton,J.H., (1976), J.Biol.Chem., 251, 5209-5218. 
Clark,D.G., Rognstad,R. and Katz,J., (1973), Biochem.Biophys.Res.
Commun., 54, 1141-1148.
Clark,D.G., Filsell,O.H. and Topping,D.L., (1979), Biochem.J., 184, 
501-507.
Clark,M.G,, Bloxham,D.P., Holland,P.C. and Lardy,H.A., (1973),
Biochem.J., 134, 589-597.
Clark,M,G., Kneer,N.M., Bosch, A.Z. and Lardy, H.A., (1974), J.Biol.
Chem., 249, 5695-5703.
Claus,T.H. and Pilkis,S.J., (1976), Biochim. Biophys.Acta., 421,
246-262.
Claus, T.H., El-Maghrabi,M.R. and Pilkis, S.J., (1979), J.Biol.Chem.,
254, 7855-7864.
Claus,T.H., Schlumpf,J., Pilkis,J., Johnson, R.A. and Pilkis, S.J.,
(1980), Biochem.Biophys.Res.Commun., 98, 359-366.
Cohen,R.D. and lies,R.A., (1975), CRC Crit.Rev.Clin.Lab.Sci., 2» 101-143 
Cohen,R.D., lies,R.A., Barnett,D., Howell,M.E.O. and Strunira, J., (1971), 
Clin.Sci., 41_, 159-170.
Cook,G.A., Nielsen,R.C., Hawkins, R.A., Mehlman,M.A., Lakshmanan,M.R. 
and Veech,R.L., (1977), J.Biol.Chem., 252, 4421-4424.
- 221 -
CorijC.G., Garland,R.C. and Chang,H.W., (1973), Biochemistry,
22, 3126-3130.
Cori,G.T., Ochoa,S., Slein,M.W. and Cori,C.G., (1951), Biochim.
Bio*phys .Acta., 2» 304-317.
Craig,J.W., Rall,T.W. and Larner,J., (1969), Biochim.Biophys.Acta,
177, 213-219.
Crane,R.K., (1960). Physiological Review. 40, 789-825.
Crane,R.K., (1968), in "Handbook of the Physiology of the Alimentary
Canal" (Code C.F.,ed)., Am.Physiol.Soc., Washington, III, Section 
6,pp.1323-1352.
Crisp,D.M. and Pogson,C.I., (1972), Biochem.J., 126, 1009-1023.
Czok,R. and Lamprecht,W., (1974), in "Methods in Enzymatic Analysis", 
(Bergmeyer,H. ed.), vol.3, 1446-1451, Academic Press, New York.
Dahlqvist,A., (1974), in "Sugars in Nutrition", (Sipple,H.L. and 
McNutt,K.W., eds.), pp 187-214, Academic Press, New York.
Datta,A.G., Abrams,B., Sasaki,T. and Van den Berg,T.W., (1974),
Arch.Biochem.Biophys., 165, 641-645.
Dieter,H., Koberstein,R. and Sund,H., (1981), Eur.J.Biochem., 115, 
217-226.
Di Pietro,D.L and Weinhouse S., (1960), J.Biol.Chem., 235, 2542-2545.
Dudman,N.P.B., de Maine,M.M. and Benkovic,S.J., (1978), J.Biol.Chem.,
253, 5712-5718.
Dunaway,G.A.Jr. and Weber,G., (1974), Arch.Biochem.Biophys., 162,
620-628,
Edlund,B., Andersson,J., Titanji,V., Dahlqvist,U., Ekman,P., Zetterqvist, 
0. and Engstr8m,L., (1975), Biochem.Biphys.Res.Commun., 67, 
1516-1521,
Edmondson,J.W., Lumeng,L. and Li,T-K., (1977), Biochem.Biophys.Res.
Commun., T^, 751-757.
Edmondson,J.W., Lumeng,L. and Li,T~K., (1979), J.Biol.Chem., 254, 
1653-1658.
Eggleston,L.V. (1974) in "Methods in Enzymatic Analysis" (Bergmeyer,H., 
ed), vol.3, pp 1308-1313, Academic Press, New York.
Eggleston,L.V. and Woods,H.F., (1970), FEBS Lett., 2» 43-45.
- 222 -
Eigenbrodt,E. and Schoner,W., (1975), Hoppe-Seyler*s Z.Physiol.Chem., 
356, 227-228.
Eigenbrodt,E. and Schoner,W., (1977a), Hoppe-Seyler's Z.Physiol.Chem., 
358, 1047-1054.
Eigenbrodt,E. and Schoner,W., (1977b), Hoppe-Seyler's Z.Physiol.Chem., 
358, 1057-1067.
Ekman,P., Dahlqvist,U., Humble,E. and Engstrbm, L., (1976), Biochim.
Biophys.Acta, 429, 374-382.
Elion,G.B., Kovensky,A., Hitchings,G .H., Metz,E. and Rundles, R.W., 
(1966), Biochem.Pharmacol., 15, 863-889.
El-Maghrabi,M.R., Haston,S.H., Flockhart, D.A., Claus, T.H. and Pilkis, 
S.J., (1980), J.Biol.Chem., 255, 668-675.
Emmerson,B.T., (1974), Ann.Rheun.Dis., 33, 276-280.
'Engstrüm,L., (1978), Curr.Top.Cell.Reg., 13, 29-51.
Exton, J.H., (1979), Biochem. Pharmacol., 28.* 2237-2240.
Exton,J.H. and Harper,S.C. (1975), Adv.Cyclic.Nucleotide Res., 5, 
519-532.
Exton,J.H. and Park,C.R., (1966), Pharmacol.Rev., 18, 181-188.
Exton,J.H. and Park, C.R., (1967), J.Biol.Chem., 242, 2622-2636.
Exton,J.H. and Park,C.R., (1969), J.Biol.Chem., 244, 1424-1433.
Exton,J.H., Mallette,L.E., Jefferson,!.S., Wong,E.H.A., Friedman,N^, 
Miller,T.B.Jr, and Park,C.R., (1970), Recent Prog.Horm.Res.,
26, 411-461.
Exton,J.H., Lewis,S.S., Ho,R.J., Robison,G.A. and Park,C.R., (1971), 
Ann.N.Y.Acad.Sci., 185, 85-100.
Exton,J.H., Harper,S.C., Tucker,A.L. and Ho,R.J., (1973), Biochim.
Biophys.Acta., 329, 23-40.
Fain,J.N. and Shepherd,R.E., (1977), J.Biol.Chem., 252, 8066-8070. 
Faupel,R.P., Seitz,H.G. and Tarnowski, W., (1972), Arch.Biochem.
Biophys., 148, 509-522.
Felig,P., (1973), Metabolism, 22^ , 179-207.
Feliu,J.E., Hue,L. and Hers,H-G., (1976), Proc.Nat.Acad.Sci. USA,
23, 2762-2766.
Feliu,J.E., Hue,L. and Hers,H-G., (1977), Eur.J.Biochem., 81, 609-617. 
Flanders, L.E., Bamburg, J.R. and Sallach,H.J., (1971), Biochim.Biophys. 
Acta, 242, 566-579.
- 223 -
Forsander,0,A., RûihM,N., Salaspuro,M. and M#enpMM,P., (1965),
Biochem.J., 94, 259-265.
FBrster,H., (1974), in "Sugars in Nutrition" (Sipple H.L. and
McNutt K.W., eds.), pp 259-280, Academic press. New York.
Foster,J.L. and Blair,J.B., (1976), Fed.Proc., Fed.Am.Soc.Exp.Biol.,
35, 1428.
Foster,J.L. and Blair,J.B., (1978), Arch.Biochem.Biophys., 189,
263-276.
Frandsen,E.K. and Grunnet,N., (1971), Fur.J.Biochem., 23, 588-592.
Friedmann,G.,Goodman,E.H. and Weinhouse,S., (1965), J .Biol.Chem.,
240, 3729-3733.
Friedmann,B.,Goodman,E.H. and Weinhouse,S., (1970), Endocrinology,
86, 1264-1271.
Friedman,N., Miller,T.B.Jr. and Park,C.R., (1971), Rec.Prog.Horm.Res.,
26, 411-461.
Friedrichs,D., (1976), in "Use of Isolated Liver Cells and Kidney 
Tubules in Metabolic Studies", (Tager,T.M., Soling,H.D. and 
Williamson,J.R., eds.), pp 444-447, North-Holland Publishers, 
Amsterdam.
Froesch,E.R. and Jakob,A., (1974), in "Sugars in Nutrition", (Sipple,
H.L. and McNutt,K.W., eds.), pp 241-258, Academic Press, New York.
Furfine,C.S. and Velick,S.F., (1965), J.Biol.Chem., 240, 844-855.
Furuya, E. and Uyeda, K., (1980), Proc.Natl.Acad. Sci. USA, Tl_, 5861-5864,
Furuya,E. and Uyeda, K., (1981), J.Biol.Chem., 256, 7109-7112.
Gabrielli,F. and Baldi, S., (1972), Eur.J.Biochem. 21» 209-214.
Gale,M.M. and Crawford,M.A., (1969), Metabolism, 18, 1021-1023.
Garber,A.J., Karl, I.E. and Kipnis,D.M., (1976), J.Biol.Chem., 251, 
826-835.
Garrison,J.C. and Borland,M.K., (1978), J.Biol.Chen., 253, 7091-7100.
Garrison,J.C. and Haynes,R.C., (1973), J .Biol.Chem., 248, 5333-5343.
Garrison,J.C. and Haynes,R.C. Jr., (1975), J.Biol.Chem., 250, 2769-2777.
Gessner,P .K., Parke,D.V, and Williams,R.T., (1961), Biochem.J., 79, 
482-489.
Gibson,D.M., Davisson,E.O., Bachhawart, B.K., Ray,B.R. and Vestling,C.S., 
(1953), J.Biol.Chem., 203, 397-409.
- 224 -
GimpeljJ.A., de Haart,E.J. and Tager,J.M., (1973), Biochim.Biophys.
Acta.. 292, 582-591.
Gracey,M., Burke,V. and Oshin,A., (1972), Biochim.Biophys.Acta.,
266, 397-406.
Gracia,A., Williamson,J.R. and Cahill,G.F.Jr., (1964), Fed.Proc.,
Fed.Am.Soc.Exp.Biol., 520.
Grande,F., (1967), Am.J.Clin.Nutr., 20, 176-184.
Green,D.E., (1936), Biochem.J., 30, 629-644.
Greene,H.L., Taunton,0 .D., Stifel,F.B. and Herman,R.H., (1974), J.Clin.
Invest., 53, 44-51.
Gregory,R.B. and Ainsworth,S., (1981), Biochem.J., 195, 745-751.
GUnther,M.A., Sillero,A. and Sols,A., (1967), Enzymol.Biol.Clin.,
8, 341-352.
Gutmann,I. and Wahlefeld,A.W., (1974), in "Methods in Enzymatic Analysis" 
(Bergmeyer,H.U. ed.), vol.3, pp 1464-1468. Academic Press,
New York.
Guy,M.J. and Deren,J.J., (1971), Am.J.Physiol., 221, 1051-1056.
Hall,E.R., McCully,V. and Cottam,G.L., (1979), Arch.Biochem. Biophvs.
195, 315-324.
Harris, R.A., (1975), Arch.Biochem.Biophys ., 169, 168-180.
Haslam,J.M. and Krebs,H.A., (1968), Biochem.J., 107, 659-667.
Haynes,R.C.Jr., (1972) in "Energy Metabolism and the Regulation of
Metabolic Processes in Mitochondria" (Mehlman,M.A. and Hanson,R.W., 
eds.), pp 239-252, Academic Press, New York.
Heinz,F. and Junghdnel,J., (1969), Hoppe-Seyler's Z.Physiol.Chem.,
350, 859-866.
Heinz,F. and Lamprecht,W., (1967), Hoppe-Seyler's , Z.Physiol.Chem.,
348, 855-863.
Hems,R., Lund,P. and Krebs, H.A., (1975), Biochem.J., 150, 47-50.
Herman,R.H. (1974), in "Sugars in Nutrition" (Sipple^H.L. and McNutt^
K.W., eds.), pp 145-172, Academic Press, New York.
Hers,G.H., (1952a), Biochim.Biophys.Acta, 2» 416-423.
Hers, G.H., (1952b), Biochim.Biophys.Acta., 2» 424-430.
Hers,G.H., (1976), Ann.Rev.Biochem., 45, 167-189.
Hers, G.H. and Kusaka, T., (1953), Biochim.Biophys.Acta., 11, 427-437.
Hers, G.H., Berthert, J., Berthert, L. and de Duve, C ., (1951), Biochem.
Soc.Trans., 2, 1051-1055.
- 225 -
Hers,G.H., Stalmans,W,, de Wulf,H., Laloux,M. and Hue,L., (1973), in
"Regulation of Hepatic Metabolism" (Lundquist,F. and Tygstrup,N., 
eds.)» Alfred Benzon Symposium Vol.6, pp 237-253, Munksgaard, 
Copenhagen.
Hess,S., Haeckel,R. and Brand,K., (1966), Biochem.Biophys.Res.Commun., 
24, 824-831.
Hjelraquist,C., Anderson,J., Edlund,B. and Engstr8m,L., (1974),
Biochem.Biophys.Res. Commun., 61, 559-563.
Ho,L.Y. and Pace,N., (1958), Arch.Biochem.Biophys., 7_5, 125-128.
Hodgkinson,A., (1977), in "Oxalic Acid in Biology and Medicine", 
pp 179-192, Academic Press, New York.
Hofmann,E., (1976), Rev.Physiol.Biochem.Pharmacol., 75, 1-68.
Hohorst,H.J., Kreutz,F.H. and Bucher,Th., (1959), Biochem.Z.,
332, 18-46.
Hopkirk,T.J. and Bloxham,D.P., (1979), Biochem.J., 182, 383-397.
Hopper,S. and Segal,H.L., (1962), J.Biol.Chem., 237, 3189-3195.
Horecker,B.L., Mellon!,E. and Pontremoli,S., (1975), Adv.Enzymol., 
193-226.
Humble,E., (1980), Biochim.Biophys.Acta., 626, 179-187.
Humble,E., Berglund,L., Titanji,V., Ljungstr8m,0., Edlund, B.,
Zetterquist,0. and EngstrÜm,L., (1975), Biochem.Biophys.Res. 
Commun., 6^ , 614-621.
Hue,L., (1981), Personal Communication.
Hue, L. and Feliu,J.É., (1978), Biochem.Soc.Trans., 29-33.
Hue,L. and Hers,H.G., (1974), Biochem.Biophys.Res.Commun., 58, 540-548.
Ibsen»K., (1977), Cancer Research, 37, 341-351.
Ibsen, K. and Trippet,P., (1972), Biochemistry, 11, 4442-4450.
lies,R.A., Griffiths,J.R., Stevens, A.N., Gadian,O.G. and Porteous,R.,
(1980), Biochem.J., 192, 191-202.
Imamura, K. and Tanaka, T., (1972), J.Biochem. (Tokyo), 71, 1043-1051.
Imamura, K., Taniuchi, K. and Tanaka, T., (1972), J.Biochem.(Tokyo),
72, 1001-1015.
Irving,M.G. and Williams, J.F., (1973), Biochem.J., 131, 287-301.
Ishibashi, H. and Cottam, G.L., (1978), J .Biol.Chem., 253, 8767-8771.
Ishikawa,E., (1976), Adv.Enz.Reg., 1^, 117-136.
Ishikawa,E., Aikawa,T. and Matsutaka,H., (1972), J.Biochem.(Tokyo),
71, 1093-1095.
- 226 -
Jakob,A., (1976), Mol.Cell.Endorcrinol., 47-56.
Jakob,A., Williamson,J.R. and Asakura,T.,(1971), J.Biol.Chem., 246, 
7623-7531.
Jimenez De Asua,L., Rozengurt,E. and Carminatti,H., (1970), J.Biol.
Chem., 245, 3901-3905.
Jimenez De Asua,L., Rozengurt,E., Devalle,J.J. and Carminatti,H., (1971), 
Biochim.Biophys.Acta, 235, 326-334.
John,R.A., Chatteris,A. and Fowler,L.J. (1978), Biochem.J., 171,
771-779.
Jomain-Baum,M. and Schramm,V.L. (1978), J.Biol.Chem., 253, 3648-3659. 
Jomain-Baum,M., Schramm,V.L. and Hanson,R.W., (1976), J.Biol.Chem.,
251, 37-44.
Kageyama,N., (1971), Clin.Chim.Acta., 31, 421-425.
Kagimoto,T. and Uyeda,K., (1979), J.Biol.Chem., 254, 5584-4487. 
Kagimoto,T. and Uyeda, K., (1980), Arch.Biochem.Biophys., 203, 792-799. 
Kahn,A., Carreau,M.J. and Sprengers,E.D., (1978 ) Biochim.Biophys.
Acta, 523, 59-74.
Kato,K. and Bishop,J.S. (1972), J.Biol.Chem., 247, 7420-7429. 
Keech,D.B. and Utter,M.F., (1963), J.Biol.Chem., 238, 2609-2614. 
KekoraHki,M., Louhimo,I., Rahiala,E-L. and Suutarinen, T., (1972), Acta.
Clin.Scand., 138, 239-243.
Kemp,B.E. and Clark,M.G., (1978), J.Biol.Chem., 253, 5147-5154. 
Keppens,S., Van den Heede,J.R. and de Wulf, H., (1977), Biochim.Biophys 
Acta., 496, 448-457.
Kjerulf-Jensen, K., (1942), Acta.Physiol.Scand., 249-258. 
Klingenberg,M. and Bucher,T., (1960), Ann.Rev.Biochem., 669-710.
Kneer,N.M., Bosch,A.L., Clark,M.G. and Lardy, H.A., (1974), Proc.Natl.
Acad. Sci.USA, 7T[, 4523-4527.
Kneer,N.M., Wagner,M.J. and Lardy, H.A., (1979), J.Biol.Chem., 254, 
12160-12168.
Kohl,E.A. and Cottam,G.L., (1976), Arch.Biochem.Biophys., 176, 671-682 
Kohl,E.A. and Cottam,G.L., (1977), Biochim.Biophys.Acta., 484, 49-58.
- 227 -
Koshland,D.E., (1970), in "The Enzymes" (Boyer P.D.ed.), vol.l, 
pp 305-344, Academic Press, New York.
Koshland,D.E. and Neet,K.W., (1968), Ann.Rev.Biochem., 37, 359-410
Koster,J.F. and Hulsmann,W.C., (1970), Arch.Biochem.Biophys.,
141, 98-101.
Koster,J.F., Slee,R.G., Staal,G.E.J. and Van Berkel,T.J.C., (1972), 
Biochem.Biophys.Ac ta., 258, 763-768.
Krebs,H.A., (1968), Adv.Enz.Reg., 467-479.
Krebs,H.A. and Eggleston,L.V. (1965), Biochem.J., 94, 3c-7c.
Krebs,H.A. and Henseleit,K., (1932), Hoppe-Seyler*s Z.Physiol.Chem.
210, 33-66.
Krebs,H.A., Freedland,R.A., Hems,R.and Stubbs,M., (1969), Biochem.J.,
112, 117-124.
Krebs,H.A., Cornell,N.W., Lund,P. and Hems,P., (1974), in "Regulation
of Hepatic Metabolism" (Lundquist,F . and Tygstrup,N., eds.), vol.
726-753, Munksgaard, Copenhagen.
Kuo,J.F. and Greengard,P., (1969), J.Biol.Chem., 244, 3417-3419.
Kutzbach,C. and Hess,B., (1970), Hoppe-Seyler's Z ., Physiol.Chem.,
351, 272-273.
Kutzbach,C., Bischofberger, H., Hess,B. and Zimmermann-Telschow,H.,
(1973), Hoppe-Seyler’s Z.Physiol.Chem., 354, 1473-1489.
Kwan,C-Y. and Davis,R.C., (1981), Can.J.Biochem., 59, 92-99.
Lardy,H.A., Paetkau,V. and Walter,P., (1965), Proc.Natl.Acad.Sci.
USA, 22, 1410-1415.
Lawson,J.W.R., Guynn,R.W., Cornell,N. and Veech,R.L., (1976), in
"Gluconeogenesis: Its regulation in Mannalian Species" (Hanson,
R.W. and Mehlamn,M.A., eds.), pp 481-512, J.Wiley & Sons, New York,
Lea,M.A. and Weber,G., (1968), J.Biol.Chem., 243, 1096-1102.
LeCam,A. and Freychet,P., (1977), J.Biol.Chem., 252, 148-156.
Lehninger,A.L., (1951), J.Biol.Chem., 190, 334-337.
LeissingtN. and McGuinness,E.T. (1978), Biochim.Biophys.Acta., 524, 
254-261.
Leiter,A.B., Weinberg,M., Isohashi'F., Utter,M.F . and Linn, T.C., 
(1978), J.Biol.Chem., 253, 2716-2723.
- 228 -
LeuthartjF. and Wolf,H.P. (1954), Helv.Chim.Acta., 37, 1732.
Levin,B., Oberholzei; V.G., Snodgrass,G.J.A.I., Stimmler,L. and 
Wilmers,M.J. (1963), Arch.Pis.Chil., 38, 220-230.
Lieber,C.S.and De Carti,L.M., (1968), Science, 162, 917-918.
Lincoln,D.R., Black,J.A. and Rittenberg,M.B., (1975), Biochim.
Biophys.Acta., 410, 279-284.
Lindros,K.O., Vihma,R. and Forsander,O.A., (1972), Biochem.J., 126, 
945-952.
Ljungstrdm,0. and Ekman,P., (1977), Biochem.Biophys.Res.Commun..
78, 1147-1155.
Ljungstrdm,0., Hjelmquist,G. and Engstr8m,L., (1974), Biochim.Biophys.
Acta., 358, 289-298.
Ljungstr8m,0.,Berglund,L. and Engstr8m,L., (1976), Eur.J.Biochem.,
68, 497-506.
Llorente,P., Marco,R. and Sols,A., (1970), Eur.J.Biochem., 13, 45-54. 
Lloyd,M.H., lies,R.A., Simpson,B.R., Strunim,J.M., Layton,J.M. and 
Cohen,R.D., (1973), Clin.Sci.Mol.Med., 45, 543-549.
Lowenstein,L.M., Simone,R., Boulter,P. and Nathan,P., (1970), J.Am.
Med.Assoc., 213, 1899-1901.
Lundquist,F ., Damgaard,S.E. and Sestoft,L., (1974), in "Alcohol and 
Aldehyde Metabolising Systems" (Thurman,R.G. ed.), pp 405-416, 
Academic Press, New York.
Macdonald,!., (1971), in "Sugar: Chemical, Biological and Nutritional 
Aspects of Sucrose" (Yudkin,J., Edelman,J. and Hough,L., eds.),
pp 192-199, Butterworths, London. ---
Madison,L.L., Lochmer,A. and Wulff,J., (1967), Diabetes, 16, 252-258. 
MHenp^y,P.H., Raivio,K.O. and Kekomaki,M.P., (1968), Science, 161, 
1253-1254.
Mahmoud,S.A.F. (1979), Ph.D. Thesis, London University.
Mallette,L.E., Exton,J.H. and Park,C.R., (1969a), J.Biol.Chem., 244, 
5713-5723.
Mallette,L.E., Exton,J.H. and Park,C.R., (1969b), J.Biol.Chem., 244, 
5724-5728.
Mansour, T.E., (1972), Curr.Top.Cell.Reg., 5^, 1-46.
Marie,J., Kahn,A. and Boivin,P., (1976), Biochim.Biophys.Acta., 43^ 
393-406.
- 229 -
Massey,V., Komai,H., Palmer,G. and Elion,G., (1970a), J.Biol.Chem.,
245, 2837-2844.
Massey,V., Komai,H., Palmer,G. and Elion,G., (1970b), Vit.Horm.,
505-531.
McClurke,W.R. and Lardy,H.A., (1971), J.Biol.Chem., 246, 3591-3596.
Mendeloff,A.I. and Weichselbaum,T.E., (1953), Metab., Clin.Exp.,
I, 450-458.
Mendicino,J. and Vasarhely,F. (1963), J.Biol.Chem., 238, 3528-3534.
Mendicino,J., Leibach,F. and Reddy,S., (1978), Biochemistry, 17,
4662-4669.
Michal,G. and Beutler,H.O., (1974), in ''Methods in Enzymatic Analysis"
(Bergmeyer,H., ed.), vol.3, pp 1314-1319, Academic Press, New York,
Michal,G. and Lang,F., (1974), in "Methods in Enzymatic Analysis"
(Bergmeyer,H., ed.), vol.3, pp 1417-1418, Academic Press, New York,
Miller,T.B.Jr., (1978), Biochim.Biophys.Acta, 540, 151-161.
Monod,J., Wyman,J. and Changeux,J.P., (1965), J.Mol.Biol., 12, 88-118.
Muirhead,H., Grant,J.P., Lawton,M.A., Midwinter,C.A., Nocton,J.C. and 
Stuart,D.I., (1981), Biochem. Soc .Trans ., 9_y 212-213.
Naismith,D.J. (1971), in "Sugar: Chemical, Biological and Nutritional 
Aspects of Sucrose" (Yudkin,J., Edelman,J. and Hough,L., eds.), 
pp 183-191, Butterworths, London.
Nakashima,K., (1974), Clin.Chim.Acta, 55, 245-254.
Newsholme,E.A., (1978), Biochem.Soc.Symp., 183-205.
Newsholme,E.A. and Crabtree,B., (1976), Biochem.Soc. Symp., 41, 61-109.
Newsholme,E.A. and Start,C., (1976), in "Regulation in Metabolism",
A.Wiley-Interscience Publication.
Niemeyer,R., Ureta,T. and Clar-Turn,L., (1975), Mol.Cell.Biochem.,
6, 100-126.
Nifhaolain,!. and Coughlan,M.P., (1978), FEBS Lett., 90, 305-308.
Nikiforuk,G. and Colowick,S.P., (1956), J.Biol.Chem., 219, 119-129.
NikkilH, E.A., (1969), Adv.Lipid .Res ., 1^, 63-134.
NikkilM,E.A., (1974), in "Sugars in Nutrition", (Sipple, H.L. and 
McNutt,K,W., eds.), pp 439-448, Academic Press, New York.
Nimmo,H.G. and Tipton,K.F., (1975), Biochem.J., 145, 323-334.
Nordlie,R.C. and Lardy,H.A., (1963), J.Biol.Chem., 238, 2259-2263.
Nyfeler,F., Easel,P. and Walter,P., (1981), Biochem.Biophys.Acta., 675, 
17-23.
- 230 -
OttOjK., (1965), Hoppe-Seyler* s Z.Physiol.Chem., 341, 99-104.
Otto,M., JacobaschjG. and Rapoport,S., (1976), Eur.J.Biochem.,
201-206.
Pande,S.V. and Mead,J.P., (1968), J.Biol.Chem., 243, 6180-6185.
Papenberg,J., Von Wartburg, J.P. and Aebi,N., (1970), Enz.Biol.Clin.,
U, 237-250.
Pardridge, W.M. and Oldendorf, W.J. (1977), J.Neurochem., 28, 5-12.
Parks, R.E.Jr., Ben-Gershom, E. and Lardy, H.A., (1957), J.Biol.Chem.,
227, 231-242.
Passeron,S., Jimenez Da Asua,L. and Carminatti,H., (1967), Biochem.
Biophys.Res.Commun., 27, 33-38.
Pawan,G.L.S., (1968), Nature (London), 220, 374-376.
Penhoet,E., Rajkumar,T. and Rutter,W.J., (1966), Proc.Natl.Acad.Sci.
USA., 1275-1282.
Perheentupa, J. and Raivio,K., (1967), Lancet, 2^, 528-531.
Periera,J.N. and Jangaard,N.O., (1971), Metabolism, 20, 392-400. 
Pilkis,S.J., (1970), Biochim.Biophys.Acta, 215, 461-476.
Pilkis,S.J., Claus,T.H., Johnson,R.A. and Park,C.R., (1975), J .Biol.
Chem., 250, 6328-6336.
PilkiSjS.J., Riou,J.P. and Claus,T.H., (1976a), J.Biol.Chem., 251, 
7841-7852.
Pilkis,S.J., Claus,T.H., Riou,J.P. and Park,C.R., (1976b), Metab.
Clin.Expt., 25, Supplement 1, 1341-1355.
PiIkis,S.J., Park,C.R. and Claus,T.H., (1978a), Vit.Horm., 36, 383-460.
Pilkis,S.J., Pilkis,J. and Claus,T.H., (1978b), Biochem.Biophys.Res.
Commun., 81, 139-146.
PilkiSjS.J., Claus,T.H., Riou,J.P., Cherrington,A.D., Chaisson,J.E., 
Liljenquist,J.E., Lacy,W.W. and Park,C.R., (1978c), FEBS Symp. , 
13-29.
PilkiSjS.J., El-Maghrabi,M.R., Coven,B., Claus,T.H., Tager,H.S., Steiner, 
D.F., Kein,P.S. and Heinrikson,R.L., (1980), J.Biol.Chem., 255, 
2770-2775.
Pilkis,S.J., El-Maghrabi,M.R., Pilkis,J., Claus, T.H. and Cumming,D.A. ,
(1981), J.Biol.Chem., 256, 3171-3174.
Pitot,H.C. and Yatvin,M.B. (1973), Physiol.Rev., 53, 228-328.
Pogell,B.M., Tanaka,A. and Siddons, R.C., (1968), J .Biol.Chem., 243,
1356-1367.
- 231 -
Pozefsky»T. and Tancredi,R.G., (1972), J.Clin.Invest., 51, 2359-2369. 
Purich»D.L., Fromm,H.J. and Rudolf,F.B., (1973), Adv.Enzymol., 39, 
249-326.
Raivio,K.O., KekomSki,M.P. and MMenpMM,P.H., (1968), Biochem.
Pharmacol., 18, 2615-2624.
Raivio,K.O., Becker,M.A., Meyer,L.J., Greene,M.L., Nuki,G. and 
Seegmiller ,J.E., (1975), Metabolism, 24, 861-869.
Ramaiah,A., (1974), Curr.Top.Cell.Reg., 297-350.
Raushel, F.M. and Cleland,W.W., (1977), Biochemistry, 16, 2169-2175. 
Reinecke,R.M. (1944), Am.J.Physiol., 141, 669-676.
RenoldjA.E., Hastings,A.B. and Nesbett,F.B., (1954), J.Biol.Chem.,
209, 687-691.
Richards,C.F. and Uyeda,K., (1980), Biochem.Biophys.Res.Commun., 97, 
1535-1540
Riou,J.P., Claus,T.H. and Pilkis,S.J., (1976), Biochem.Biophys.Res.
Commun ., 73, 591-599.
Riou,J.P., Claus,T.H., Flockhart ,D., Corbin,J. and Pilkis,S.J., (1977), 
Proc.Nat 1.Acad.Sci.USA, 74, 4615-4619.
Riou,J.P., Claus,T.H. and Pilkis,S.J., (1978), J.Biol.Chem., 253, 656-659 
Robinson,J. and Newsholme,E.A., (1969), Biochem.J., 112, 455-464.
Robison, G.A., Butcher,R.W. and Sutherland,E.W., (1971), in "Cyclic 
AMP", Academic Press, New York.
Rofe,A.M., Thomas,D.W., Edwards,R.G. and Edwards,J.B., (1977),
Biochem.Med., 18, 440-451.
Rognstad,R. and Clark,D.G., (1974), Arch.Biochem.Biophys., 161, 638-646. 
Rognstad,R. and Katz,J., (1972), J.Biol.Chem., 247, 6047-6054.
Rognstad,R. and Katz,J., (1976), Arch.Biochem.Biophys., 117, 337-345. 
Rosenberg,J.S., Tishima,Y. and Horecker,B.L., (1973), Arch.Biochem.
Biophys., 154, 283-293.
Ross,B.D., Hems,R. and Krebs,H.A., (1967a), Biochem.J., 102, 942-951. 
Ross,B.D., Heras,R. and Krebs,H.A., (1967b), Biochem.J., 105, 869-875. 
Rozengurt,E., Jimenez De Asua,L. and Carminatti»H., (1969),J.Biol.
Chem., 244, 3142-3147.
Rozengurt,E., Jimenez De Asua,L. and Carminatti»H., (1970), FEBS 
Lett. , JM, 284-286.
Rozengurt,E., Jimenez De Asua,L. and Carminatti»H., (1973), FEBS 
Lett., 37, 225-227.
- 232 -
Ruderman,N.B. and Berger,M., (1974), J.Biol.Chem., 249, 5500-5506. 
Ruderman,N.B. and Lund,P., (1972), Isr.J.Med.Sci., 295-302.
Rufo ,G.A.Jr., Yorek,M.A. and Ray,R.D., (1981), Biochim.Biophys.
Acta., 674, 297-305.
Sainsbury,G.M., (1980), Biochim.Biophys.Acta., 631, 305-316.
Salas,M., Vinela,E. and Sols,A., (1963), J.Biol.Chem., 238, 3535-3538. 
Sanchez,J.J., Gonzolez,N.S. and Pontis,H.G., (1971), Biochim.
Biophys.Acta., 227, 67-68.
Scheibe,P., Bert,E. and Bergmeyer,H.U., (1974) in "Methods in
Enzymatic Analysis" (Bergmeyer,H.U., ed.), vol.4, pp 1951-1957, 
Academic Press, New York.
Schimassek,H. and Mitzkat,H.J., (1963), Biochem.Z., 337, 510-518. 
Scholz,R. and Nohl,H., (1976), Eur .J.Biochem., 63^ , 449-458.
Schoner,W., Haag,U. and Seubert,W., (1970), Hoppe-Seyler*s Z.Physiol.
Chem., 351, 1071-1088.
Scrutton,M. C . and Utter,M.P., (1968), Ann .Rev. Biochem., 37_, 249-302. 
Scrutton,M.C. and White,M.D., (1974), J.Biol.Chem., 249, 5405-5415. 
Seglen,P.O., (1974), Biochim.Biophys.Acta., 338, 317-336.
Sestoft,L., (1974), Biochim.Biophys.Acta., 343, 1-16.
Sestoft,L. and Fleron,P., (1974), Biochim.Biophys.Acta., 345, 27-38. 
Sestoft,L., T^nnesen,K., Hansen,F.V. and Damgarrd,S.E., (1972), Eur.
J.Biochem., 30, 542-552.
Seubert,W. and Schoner,W., (1971), Curr.Top.Cell.Reg., 3^, 237-267. 
Seubert,W., Henning,H.V., Schoner,W. and L'ag«,M., (1968), Adv.
Enz.Reg., 153-187.
Sharraa,C., Manjeshwar,R. and Weinhouse,S ., (1963), J.Biol.Chem.,
238, 3840-3845.
Sherline,P., Lynch,A. and Glinsmann,W.H., (1972), Endocrinology, 91, 
680-690.
Siess,E.A. and Wieland,0.H., (1972), Eur.J.Biochem., 26, 96-105. 
Siess,E.A., Brocks,D.G., Lattke»H.K. and Wieland,O.H., (1977), Biochem, 
J_., 166, 225-235.
Sigrist-Nelson,K. and Hopfer,U., (1974), Biochim.Biophys.Acta.,
364, 247-254.
Sillero,M.A.G., Sillero,A. and Sols,A., (1969), Eur.J.Biochem., 10, 
345-351.
- 233 -
Simkin,P.A., (1972), Metab.Clin.Exp., 21, 1029-1036.
SipSjH.J., Van Amelsuoort,J.M.M. and Van Dam, K., (1980a), Eur.J. 
Biochem., 105, 217-224.
Sips,H.J., Groen,A.K. and Tager,J.M., (1980b), FEBS Lett., 119, 217-274
Smith,C.M., Ravamo,L.M., KekomMki,M.P. and Raivio,K.O., (1977a),
Can. J .Biochem. , 1134-1139.
Smith,C.M., Ravarao,L.M. and Raivio,K.O., (1977b), Can.J.Biochem., 55, 
1237-1240.
Smith,M.G., (1962), Biochem.J., 135-144.
Smith,S.B. and Freedland,R.A., (1979), J.Biol.Chem., 254, 10644-10648.
Smith,S.B. and Freedland,R.A., (1981), Am.J.Physiol., 240, 279-285.
Snell,K., (1976), Biochem.Soc.Trans., 287-288.
Snell,K., (1979), TIBS, 4, 124-128.
Snell,K. and Duff,D.A., (1977), Biochem.J., 162, 399-403.
Sobell,S., Scholz,R., Freisl,M., Fibers,R. and Heldt,H.W., (1976),
in "Use of Isolated Liver Cells and Kidney Tubules in Metabolic 
Studies" (Tager, J.M., Süling,H.D. and Williamson,J.R., eds.), 
pp 22-40, North-Holland Publishing Company, Amsterdam .
Sokoloff,L., Fitzgerald,G.G. and Kaufman,E.E., (1977), in "Nutrition 
and the Brain", (Wurtman,P.J. and Wurtman, J .J ., eds.), vol.l, 
pp 87-139, Raven, New York.
S8ling,H.D. and Kleineke, J., (1976), in "Gluconeogenesis? Its
Regulation in Mammalian Species", (Hanson, R.W. and Mehlman,M.A., 
eds.),pp 369-462, J.Wiley & Sons, New York.
Süling,H.D., Williams,B. and Janson,G., (1970), FEBS Lett., 11, 324-327
Sdling, H.D., Kuduz,J. and Brand,I.A., (1981), FEBS Lett., 130, 309-313.
Sols, A. and Marco,R., (1970), Curr.Top.Cell.Reg., 227-273.
Soterakis,J. and Iber, F.L., (1975), Am.J.Clin.Nutr., 28, 254-257.
Spector, T. and Johns, D.G., (1970), J.Biol.Chem., 254, 5079-5085.
Spiro, R., (1959), J.Biol.Chem., 233, 546-550.
Spiro, R., Ashmore,J. and Hastings, A.B., (1958), J.Biol.Chem., 230, 
761-771.
Stadraan, E.R. (1966), Adv.Enzymol., 28, 41-154.
Stalmans,W. , (1976), Curr.Top.Cell.Reg., 11, 51-97.
Stalmans, W. and Hers,H.G., (1975), Eur.J.Biochem., 54, 341-350.
Stifel,F.B., Taunton,O.D., Greene, H.L. and Herman, R.H., (1974), 
J.Biol.Chem., 249, 7240-7244.
— 234 —
Stripe,F., Della Corte,F., Bonetti,E., Abbondanza,A., Abbati,A.
and De Stefano,F., (1970), Lancet, 1310-1311.
Struck,E., Ashmore,J., Wieland,0., (1965), Biochem.Z., 343, 107-110. 
Stubbs,M., Kirk,C.J. and Hems,D.A., (1976), FEBS Lett., 199-202. 
Susor,W.A. and Rutter,W.J., (1968), Biochem.Biophys.Res.Commun.,
30, 14-20.
Sutherland,E.W., (1972), Science, 177, 401-408.
Taketa,K. and Pogell,B.M., (1963), Biochem.Biophys.Res.Commun.,
U, 229-235.
Taketa,K. and Pogell,B.M., (1965), J.Biol.Chem., 240, 651-662.
Tanaka,T., Harano,Y., Morimura,H. and Mori,R., (1965), Biochem.
Biophys.Res.Commun., 2^* 55-60.
Tanaka,T., Sue,F. and Morimura,H., (1967a), Biochem.Biophys.Res.
Commun., 29, 444-449.
Tanaka,T., Harano,Y., Sue,F. and Morimura,H., (1967b), J .Biochem.
(Tokyo), 71-91.
Taunton,O.D.,Stifel,F.B., Greene,H.L. and Herman,R.H., (1972), Biochem.
Biophys.Res.Commun., 1663-1676.
Taunton,O.D., Stifel,F.B., Greene,H. and Herman,R.H., (1974), J.Biol.
Chem., 249, 7228-7239.
Taylor,C.B. and Bailey,E., (1967), Biochem.J., 102, 32c-33c.
Tejwani,G .A., Pedrosa,F .0., Pentrenoli,S. and Horecker,B.L., (1976), 
Arch.Biochem.Biophys., 177, 253-264.
Thieden,H.I.D. and Lundquist,F., (1967), Biochem.J., 102, 177-180. 
Thieden,H.I.D., Grunnet,N., Damgaard,S.E. and Sestoft,L., (1972),
Eur.J.Biochem., 30, 250-261.
Thurston,J.H., Jones,E.M. and Hauhart,R.E., (1974), Diabetes, 23, 
597-604.
Tilghman,S.M., (1976), in "Gluconeogenesis: Its Regulation in Mammalian 
Species" (Hanson,R.W. and Mehlman,M.A.,eds.), pp 47-91, Academic 
Press, New York.
Tischler,M.E., Friedrichs,D., Coll,K. and Williamson, J.R., (1977),
Arch.Biochem.Biophys., 184, 222-236.
Titanji,V.P.K., (1977), Biochim.Biophys.Acta., 481, 140-151.
Titanji,V.P.K., Zetterqvist, 0. and Engstr8m,L., (1976), Biochim.
Biophys.Acta., 422, 98-108.
- 235 -
Titheradge,M.A. and Coore,H.G., (1976a), FEBS Lett., 63, 45-50.
Titheradge,M.A. and Coore,H.G., (1976b), FEBS Lett., 71, 73-78.
Tolbert,M.E.M. and Fain,J.N., (1974), J.Biol.Chem., 249, 1162-1166.
Tolbert,M.E.M., Butcher,F.R. and Fain,J.N., (1973), J.Biol.Chem.,
248, 5686-5692.
Topping,D.L. and Mayes,P.A., (1971), Nutr.Metab., 13, 331-338.
Topping,D.L. and Mayes,P.A., (1977), Biochem.Soc. Trans., _5, 1001-1002,
Tygstrup,N., Winkler,K. and Lundquist,F., (1965), J.Clin.Invest., 
817-830.
Ui M . , Claus,T.H., Exton,J.H. and Park,C.R., (1973a), J.Biol.Chem.,
248, 5344-5349.
Ui,M., Exton,J.H. and Park,C.R., (1973b), J.Biol.Chem., 348, 5350-5359,
Underwood,A.H. and Newsholme,E.A.,(1965), Biochem.J., 95, 767-774.
Utter,M.F. and Keech,D.B. (1960), J.Biol.Chem., 235, PC17-PC18.
Utter,M.F. and Keech,D.B. (L963), J.Biol.Chem., 238, 2603-2608.
Uyeda,K., (1979), Adv.Enzymol., 48, 193-244.
Uyeda,K., Furuya,E. and Luby,L.J., (1981a), J.Biol.Chem., 256, 
8394-8399.
Uyeda,K., Furuya,E. and Dean Sherry,A., (1981b), J.Biol.Chem., 256, 
8679-8684.
Van Amelsvoort,J.M.M., Sips,H.J. and Van Dam, K. , (1978), Biochem.J., 
174, 1083-1086.
Van Amelsvoort,J.M.M., Sips,H.J., Apitule,M.E.A. and Van Dam, K.,
(1980), Biochim.Biophys.Acta., 600, 950-960.
Van Berkel,T.J.C., Koster,J.F. and Hulsraann,W.C., (1972), Biochim.___
Biophys.Acta., 276, 425-429.
Van Berkel,T.J.C., Koster,J.F., Kruijt,J.K. and Hulsmann, W.C.,
(1974), Biochim.Biophys.Acta., 370, 450-458.
Van Berkel,T.J.C., Kruijt,J.K. and Koster,J.F., (1975), FEBS Lett.,
52, 312-316.
Van Berkel,T.J.C., Kruijt,J.K., Koster,J.F. and Hulsmann,W.C., (1976), 
Biochem. Biophys .Res .Commun., 7_2, 917-925.
Van Berkel,T.J.C., Kruijt,J.K. and Koster,J.F., (1977a), Eur.J.
Biochem., 81, 423-432.
Van Berkel,T.J.C., Kruijt,J. and Koster,J.F., (1977b), Biochim.Biophys 
Acta., 500, 267-276.
- 236 -
Van Berkel, T.J.C., Kruijt,J., Van den Berg,G.B. and Koster,J.F.,
(1978), Eur.J.Biochem., 9^, 553-561.
Van den Berghe,G., (1978), Curr.Top.Cell.Reg., 13, 97-135.
Van den Berghe,G., Hue,L. and Hers,H.G., (1973), Biochem.J.,
134, 637-645.
Van den Berghe,G.,Bronfman,M., Vannesle,R. and Hers,H.G., (1977a),
Biochem.J., 162, 601-609.
Van den Berghe,G., Van Pottelsberghe,C. and Hers,H.G., (1977b)
Biochem. J ., 162, 611-616.
Van den Berghe,G., Bontemps,F. and Hers,H.G., (1980), Biochem.J.,
188, 913-920.
Van de Werve,G. and Hers,H.G., (1979), Biochem.J., 178, 119-126.
Van de Werve,G., Hue,L. and Hers,H.G., (1977), Biochem.J., 162,
135-142.
Van Schaftingen,E. and Hers,H.G., (1980), Biochem.Biophys.Res.
Commun., 96 , 1524-1531.
Van Schaftingen,E. and Hers,H.G., (1981a), Proc.Natl.Acad.Sci.USA,
7^, 2861-2863.
Van Schaftingen,E. and Hers,H.G., (1981b), Biochem.Biophys.Res.
Commun., 101, 1078-1084.
Van Schaftingen,E., Hue,L. and Hers,H.G., (1980a), Biochem.J., 192, 263-261,
Van Schaftingen,E., Hue,L. and Hers,H.G. (1980b), Biochem.J., 192, 887-895.
Van Schaftingen,E,, Hue,L. and Hers,H.G., (1980c), Biochem.J.,192, 897-901.
Van Schaftingen,E., Davies, D.R. and Hers, H-G., (1981a),Biochem.Biophys.
Res.Commun., 103, 362-368.
Van Schaftingen,E., Jett,M-F., Hue,L. and Hers,H.G., (1981b), Proc.Natl.
Acad.Sci.,USA, 7^, 3483-3486.
Van Veelen,C.W.M., Rijksen,G., Vlug,A.M.C. and Staal,G.E.J., (1981),
Clinica.Chimica Acta, 110, 113-120.
Veloso,D., Guynn,R.W., Oskarsson,M. and Veech,R.L., (1973), J.Biol.
Chem., 248, 4811-4819.
Veneziale,C.M., (1971), Biochemistry, 10, 3443-3447.
Veneziale,C.M., (1972a), Biochemistry, 11, 3286-3289.
Veneziale,C.M., (1972b), Eur.J.Biochem., 31, 59-62.
Veneziale,C.M. (1976), in "Gluconeogenesis: Its Regulation in Mammalian
Species" (Hanson,R.W. and Mehlman,M.A., eds.), pp 463-480, Academic 
Press, New York.
- 237 -
Veneziale ,C.M. and Lohmar,P.H., (1973), J.Biol.Chem., 248, 7786-7791.
Vernon,R.G., Eaton,S.W. and Walker,D.G., (1968), Biochem.J., 110, 
725-731.
Vessal,M,, Choun,M.O., Bissel,M.J. and Bissell,D.M., (1980),
Biochim. Biophys.Acta, 633, 201-210.
Videla,L. and Irael,Y., (1970), Biochem.J., 118, 275-281.
Vinuela,E., Salas,M., Sols,A., (1963), J.Biol.Chem., 238, PC1175-PC1177
Vogels,G.D. and Van den Drift,C., (1970), Analytical Biochemistry,
33, 143-157.
Wagle,S.R. and Ingebreston,W.R.Jr., (1975), Methods in Enzymology,
XXXV, 579-607.
Walker,D.G., (1963), Biochim.Biophys.Acta, 77, 209-226.
Walker,D.G. and Rao,S., (1964), Biochem.J., 90^ , 360-368.
Walker,P.R. and Potter,R., (1973), J .Biol.Chem., 248, 4610-4616.
Walli,A.K., Birkmann,L. and Schimassek,H., (1975), Biochem.Soc.Trans., 
3_, 1037-1042.
Walli,R.A., (1978), Biochim.Biophys.Acta, 539, 62-80.
Walsh,D.A. and Chen,L-J., (1971), Biochem.Biophys.Res.Commun.,
669-675.
Walsh,D.A., Ashley,C.D., Gonzalez,C., Calkins,D., Fisher,E.H. and 
Krebs,E.G., (1971), J.Biol.Chem., 246, 1977-1985.
Walter,P., (1976), in "Gluconeogenesis: Its Regulation in Mammalian 
Species" (Hanson,R.W. and Mehlman,M.A., eds.), pp 239-265,
J.Wiley & Sons, New York.
Weber,G., Singhal,R.L. and Srivastava,S.K., (1965a), Adv.Enz.Reg.,
3, 43-75.
Weber,G., Stamm,N.B. and Fisher,E.A., (1965b), Science, 149, 65-67.
Weber,G., Lea,M.A., Convery,H.J.H. and Stamm,N.B., (1968a), Adv. 
Enz.Reg., 257-298.
Weber,G., Lea,M.A. and Stamm,N.B., (1968b), Adv.Enz.Reg., i6, 101-123.
Weinhouse,S., (1976), Curr.Top.Cell.Reg., 11, 1-45.
Widdas,W.F., (1971), in "Sugar : Chemical, Biological and Nutritional 
Aspects of Sucrose" (Yudkin,J., Edelman,J. and Hough,L., eds.), 
pp 155-171, Butterworths, London.
Williams,J.F., Layde,M.M. and Utter,M.F., (1969), Proc.Aust.Biochem.
Soc., 2, 68-79.
- 238 -
Williams,T.F., Exton,J.H., Park,C.R. and Regen,D.M., (1968), Am.J . 
Physiol., 215, 1200-1209.
Williamson,D.H., (1974), in "Methods in Enzymatic Analysis",
(Bergmeyer,H.U., ed.), vol.4, pp 1679-1685, Academic Press,
New York.
Williamson,D.H. and Brosnan,J.T., (1974), in "Methods in Enzymatic 
Analysis" (Bergmeyer,H.U. ed.), vol.4, 2266-2302, Academic 
Press, New York.
H*
Williamson,D.H., Lund,P. and Krebs^A., (1976a), Biochem.J., 103, 
514-527.
Williamson,D.H., Lopes-Vieira,0. and Walker,B., (1967b), Biochem.J., 
104, 497-502.
Williamson,J.R., Wright,P.H., Malaisse, W. J. and Ashmore,J., (1966a), 
Biochem.Biophys.Res.Commun., 2^, 765-770.
Williamson,J.R., Browning,E.T. and Olson,M.S., (1968), Adv.Enz.
Reg., 67-100.
Williamson,J.R., Jakob,A. and Refine,C., (1971), J.Biol.Chem.,
246, 7632-7641.
Wilson,J.E., (1980), Curr.Top.Cell.Reg.,_L6, 2-53.
Wolfe,B.M., Ahuja, S.P. and Mar1iss, E .B ., (1975), J.Clin.Invest.,
56, 970-977.
Wood,C.L., Babcock,C.J. and Blum,J.J., (1981), Arch.Biochem.Biophys., 
212, 43-53.
Woods, H-F. and Krebs,H.A., (1973), Biochem.J., 132, 55-60.
Woods,H-F., Eggleston, L.V. and Krebs, H.A., (1970), Biochem.J., 119, 
501-510.
Yip, B.P. and Lardy, H.A., (1981), Arch.Biochem.Biophys., 212, 370-377
Ylikahri,R.H., Kdhbnen^M.T. and Hassinen,I., (1972), Acta.Med.Scand. 
Suppl,, 542, 141-150.
YorekpM.A., Rufo^G.A.Jr. and Ray,R.D., (1980), Biochim.Biophys.Acta, 
632, 517-526.
Yorek,M.A., Rufo,G.A.Jr., Blair,J.B. and Ray,R.D., (1981), Biochim. 
Biophys.Acta, 675, 309-315.
Yudkin,J., (1971), in "Sugar:Chemical, Biological and Nutritional
Aspects of Sucrose", (Yudkin,J., Edelman,J. and Hough,L., eds.), 
pp 231-242, Butterworths, London.
Zakin,D., Pardini,R.S., Herman,R.H. and Sauberlich,H.E., (1967), 
Biochim.Biophys.Acta, 144, 242-251.
— 239 —
Zahner,J., Loy,E., MUllhofer,G. and Bûcher,T., (1973), Eur.J.
Biochem., 34, 248-255.
Zuurendonk,P.F., Akerboora,!.B.F. and Jager,J.M., (1976), in "Use of 
Isolated Liver Cells and Kidney Tubules in Metabolic Studies", 
(Tager,J.M., S81ing,H.D. and Williamson,J.R., eds.), pp 17-27, 
North-Holland Publishing Company, Amsterdam.
